¥Íª«®ñ¤ÆÀøªk
§Ç 2
ºü¨¥ 2
¦ó¿×¥Íª«®ñ¤ÆÀøªk¡H 3
¨Åé¦ó¥H¯Ê®ñ¡H 4
ªÅ®ð¦Ã¬V 4
¹ª«¾i¥÷³à¥¢ 4
¤£¨}©I§l²ßºD 4
®ñ¤Æ§@¥Î 4
®ñ¤Æ§@¥Î»P´åÂ÷½èªº²£¥Í 4
§Ü®ñ¤Æª« 5
Àç¾i§Ü®ñ¤Æª« 5
¥Íª«®ñ¤ÆÀøªk 5
¤ß¦åºÞ¯e¯f 13
°Ê¯ßµw¤Æ 13
¤ßŦ¯Ê·l(¤ß¤º½¤ª¢·P¬V¤Þ°_) 14
¦åÁx©T¾J¹L¦h¯g 14
¯Ê®ñ 14
¤j¸£¦åºÞ³h¦å 15
Àù ¯g 16
¤G®ñ¤Æ²B¬ã¨s 16
¯ä®ñ¬ã¨s 17
¥Ø«eªºÀøªk 17
HIV»PAIDS 19
I´º 19
¸ÕºÞ¬ã¨s 20
Á{§É¸gÅç 21
·R´þ¯f©M¥Íª«®ñ¤ÆÀøªkªº¬Fªv°ÝÃD 22
¥Íª«®ñ¤ÆÀøªkªº¨ä¥L¥Î³~ 23
¹L±Ó 23
¤îµh 23
Ãö¸`°h¤Æ 23
¤ä®ðºÞ©Ê®ð³Ý 23
¿N¶Ë 23
©À¯]µß 23
¿}§¿¯f 24
¤Q¤G«ü¸z¼ìºÅ 24
²´¯e 24
G¸zª¢ 24
±ù§ÎÃ@¤ò¦ä¯f 24
°ü¤k¶Ç¬V¯f 25
¨xª¢ 25
¬y¦æ·P«_ 25
¤fµÄ¯e¯f 25
¯«¸g©Ê¥Öª¢ 25
¼W¥Í©ÊÃö¸`ª¢(¦ñ¦³°©¨ë) 26
°©½è²¨ÃP¯g 26
Ãþ·Àã©ÊÃö¸`ª¢ 26
¦Ñ¦~è§b 26
±Ñ¦å¯f 26
ÅIª¬¦å²y³h¦å 26
ª¿¤Æª«¤Þ°_§K¬Ì¥\¯à¥¢½Õ¯gª¬ 26
¥Ö½§¯f 26
»´ä¸} 27
³æ¯Âªw¯l 27
±aª¬ªw¯l 27
¬Ð 27
³D«r 27
ÀR¯ß¦±±i¼ìºÅ 27
Àø¶Ë 27
§Ç
¥»®Ñ©Ò´£¨Ñªº¥Íª«®ñ¤ÆÀøªk¤Jªù«ü¤Þ±N«P¶i¥@¤HÁA¸Ñ¯ä®ñ©M¤G®ñ¤Æ²B
ªºÂåÀø®Ä¯q¡C®Ñ¤¤¤j³¡¤Àªº¸ê®Æ¹ï¤j³¡¥÷ªºÂåÀø·~ªÌ©M¯f±w¨Ó»¡¡A³£¬Oªì
¨£ªº¡CÃÒ¾ÚÅã¥Ü¼Æ¦Ê¸U³Q»{¬°µLªk¥iªvªº¦UºØ¯f±w¡A²{¦b¥i¥H³Q¦³®ÄªvÀø
¡C¾A·í¹B¥Î³o¨Çª«½è¡A´X¥G§¹¥þ¨S¦³¤£¨}¤Ï§@¥Î¡A¨Ï±o¯ä®ñ©M¤G®ñ¤Æ²B¦¨
¬°«e©Ò¥¼¦³ªº¶W¯ÅÂåÀø´C¤¶¡C
´yz¥»®Ñ¥DÃD©Ò¥Îªº¦Wµü¢w¢w®ñ¡B¯ä®ñ¡B¤G®ñ¤Æ²B¡B§Ü®ñ¤Æª«¡B´åÂ÷
½è¢w¢w¥i¯à·|¤Þ°_§x´b¡A¨Ò¦p"oxidation"©M"oxygenation"´yz¦³Ãö®ñ¡B
¯ä®ñ©Î¤G®ñ¤Æ²Bªº¨âºØ¤Æ¾Ç²{¶H¡A¤@¨Ç³ÌÀu¨qªº¥Íª«¤Æ¾Ç®a¤£¨£±o§¹¥þÁA
¸Ñ¡C¥H¥»®ÑÃD¥Ø"bio-oxidative therapy"¬°¨Ò«K¥iª¾¹D¥¦¥O¤H§x´bªº¥i¯à
©Ê¡C
"Bio"¬°¥Íª«¾Ç¦Wµü¡A·N¬°"¥Í©R"(life)©Î"¥Í¬¡"(living)¡C"oxidative"
¤j³¡¥÷¤H·|»{¬°¬O"®ñ "(oxygen)¡C¨âÓ¦r©ñ¦b¤@°_«h¦¨"¥Í©R®ñ"¡C³o¨Ã¤£
¥¿½T¡C
Oxidation(®ñ¤Æ§@¥Î)©Moxygenation(®ñ¹¡©M§@¥Î)¤£¦P¡C"oxidation"
·N¬°¹q¤l±q¬Y¤Æ¾Ç¤À¤l"§ì¦í"(grabbing)¡A"¦û¦³"(taking up)¡A©Î"²M°£
"(scavenging)(¬Yª«)¡C"Oxygenation"«h¬O«ü®ñ¤À¤l¼Æ¶q¥[¡C³\¦hª«½è(¨Ò
¦pºû¥L©RC)¦b¤Æ¾Ç¤ÏÀ³¤¤·|¤Þ°_¤£·|¼W¥[®ñ¤À¤l¶qªº®ñ¤Æ§@¥Î (oxidation)
¡A®ñ«h¯à¤Þ°_®ñ¤Æ§@¥Î¦P®É¼W¥[®ñ¤À¤l¶q¡A³o¤~¥s°µ"®ñ¹¡¦X§@¥Î"(oxygenation)¡C
¥Í¦s©M²¬Â¡¦³¿à©óÅ餺ªº¤Æ¾Ç¥¿Å¡C¤@¨Ç¤Æ¾Ç¤ÏÀ³©¹©Ò¿×ªº"®ñ¤Æ§@¥Î"¤è¦V
¡A¥t¤@¨Ç¤Æ¾Ç§@¥Î«h©¹¤Ï¤è¦V¡A¥s°µ"ÁÙì§@¥Î"¡C©Ò¦³¥Í©R¹Lµ{¥õ¿à³o¨âºØ
§@¥Îªº°ÊºA¥¿Å¡C
¥Ñ©ó³\¦h¥~¦bªº¼vÅT¦]¯Àº¯¤J³o¨Ç±Ó·Pªº®ñ¤Æ»PÁÙì¤ÏÀ³¢w¢w¨Ò¦pªÅ®ð
©M¤ô½è¦Ã¬V¢w¢w¨Ï±o¤Æ¾Ç¤ÏÀ³Ãø¥Hºû«ù¥¿Å¡C¶V¨Ó¶V¦hªºÃÒ¾ÚÅã¥Ü¡A¥~¦bÀô
¹Ò¦]¯À·|¨Ï¨Å骺®ñ¤Æ©M§Ü®ñ¤Æ¨t²Ît¾á¹L¶q¦Ó¥¢¥h¥¿±`¥\¯à¡C³Ì¤jªºÃa³B
¬O¨Ï§K¬Ì¨t²ÎµLªk§Ü¿m·P¬V¡B¹L±Ó¡B¬r¯À©M¨ä¥L¦³®`ª«½è¡C³o¨Ï§Ú§Ú̦Ҽ{
¨Ï¥Î¤G®ñ¤Æ²B©M¯ä®ñµ¥®ñ¤Æ¾¯(oxidizers)¨Ó¿EµoÅ餺®ñ¤Æ»Ã¯À¨t²Î (oxidative
enzyme systems)¡Aºû«ù¨Å骺¥¿Å©M°·±d¡C
¤G®ñ¤Æ²B©M¯ä®ñ³Q¥Î§@ÂåÀø´C¾¯¤§«á¡A«Ü§Ö³Qµo²{¥¦Ìªº¥Î®Ä¼sªx¡C¤j
³¡¥÷ªº¤HªºÆ[©À¬O"¤@ºØì¦]¡A¤@ºØ¯e¯f¡A¤@ºØÀø¤è"¡A¦Ó«ÜÃø¬Û«H¦³©Ò¿×ªº
¸UÆFÃÄ¡C¦ý¬O¡A¦bµÛ¤â±´¨s®ñ¤À¦bÅ餺·s³¯¥NÁ©ҧêºtªº¨¤¦â¤§«á¡A«K·|ı
±o"¨Ò¦p¤G®ñ¤Æ²B¥i¯à¬O¤@ºØ¸UÆFÃÄ"³o¤@¬Ýªk¨Ã¨S¦³¨¥¹L¨ä¹ê¡C
¨Åé»s³y¤G®ñ¤Æ²B¨Ã¥B²×¥Í«O«ù¤@©w¤ô¥¡C¥¦¬O¥¦¬O½Õ¸`¬¡²ÓM½¤ªº¾÷
¯à¤§¤@³¡¥÷¡C¥¦¬O»s³y»Û¿E¯À¡B¶ÀÅé¯À¡B¥Òª¬¸¢¯Àµ¥¶Pº¸»X©Ò¥²nªº½Õ¸`ª«
½è¡C¥¦¬O½Õ¸`¦å¿}©M©Ò¦³Å餺²ÓM¯à¶q¥Í²£ªº¥²nª«½è¡C¥¦À°§U½Õ¸`¬Y¨Ç¤Æ
¾Çª«¥H¹B§@¤j¸£©M¯«¸g¨t²Î¡C¥¦¹ï§K¬Ì¨t²Î¦³¿EÀy©M½Õ¸`¥\¯à¡F¤]¯àª½±µ©Î
¶¡±µ±þ·À¯f¬r¡B²Óµß¡B±H¥Íª«¡BÅð¡B¿¸©M¨ä¥L¦³®`·L¥Íª«¡C¬ã¨sÅã¥Ü¤G®ñ¤Æ
²BÀR¯ßª`®g¹ï·s³¯¥NÁ¦³¥¿±ªº®ÄªG¡C°£¤F¥Í²£¤w¼W¥[ªº²Õ´©M²ÓMªº®ñ¤À
±i¤O¡A¥¦¯à®ñ¤Æ´X¥G©Ò¦³¥Í²z©M¯f²zª«½è¡A³o¤@¯à¤OÃÒ©ú¥¦¦³ÂåÀø»ùÈ¡C
¯ä®ñ¦b¶i¤J¤HÅé«á«KÂà¤Æ¦¨¤G®ñ¤Æ²B¡A¦Ó²£¥Í¬Û¦üªº¥\¯à¡C©úÁA¤G®ñ¤Æ
²B»P¤HÅé·s³¯¥NÁªºÃö¯A¤§«á¡A¥Íª«®ñ¤ÆÀøªk¹ï¦UºØ¯e¯fªººØºØÀø®Ä«K¸û®e
©ö²z¸Ñ¡C
³\¦hµo²{¤w¸ü¤J¥»®Ñ¤¤¡A§@ªÌ©Ò´£¨ÑªºÃÒ¾ÚÀ³¥i¹ï¥Íª«®ñ¤ÆÀøªkªºÀ³¥Î
¤Þµo·sªº»â·|¡C¥»®Ñ©Ò´£¨Ñªº¸ê°T±N·|¬°²{¥NÂå¾Ç¥v¼W²K³\¦h·s¶¡C
Charles H. Farr, M.D., Ph.D.
Founder and Medical Director,
International Bio-Oxidative Medicine
Foundation nominee, Nobel Prize (Medicine) 199
ºü¨¥
Ó¤H¹ï¥Íª«®ñ¤ÆÀøªkªº¿³½ì¬O¥Ñ©ó·ÓÅU¤@¦ì·R´þ(AIDS)¯f«ªºªB¤Í¦Ó¤Þ
°_¡C¥L¦]¯f«µL±æ¦Ó³QÂå°|°e¦^®a¡C
¦b¥LÁ{²×³Ì«á´X¬P´Á¡A§Ú¦bÂå¥Íªº«ü¾É¤§¤U¨C¤Ñ¬°¤Í¤Hª`¤J35%¹«~¯Å
¤G®ñ¤Æ²Bµ}ÄÀ²G¡C¥O§ÚÅ岧ªº¬O¥¦ªº®Ä¯q¡AÁöµM§ÚªºªB¤Í²×¨s¤£ªv¡A¦ý¤G®ñ
¤Æ²Bµ¹¥Lªº¤¸®ð¡B¦w²»¡B¼ÖÆ[«o¨Ï§Ú¦L¶H²`¨è¡F¥LªºµhW´î»´³\¦h¡A¦Ó¥BºÎ
¯v§ïµ½¡C±N¥¼µ}ÄÀªº¤G®ñ¤Æ²Bª½±µ¶î¦b¨¬³¡¥dªi¦è¸~½F±w³B¡A¸~½F¦b¤T¶g¤º
ÁY¤p¤@¥b¡C¤G¤Q¦h¦~¨Ó¤@¦V¹ïÀç¾i¸É¥R©M¤ÑµMÀøªk¦³¿³½ìªº§Ú¡A³Q¤G®ñ¤Æ²B
ªºÀø®Ä©Ò§l¤Þ¡G¦pªG¥¦¹ïÁ{²×ªº·R´þ¯f±w³o»ò¦³À°§U¡A¹ï¤@¯ë¯f±w±N¦³¦óµ¥
§U¯q¡H
¯ä®ñ¡A¥t¤@ºØ¥Íª«®ñ¤ÆÀøªk¡A¦b¼Ú¬w³Q¼sªx¦a¥Î©óªvÀø¦UºØ¯f¯g¤w¦³¤T
¤Q¦h¦~¡A¥]¬A¤ßŦ¯f¡BÀù¯g¡B¤Î·R´þ¯f¡CµM¦Ó¡A¬ü°ê©M¥[®³¤j¨Ï¥Î¥Íª«®ñ¤Æ
ÀøªkªºÂå¥Í±`³Q¦{ÂåÀø·í§½©MÂåÀø¬É©Ò¢®`¡A¦³¨Ç¥ô¬Æ¦Ü³Q¦Q¾PÀç·~¡C³o¬O
¤@ºØ¤ÑµMª«½è¡A¯à¦³®Ä¼W¶i°·±d¡A¥B·G»ù¡B¦w¥þ¡A®e©ö¨Ï¥Î¡C¼Ú¬w¤w¦³¼Æ¤d
Âå¥Í¥Î©ó¼Æ¦Ê¸U¯f±w¡A¦ý¦b¬ü°ê«o±`³Qµø¬°«Dªk¡C¨C¦~¦³¼Æ¤d¤HÂ÷¶}¬ü°ê¡B
¥[®³¤j¡A¨ì¥~¦a´M¨D¦¹¤@®ñ¤ÆÀøªk¡C«OÀI¤½¥q¤£©Ó¾á³oºØ"¹êÅç"ÂåÀø¶O¡A¥u
¦³Ó¤H¦Û±Ç¸y¥]¡C¦P®É¡A¥D¬y´CÅ駹¥þ©¿µø³oºØÀøªk¡Aª½¨ì²{¦b¡A¦³Ãö³oÃþ
ÃD¥ØªºµÛ§@¡A³£¥Ñ§@ªÌ¦Û¶O¥Xª©¡C
§Ú¶}©l¾\Ū¦³Ãö¤G®ñ¤Æ²B©M¯ä®ñªº®Ñ¡A¦P®É°Ñ¥[°ê»Ú®ñ¤ÆÂåÀø°òª÷¤j·|
(International Bio-Oxidative Medicine Foundation cnference)¡A¬ãŪ¼Æ
¤Q¦ìÂå®v¡B¤Æ¾Ç®a©M¨ä¥L¬ã¨sû©Ò´£¥XªºÂåÀø¤åÄm¡CÁöµM¹L¥h¤G¤Q¦h¦~¨Ó§Ú
¼g¹L¦³Ãö¾ãÅéÀøªk(holistic)©M¨ä¥L¦ÛµMÀøªk¡A§Ú¨S±µÄ²¹L¥Íª«®ñ®ðÀøªkªº
¸ê°T¡Aª½¨ì¤Í¤H¯f«ªº¶¥¬q¡C¤w¦³´X¥»¦Û¶O¥Xª©ªº®Ñ¬y³q¡A¤@¨ÇÂå¥Í¦pEd
MacCabe¡BGary Null¤ÎWalter Grotz µ¥¾Ä¤O±Ð¨|¤j²³¤w¦³¼Æ¦~¡A¦ý¬O¦³³\¦h
¤H(¥]¬A§Ú¦Û¤v) ÁÙ¬O¨S¦³±µÄ²¨ì³o¨Ç°T®§¡C·Q¤£¨ìªº¬O¹L¥h¤»¤Q¦~¡A¬ì¾Ç©M
ÂåÀø¤åÄm¤w¥Z¦æ¤j¶q¦³Ãö¯ä®ñ©M¤G®ñ¤Æ²BªºÂåÀø¨Ï¥Î¡AÁöµM¦³¤@¨Ç¤å³¹¥Z¸ü©ó
ª¾¦W¥Zª«¦pScienc¡B Cancer©MThe lancet¡A ¤j³¡¤À³£µoªí©ó¤£ª¾¦Wªº¾Ç³N
¥Zª«¡A¤Ö¬°¤j²³¾\Äý¡C§Ú«Ü§Ö´Nµoı¹ï©ó¯ä®ñ©M¤G®ñ¤Æ²B¦³«Ü¦hªF¦èÁÙn¾Ç
²ß¡A¤×¨ä¬O¹w¨¾«O°·ªºÀ³¥Î¤è±¡C§ÚÀòª¾Ä¬«X©M¥j¤Ú¦³¤@¨Ç¥O¤H¿³¾Äªº¯ä®ñ
ÂåÀøªk«o¤Ö¬°¥~¬É©Òª¾¡C
§Ú·Q¤j²³»Ýn¤@¥»³q«U¥iŪ¦Ó¤S«ÈÆ[¦³¬ì¾Ç®Ú¾Úªº®Ñ¡C§Ú¤@¦V¬Û«H¸ê°T
¬O¨Ï§Ú̹ïÓ¤H°·±d§@©ú´¼§à¾Üªº«n¦]¯À¡A§Ú¨M©w½s¿è¦³Ãö¥Íª«®ñ¤ÆÀøªk
³Ì·s¦Ó¥i¾aªº¸ê°T¡G¥¦Ì¬O¤°»ò¡B¦p¦ó§@¥Î¡B¦p¦ó¯à«P¶i±d´_¡C§Ú¤]n§â³o
¨ÇÀøªk§@¬°¾ãÅé«O°·ªkªº¤@³¡¥÷¡A¾ãÅéÀøªk(¥]¬A²M°£Åé¬r¡B½Õ¸`¶¼¹©M¹B°Ê
)¦³§U©ó´£¤É³o¨Ç®ñ®ðÀøªkªº«~½è¡C¡C¡C¡C
¹ï©ó¬ü°êÂåÀø·í§½©M¬ü°ê¬F©²Ä~Äò¤Ï¹ï³o¨ÇÀøªkªº¬ã¨s¡A¤£³\¦bÂå¥Í«ü
¾É¤U¨Ï¥Î¡AÁö¤£·N¥~¡A«o·P¨ì¦YÅå¡CÁöµM¤£¬O"¸UÆF©_ÃÄ"¡A¤G®ñ¤Æ²B©M¯ä®ñ
ªº¦w¥þ¡B¦³®Ä©MÂåÀøÀ³¥Î¤w¦b°ê¥~¤Þ°_·¥¤jªºÃöª`¡A»·³Ó©ó¬ü°ê¶Ç¼½´CÅé©M
Âå¾Ç¬ÉªºÃö¤ß¡C°ÝÃD¦b©ó¥¦Ì¬O«D±M§Qªº¡A·G»ù©M¨ã¦³¦hºØÀø®Ä¡C¤£¹³©ù¶Q
ªºÃľ¯¡B¤â³N©M°ª¯ÅÂåÀø¼Ò²Õ¡A³o¨Ç²³æªºÀø¤èµLªk²Kº¡Âå¥Í¡B»sÃĤ½¥q¡B
»ö¾¹»s³y¼t¡B«OÀI¤½¥q©MÂå°|ªº¤f³U¡C¥Ñ©ó³o¨Ç§Q¯q¨ú¦V¢w¢w¥Dn³z¹L±M·~
¡B°Ó·~©M¬Fªv¬¡°Ê²Õ´¢w¢w¼vÅT¬ü°ê«O°·¬Fµ¦ªº¤è¦V¡A¥¼¨Óªº¥Íª«®ñ¤ÆÀøªk
¬ã¨s¤£¥i¯à¥Ñ¥Ḻa°Ê¡C¡C¡C¡C¡C
¥»®Ñªº©v¦®¤£¬On»¡ªA¥ô¦ó¤H¨Ï¥Î¤G®ñ¤Æ²B©Î¯ä®ñÀøªk¡A¦Ó¬On§e²{³o
¨ÇÀøªk¦b¥@¬É¦UÂå°|ªºÀ³¥Î¯u¬Û¡C§Æ±æ³o¥»®Ñ¯à¿E°_°Q½×¤D¦Ü¤Þ°_¤j²³©MÂå
¾Ç¬Éªº»{¯u¦a¬Ý«Ý¯ä®ñ©M¤G®ñ¤Æ²BªºÂåÀø¥\®Ä¡A²×P®ø¶OªÌ¯à§@¸û©ú´¼ªº«O
°·§à¾Ü¡C
¦ó¿×¥Íª«®ñ¤ÆÀøªk¡H
®ñ®ð¬O¥Í©Rªºn¯À¡C¦a´ß³ÌÂ×´Iªº¦¨¥÷¬O
®ñ¡A®ñ½Æ¦Xª«ºc¦¨®ü¬v¡A©¥¥Û©M©Ò¦³¨ä¥L¥Íª«
ªº¥Dn¦¨¥÷¡C®ñ¥÷¦û¦³¦a´ß½è¶qªº62%¡A¤HÅé
¤¸¯À½è¶qªº65%¡A¥]¬A¦å²G¡A¾¹©x¡B²Õ´©M¥Ö
½§¡C¡C¡C¡C
¨Åé¤@¤Á¥\¯à³£©M®ñ®ð¦³Ãö¡A¦Ó¥B»Ýn®ñ
®ð¤£Â_¨ÑÀ³¤~¯àºû«ù¥Í©R¡C¡C¡C
¨Åé©Ò§l¤Jªº®ñ®ð©M¿}(±q¹ª«©M¤À¸ÑÅé
¤º¯×ªÕ¡B¾ý¯»¦Ó¨Ó)°_§@¥Î¡A²£¥Í¤G®ñ¤ÆºÒ¡B¤ô
©M¯à¶q¡C¯à¶qÀx¦s©ó¥s°µATP(adenosine
triphosphate¤TÁC»Ä¸¢¥Ì»Ä)ªº½Æ¦Xª«¤¤¡CATP
¬O§ÚÌ¿à¥H¥Í¦s¡B«ä¦Ò©M¬¡°Êªº¿U®Æ¡C¡C¡C
¡C¡C¡C
®ñ®ð¬O°·±dªº²ÓM©Ò¥²nªº¡A¥¦¯à§Ü¿mÅé
¤ºªº¬r¯À¡C³\¦h¯fµß¬OµL®ñµß¡A§Yµo®i©ó¯Ê®ñ
ªºÀô¹Ò¤U¡AÀù²ÓM¤]¬OÄÝ©óµL®ñ²ÓMÃþ¡C1966
¦~¿Õ¨©º¸±o¼ú¤H¥Ë§B®æÂå¥Í(Dr. Otto Warburg)
½T©wÀù¯gµo®iªº¥ý¨M±ø¥ó¬O²ÓM¯Ê®ñ ¡C
¨Åé¦ó¥H¯Ê®ñ¡H
ªÅ®ð¦Ã¬V
¤G¤â·Ï¡B¨T¨®¼o®ð¡B¤u¼t¼o®ð¡B©U§£¿U¿N
µ¥¡A¨ÏªÅ®ð®ñ¥÷¤j¶q´î¤Ö¡C¡C¡C
¹ª«¾i¥÷³à¥¢
·sÂA¹ª«§t¦³¤j¶q®ñ¤À©Mºû¥Í¯À¡BÄqª«½è
¡A¸g¹Lºë²Ó¥[¤u¡Bª¤µN¡BÅø¸Ë¨¾»Gµ¥¹Lµ{¡A®ñ
®ð©MÀç¾i¥÷¤j¶q´î¤Ö¡C°ªªo¯×¹ª«¤]¬O§C®ñ¤À
¡C³o¨Ç¤£¨}ªº¶¼¹²ßºD©M¦åºÞµw¤Æ¡BÀù¯g¡B¿}
§¿µ¥°h¤Æ©Ê¯e¯f¦³Ãö¡C
¤£¨}©I§l²ßºD
¥Ñ©ó¦Ã¬V¡BÀ£¤O©Î²ßºD¡A¤j³¡¥÷¤H¥¼¯à¥R
¤À©I§l¡C¨Ò¦p§Ú̳Q±Ð¥H¯Ý³¡©I§l¦Ó¤£¬O¸¡³¡
©I§l¡C¡C¡C
®ñ¤Æ§@¥Î
¡C¡C¡C
·í®ñ®ð±N¿}Âà¤Æ¦¨¯à¶q¡A«K§Î¦¨©Ò¿×ªº®ñ
¤Æ§@¥Î¡C¨Åé¤]§Q¥Î®ñ¤Æ§@¥Î¤Î¨ä²£ª«§@¬°§Ü
¿m¯f¬r¤J«Iªº²Ä¤@¹D¨¾½u¡C¡C¡C
®ñ¤Æ§@¥Î¤§«á¡A³Ì«nªº©I§l®Ä¥Î´N¬O®ñ
¹¡©M§@¥Î¡C¡C¡C©I§l¬O®ñ¹¡©Mªº¥Dn¨Ó·½¡C¤G
®ñ¤Æ²B©M¯ä®ñ¬O¦³¦Wªº®ñ¤Æ¾¯(oxidizers)¡A¤]¬O
±j¤Oªº®ñ¹¡©M¾¯(oxygenators)¡C
¦pªG¨Å骺®ñ¹¡©M§@¥Î°I®z¡A«KµLªk±N¬r
¯À¥R¤À±Æ°£¡A¦Ó¤Þ°_¤¤¬r¤ÏÀ³¡A»´·Lªºª¬ªp´N
¬O¬r¯À²Ö¿n¦Ó¾ÉP«å¡A©ü¨I¡B¿ð¶w¡Cªø´Á®ñ
¹¡©M§@¥Î¤£¨}¨Ï§K¬Ì¨t²Î°I°h¦Ó®e©ö¬°¦UºØ¯e
¯f©Ò«Iŧ¡C
®ñ¤Æ§@¥Î»P´åÂ÷½èªº²£¥Í
¬J¦¨ÂåÀøÅé¨î¹ï¯ä®ñµ¥±Ä«O¦uºA«×ªºì¦]
¤§¤@´N¬O´åÂ÷½è(free radicals)ªº²£¥Í¡C´åÂ÷½èªº
©w¸q¬°"±a¦³¤£¥¿Å¹q¤lªº¤À¤l¡A¦¹¹q¤lÀHy¹D
¹B¦æ¡A´M§ä¨ä¥L¹q¤l¥H¨D¥¿Å" ¡C
éwªº¤À¤l¦³¦¨¹ïªº¹q¤l¡A¬°¨Déw¡A´å
Â÷½è·|¦Véwªº¤À¤lÅѨú¹q¤l¡A¨Ïéw¤À¤l¤Ï
¦¨´åÂ÷½è¡A³y¦¨ÃìÂê¤ÏÀ³¡A¤Þ°_³\¦h¤À¤lªºµ²
ºcÅܤơA©¹©¹¨Ï²ÓM¨ü·l¡A¬Æ¦Ü¤Þ°_¬ðÅÜ¡C
µM¦Ó¡A´åÂ÷½è¥¼¥²´N¬O"Ãa"ªº¡A¦³³\¦h´å
Â÷½è¬O¥Í©Rªºn¯À¡C´åÂ÷½è(¥]¬A¹L®ñ¤Æ²B©M²B
®ñ°ò)¥Ñ¨Åé²£¥Í¡A¥Î¥H¿é°e¯à¶q¨ì²ÓM¡C¦¹¥~
¡A´åÂ÷½è¤]¥Î¨Ó®ø·À¯f¬r¡C´åÂ÷½è¦b½Õ¸`¥Í©R
©Ò»Ýªº¤Æ¾Çª«(¦p¶Pº¸»X)¤]§êºt«nªº¨¤¦â¡C
´åÂ÷½è¥Ñ¨Åé²£¥Í(¼@¯P¹B°Ê²£¥Í¤j¶q´å
Â÷½è¡A¦pªG¨Åé°·±d«h¥i»´©ö®ø¸Ñ)©M¬Y¨ÇÃľ¯
²£¥Í¡C¥ÑÂ÷½è¤]¥Ñ¥~¦bÀô¹Ò²£¥Í¡AªÅ®ð¦Ã¬V(¥]
¬A¯ä®ñ·ÏÃú¡B¨T¨®¼o®ð©MµÒ¯ó·Ï)¡B¦³¬r¼oª«¡B
¹«~²K¥[ª«¡B±þ¦ä¾¯´Ý¾l¡B¿ç®g½u(¦pX¥ú)µ¥
¡A³£·|²£¥Í´åÂ÷½è¡A¥H¤£¦P¤è¦¡¼vÅT¨Åé¡C
Å餺¦³¤Ó¦hªº´åÂ÷½è¡A¹ï²ÓM¦³®`¡AªL¤j
½Ã(David Lin)¦b¥LªºµÛ®Ñ´åÂ÷½è»P¯e¯f¹w¨¾¦C
¥X¹L¶q´åÂ÷½è¹ï²ÓM¥i¯à³y¦¨ªº·l®`¡G
l ¬ð¯}²ÓM½¤³J¥Õ¡A¶Ê·´²ÓM
l ¨Ï²ÓM½¤ªo¯×©M³J¥Õ²V¿Ä¡Aµw¤Æ¦Ó©ö¸H
l ÂW¯}²ÓM½¤¡A¨Ï¯f¬r®e©ö¶i¤J
l ¨Ï²ÓM®Ö½¤¯}µõ¡A¼ÉÅS²ÓM®Ö©M°ò¦]
l ¨Ï°ò¦]¬ðÅÜ©M¯}Ãa¡A§ïÅÜ©M¯}Ãa°ò¦]¤§
§Î¦¨
l ¤W¦C¼vÅT³y¦¨§K¬Ì¨t²Ît¾á¡A¨Ã¨Ï§K¬Ì
¨t²Î¨üÃþ¦ü·l®`¤§«Â¯Ù
µ²ªG¡A´åÂ÷½èªº®`³B©M¤@¨Ç°h¤Æ©Ê¯e¯f¦³
Ãö¡A¥]¬A¦åºÞµw¤Æ¡BÀù¯g¡B¥Õ¤º»Ù¡B¿}§¿¡B¹L
±Ó¡Bºë¯«²§±`©MÃö¸`ª¢¡C¹L¶qªº´åÂ÷½è¤]©M¥[
³t°I¦Ñ¡B§K¬Ì¤ÏÀ³´î°h¦³Ãö¡A¶}±Ò§K¬Ì¥¢½Õ¯g
ªº¤jªù¡A¥]¬A·R´þ¯f¡C
§Ü®ñ¤Æª«
¤j³¡¥÷±¡§Î¤U¡A¨Åé·|²£¥Í§Ü®ñ¤Æª«¨Ó½Õ
¨î´åÂ÷½è¹L¶q¡C§Ü®ñ¤Æª«¬O»Ã¯À(enzymes)(¦pIJ
×Q(catalase)¡B¹L®ñ¤Æª«ª[¤Æ×Q(superoxide
dismutase)¥H¤Î½\¯Ö¥Ì¤Ó¹L®ñ¤Æ×Q(glutathione
peroxidase))¡A³z¹L¤Æ¾ÇÅܤƱN´åÂ÷½èÂনµL®`
ªº½Æ¦Xª«(¦p®ñ¤À¤l©M¤ô)¡A¨Ï²ÓM§K¨ü´åÂ÷½è¤§
®`¡C¡C¡C
Àç¾i§Ü®ñ¤Æª«
¥Ñ©ó¹L¶qªº´åÂ÷½è¬¡°Ê·|ÄY«®ø¯ÓÅ餺¤Ñ
µM§Ü®ñ¤Æª«ªº¦s¶q¡AÀç¾i¾Ç®a«Øij¼W¥[Äá¨ú§Ü
®ñ¤Æª«Â×´Iªº¹ª«¡C¤TºØ´¶³qªººû¥L©R¢w¢wb
Jù½³¯À(ºû¥L©RA)¡Bºû¥L©RC©Mºû¥L©RE¢w¢w
¤ÎÄqª«½è¾N¡BÖ´µ¥¡A¬O«nªº§Ü®ñ¤Æª«¡C¡C¡C
½µæ¡B¤ôªG¡BµwªG©MºØ¤l¡A§t¦³¦h¶q§Ü®ñ
¤Æªººû¥L©R©MÄqª«½è¡AÀ³¬°°·±d¶¼¹ªº¥Dn³¡
¥÷¡C³\¦h¤HÄá¨ú§t§Ü®ñ¤Æª«ªºÀç®ñ¤£¥R¾¯¡C
¥Íª«®ñ¤ÆÀøªk
¤j³¡¥÷´åÂ÷½èªº¬¡°Ê©M(§Q¥Î®ñ¤Æ§@)±Æ°£
²{¥N¥Í¬¡ªº°Æ²£«~¢w¢wP¯fª«¢w¢w¦³Ãö¡A³o¬O
¥Ñ©óÀô¹Ò¦Ã¬V¡BÀ£¤O©M¿ç®gµ¥³y¦¨ªº¡C¶V¨Ó¶V
¦hªºÂå¥Í¬Û«H¡A¦pªG¨Å馳§Ü®ñ¤Æªº»Ý¨D¡A¥[
¤J¬Y¨Ç®ñ¤Æª«(oxidative substance)¨ìÅ餺¬O¦w
¥þªº¡A¥un¨Ï¥Îªºª«½è©M¤èªk¬O¾A·íªº¡C§Q¥Î
®ñ¤Æ§@¥Îªºì²z§ïµ½¨Å骬ªp¡A¥s°µ¥Íª«®ñ¤Æ
Àøªk(bio-oxidative therapy)¡C³o¤@¦Wµüº¥ý¥Î©ó
1986¦~ªkº¸Âå¥Í(Dr. C. H. Farr)ªº±M½×The
Therapeutic Use of Intravenous Hydrogen
Peroxide¡C
¦³®ñ¹B°Ê¡B²`©I§l¡B°ª®ñ¹ª«(¦p·sÂAªG½
)µ¥¡A³£¥i«P¶i¨Å饿±`ªº®ñ¤Æ§@¥Î¡A¦ý¬O¨âºØ
¤ÑµM¦¨¥÷¢w¢w¤G®ñ¤Æ²B©M¯ä®ñ¬O¥Ø«e¥Íª«®ñ¤Æ
Àøªkªº¥D¶b¡C
¥Íª«®ñ¤ÆÀøªkªºÀø®Ä¬O®Ú¾Ú®ñ©M¤HÅé²ÓM
ªºÃö«Y¡C¦¹¤@Àøªk¼W¶i®ñ·s³¯¥NÁ¨èë¿E¦å²G
ÄÀ©ñ®ñ¤¸¤l¨ì²ÓM¡C®ñ¤ô¥´£°ª¡A±w¯f¾÷²v´N
´î¤Ö¡C¤j¶qªº®ñ¦bÅ餺¬y°Ê¡A¦UºØ¦³®`·L¥Íª«
´NÀHµÛ¦º¤`©Î°I·Lªº²ÓM¦Ó³Q°£·À¡F¦P®É¡A°·
±dªº²ÓM¤]¸û©öÁc´Þ¡A§K¬Ì¨t²Î©M¥\¯à¤]¬Û¹ï
´£°ª¡C
¯Â¯ä®ñ©M¤G®ñ¤Æ²B¹ï¤HÅ馳®`¡A¦ý¬Oµ}ÄÀ
¨ì¬YºØµ{«×«o¬O¦w¥þ¦Ó¦³ÂåÀø¥\®Äªº¡A¦Ó¥B¤Ï
§@¥Îªº¾÷²v·¥·L¡A¦p¼w°êªº¤@¶µ¬ã¨s¡Aµû¦ô¨Ï
¥Î¯ä®ñ©ó¤¦Ê¸UÀø¦¸ªº¨}°Æ§@¥Î¾÷²v¬°
0.0005%¡A³o¤@¼Æ¦r»·§C©ó¨ä¥L¥ô¦óÂåÀøªk¡C
ÁöµMª¾¹D³o¤@Àøªkªº¤H¤£¦h¡A¼Ú¬wÂå¥ÍÀ³
¥Î³o¤@Àøªk¤w¦³¤@¦Ê¦~¥H¤W¡A²Ä¤@¦¸³ø§i«h¥X
²{©ó1920¦~^°êÂå¾Ç´Á¥ZThe Lancet¡C¦¹«á¡A
¥@¬É¦U°ê¤jÂåÀø¬ã¨s¤¤¤ß¬ÛÄ~µoªí¬ã¨s³ø§i¡A
¥]¬A¬ü°êBaylor University¡BYale University¡B
the University of California (L.A.)¡BHarvard
University¡A¥H¤Î^¡B¼w¡BĬ¡B¥[¡B¤é¡B¥j¡B¾¥
¡B¤Úµ¥°êªºÂå¾Ç°|©M¹êÅç«Ç¡C¥Ø«e¡A¨C¤ë¦³
50-100½gªº¬ã¨s³ø§i±´°Q¯ä®ñ©M¤G®ñ¤Æ²Bªº¥Í
¤Æ®ÄÀ³¡C
¥Íª«®ñ¤ÆÀøªk¦p¦óÀ³¥Î¡H
¥Íª«®ñ¤ÆÀøªk¨Ï¥Î·L¶qªº¯ä®ñ©Î¤G®ñ¤Æ²B
¥[¨ì®ñ©Î¤ô¤¤¡A¸gÀR¯ßª`®g¡B¤fªA¡B¥Ö¤Uª`®g
©Îª½¸zÄéª`¡A±N¬¡©Ê®ñ¿é¤JÅ餺¡C¶i¤JÅ餺«á
¡A¯ä®ñ©Î¤G®ñ¤Æ²Bª½±µ©Î¶¡±µ¦¨¬°¯f¬r¡B²Óµß
¡BÅð¡B·L¥Íª«¡B¯e¯f©M°I®zªº²Õ´²ÓMµ¥ªº«g
¬P¡AÂǵۮñ¤Æ§@¥Î±N±N³o¨ÇP¯f·L¥Íª«®ø·À¨Ã
±Æ¥XÅé¥~¡C¯ä®ñ©M¤G®ñ¤Æ²Bªº§@¥Î´N¹³²b¤Æ´C
¤@¼Ë¡C
®Ú¾Ú¦ôp¡A¹L¥h27¦~¤@¤d¸U¥H¤Wªº¤H(¥D
n¬°¼w°ê¡AĬ«X¡A¥j¤Ú)±µ¨ü¥Íª«®ñ¤ÆÀøªk¡Aªv
Àø¥|¤QºØ¥H¤Wªº¯e¯f¡A¥]¬A¤ß¡B¦åºÞ¯e¯f¡BªÍ
¯f¡B¶Ç¬V¯f¡B§K¬Ì¨t²Î¥¢½Õ¯g¡C®Ú¾Ú°ê»Ú¥Íª«
®ñ¤ÆÂåÀø°òª÷·|(IBOMF)³ø§i¡A¤U¦C¦U¯g¸g¯ä®ñ
©M¤G®ñ¤Æ²BªvÀø¡A¦U¦³¬YºØµ{«×ªº¦¨®Ä¡C¦³³æ
¿W¬I¥Î¡A©Î°t¦X¶Ç²ÎÀøªk(¦p¤â³N©Î¤Æ¾ÇÀøªk)
¡B«D¶Ç²ÎÀøªk(ºû¥L©R¡B°wª¥¡B¯óÃÄ)¨Ï¥Î¡C
¤ßŦ©M¦åºÞ¯e¯f
¤ß«ß¤£¾ã
Cardioconversion (heart stoppage)
¤ßŦ¦åºÞ¯f(cardiovascular disease)
¸£¦åºÞ¯f(¤¤·»P°O¾Ð³à¥¢)
¤ßµ±µh
Ãa¯j(¤â¡B¸}«ü)
¥½±é¦åºÞ¯f(´`Àô¤£¨})
¹p¿Õ¤ó¯f("¥Õ«ü")
ù®°Ê¯ßª¢
Vascular and cluster headaches(°¾ÀYµh)
ªÍ¯e
®ð³Ý
¤ä®ðºÞÂX±i
ºC©Ê¤ä®ðºÞª¢
ªÍªý¶ë
ªÍ®ð¸~
ªÍÅn¸~©ÊªÍª¢(PCP/·R´þªÍª¢)
¶Ç¬V¯f
«æ¡BºC©Ê¯f¬r·P¬V
ºC©ÊµL¤ÏÀ³²Óµß·P¬V
EB¯f¬r(Epstein-barr virus¡AºC©Ê«å¼x
ª¬)
³æ¯Âªw¯l
±aª¬ªw¯l
§K¬Ì¨t²Î¥¢½Õ¯f¬rÃþ·P¬V
±H¥Íµß·P¬V
ºC©Ê©À¯]µß¯f
§K¬Ì¥¢½Õ
¿}§¿¯f¤A«¬
¤ÏÀ³¹L±Ó
¦hµo©Êµw¤Æ
·Àã©ÊÃö¸`ª¢
¨ä¥L¯e¯f
¦Ñ¤H·ö§b
¦å²G²O¤Úµ²Àù¯g
ºC©Ê¯kµh(¦hºØì¦])
°¾ÀYµh
²¾Âà©Ê´c©Ê¸~½F¯kµh
¥Íª«®ñ¤ÆÀøªk¦³¦ó§@¥Î¡H
¾Ú¨FªL«OÂå¥Í(Frank Shallenberger)©Ò»¡¡A
¥Íª«®ñ¤ÆÀøªk¹ï¤HÅ馳¤U¦C¼vÅT¡G
1. ¥Íª«®ñ¤ÆÀøªk¨ë¿E¥Õ¦å²y¼W¥Í¡A¥Õ¦å²y
¬°§Ü¿m¯f¬r·P¬V©Ò»Ý¡C
2. ¯ä®ñ©M¤G®ñ¤Æ²B¬°®ø¬r¾¯¡C
3. ¥Íª«®ñ¤ÆÀøªk¥[³t®ñ®ð»P¦å¬õ¯À¤ÀÂ÷
¡A¿é°e®ñ®ð¨ì²ÓM¡C
4. ¯ä®ñ©M¤G®ñ¤Æ²B§í¨î¸~½F¥Íªø
5. ¯ä®ñ©M¤G®ñ¤Æ²B¬°¨Ï¥Û¤Æ²£«~®ñ¤Æ©M
°h¤Æ
6. ¥Íª«®ñ¤ÆÀøªk¼W¶i¬õ¦å²y²ÓM½¤ÂX±i
¤O¡A¦]¦Ó¼W±j¨ä¼u©Ê©M®Ä¯à¡C
7. ¯ä®ñ©M¤G®ñ¤Æ²BÀøªk¼W¥[¤zÂZ¯À©M¸~
½FÃa¦º¦]¤l¡A³o¨Ç¬O¨Åé§Ü·P¬V©M§ÜÀù
©Ò»Ý¡C
8. ¥Íª«®ñ¤ÆÀøªk§Ü®ñ¤Æ»Ã¯À¨t²Îªº®Ä¤O
¡A³oÃþ»Ã¯À²M°£Å餺¹L¶qªº´åÂ÷½è¡C
9. ¥[³tÂfÂc»Ä´`Àô(±q¿}ÄÀ©ñ¯à¶qªº¥Dn
´`Àô)¡A¨ë¿E°ò¥»·s³¯¥NÁ¡A¤À¸Ñ³J¥Õ
½è¡BºÒ¤ô¤Æ¦Xª«©M¯×ªÕ¡A¨Ñµ¹¯à·½¡C
10. ¯ä®ñ©M¤G®ñ¤Æ²BÀøªk¼W¶i²Õ´ªº®ñ¹¡
©M§@¥Î¡A§ïµ½¯fªp¡C
ªÉ»D¡B©¿µø»P¿ò§Ñ
ÁöµM¯ä®ñ©M¤G®ñ¤Æ²BÀøªk¦b³\¦h°ê®a(¥]
¬A¼w¡A¥j¡A¾¥¡AĬ¡A·N¡Aªk¡A¿D)ªºÁ{§É¹êÅç©M
¤@¯ëªù¶EÀ³¥Î¡AÃÒ©ú¬°¦w¥þ¦³®Ä¡A¦ý¬O¦b¬ü°ê
¡B¥[®³¤j«o¤Ö¬°¤Hª¾¡C¦ôp¤w¦³¤@¸U¤¤d¼Ú¬w
Âå¥Í¨Ï¥Î¥Íª«®ñ¤ÆÀøªkªv¯f¡A¥_¬ü¨Ï¥Î³o¨ÇÀø
ªkªºÂå¥Í«h«Ü¤Ö¡A³¡¥÷ì¦]¬OÂåÀø¾Ç®Õ¤£´£¨Ñ
³o¨Ç¸ê°T¡C²{¦³ªºÂåÀøÅé¨î¤£´£Ò¥Íª«®ñ¤ÆÀø
ªk¡A¦Ó¥B¸g±`ªý¤î¦³·ÓÂå®v¨Ï¥Î¡C¥Ñ©ó¥Íª«®ñ
¤ÆÀøªk¦b¬ü°ê³Q»{¬°¬O"¹êÅç©Êªº"©Î"ÄF³N"¡A¨Ï
¥Î³o¨ÇÀøªk±`¨ü¨ì¦Q·Ó©Î§¤¨cªº«Â¯Ù¡C
¤@¶µ¥Íª«®ñ¤ÆÀøªk³Q©¿µøªºì¦]¬O¡G¯ä®ñ
©M¤G®ñ¤Æ²B¤£¬O±M§Qª«½è¡A¥i¥H·G»ù¥Í²£©MÀ³
¥Î¡A¨S¦³¸gÀÙ»¤¦]±N¥¦Ì¯Ç¤J¶Ç²ÎÂåÀøªk¤¤¡C
¥Íª«®ñ¤ÆÀøªk³q±`¸û¶Ç²ÎÀøªk¸`¬Ù¤@¥b¶O¥Î¡A
¯S§O¬OºC©Ê©M°h¤Æ©Ê¯e¯f¡C¯ä®ñ©M¤G®ñ¤Æ²B«Â
¯Ù¨ì¶Ç²ÎÂåÀøÅé¨îªºÀu¶Õ¡G»sÃÄ¥ø·~¡BÂåÀø¤¤
¤ß¡B·R¶}¶QÃĪºÂå¥Í¡A½ÆÂøªºªvÀøµ{§Ç¥H¤Îªø
´Á¦í°|¡C
¥Ñ©ó¬ü°ê¬F©²¾÷ºc¦p¹«~ÃĪ«ºÞ²z§½
(FDA)©M«O°·¸p(NIH)¡A¨üÂåÃÄ¥ø·~©MÂåÀø¬Éªº
¹C»¡¼vÅT¡A¥Íª«®ñ¤ÆÀøªkªº«ÈÆ[¬ã¨s©M¦³®ÄÂå
Àø¼Ò²Õªº¬ãµo«ÜÃø¶i¦æ¡C®Ú¾Ú¥d¥»¼wÂå¥Í
(Michael T. F. Carpendale, M.D)¡A¯ä®ñ¬ã¨s¥ý¾W
©M¥[¦{¤j¾ÇÂå¾Ç°|±Ð±Â©Ò»¡¡G
¦bFDAùØ¡AÃļt¥Nªí´X¥G¦û¦³¦U©eû·|
¡A¦pªG¦³¤ñ¤@¯ëÃÄ»ù§C·Gªº²£«~¥X²{¡A
¨Ï¥LÌÃø¥HÄvª§¡A¥LÌ·íµM·|«Ü¤£°ª¿³
¡C¯ä®ñÅãµM¬O·G»ù²£«~¡A«Ü¦³¼ç¤O¡A¥u
n¥¦ªº®Ä¤O¦³¦p¼w°ê©Ò«ÅºÙªº¤@¥b¡A¤H
¤H³£·|¨Ï¥Î¡C
©_ºÖÂå¥Í¸ÑÄÀ«Ü¤Ö¦³¬F©²¤ä«ù©M»sÃĤ½¥q
¹ï¯ä®ñ¬ã¨sªºì¦]¡G"»sÃÄ¥ø·~¤£¯à³c½æ¯ä®ñ¡A
³o³o¥Dnì¦]¡C¤@¥¹¯ä®ñ¯à°÷³c½æ¡A§Ú´±½T©w
¯ä®ñ±N¦¨¥@¬É³Ì«nªºÃľ¯¡C"
1994¦~¡A¬ü°êÂåÃÄ¥ø·~Àç·~ÃB920»õ¬ü¤¸
¡A¹wp1996¦~±N¹F1250»õ¬ü¤¸¡A¥§¡§Q¼í17.9
%¡C¬ü°êÂåÃÄ¥ø·~¬O°ª§Q¼í¥ø·~¸sªº¤@¥÷¤l¡C
±aµÛ±j¤jªº¸gÀÙ©M¸gÀÙ¤O¡A³o¨Ç»sÃĤ½¥q
¼vÅT¦U°êªº¬Fµ¦ªº¨î©w¡AÂåÀø¾Ç®Õ(¥H¬ã¨s¸g¶O
¬°»ç)¡BÂå¥Í(¼s§i¡AÃÙ§U¬ã°Q·|¡B§ª«¡B§K¶OÃÄ
¾¯¼Ë«~)¡C¡C¡C¡C
¯ä®ñ O3
¯ä®ñ¬O¦a²y¤j®ð¼h¦ÛµM¦s¦Ûªº®ñÄݤ¸¯À¡C
¡C¡C
¯ä®ñ¦b¤j®ð¼h§Î¦¨«OÅ@¼h¡A§l¦¬¤j¶qµµ¥~
½u¡A¨S¦³¯ä®ñ¼h¡A¦a²y¤Wªº°Ê¡B´Óª«±NÃø¥H¥Í
¦s¡C¥Ñ©ó´â¬tºÒ¤Æª«(chlorofluorocarbons/CFCs)
±q¦B½c¡BªÅ½Õ¾¹¡B¼QÃú¾¯µ¥ÄÀ©ñ¨ì¤j®ð¡A³y¦¨
¯ä®ñ¼h·l¯Ó¡A¤w¸g¤Þ°_¬ì¾Ç®a©MÂå¥Íªº·¥«×Ãö
¤Á¡C¡C¡C
¡C¡C¡C
¯ä®ñªº¯S©Ê©MÀ³¥Î
¯ä®ñ¬O±j¤Oªº®ñ¤Æ¾¯(oxidizer)¡A¯à±þ¦º¦U
ºØ¯f¬r¡B²Óµß©M¨ä¥L¦³®`ª«¡C¥¦¤]¯à®ñ¤Æ×ô«¬
¾¯(¥Ò¾J©M¥Ûªoºëªº¦³¬r½Æ¦Xª«)¡B±þ¦ä¾¯¡B²M¼ä
¾¯¡B¤Æ¾Ç¤u¼t¼oª«¥H¤Î´c¯äª«¡A¤ñ´â®ð¨³³t¦³
®Ä¡A¥BµL¦³®`ªº´Ý¯dª«¡C¦]¦¹¡A¯ä®ñ¤w¦¨¬°¦U
ºØ®ø¬r¡B²b¤Æ¶¼¤ô©M¼o¤ô³]¬Iªº«n¦¨¥÷¡C
³£¥«¶¼¤ô³B²z
¦b¶¼¤ô·½¦Ã¬V¤éÁÍÄY«ªº®É¥N¡A¯ä®ñº¥³Q
»{¬°¬O¤ñ´â©M¨ä¥Lª«½è·G»ù¡B¦w¥þ¡B¦³®Äªº²b
¤ô¾¯¡C¤HÅé±Æªnª«¤¤¡A¦³¤@¦Ê¦hºØ¯f¬r¥iµo²{
©ó¦Ã¬Vªº¶¼¤ô¤¤¡C¡C¡C¦p¤Æ¤u¦Ê¬ì¥þ®Ñ©Ò»¡¡G
¤â´£²b¤ô¾¹¤u¼t©Ò¥Îªº´â¤Æ§@¥ÎµLªk
±Æ°£¯f¬r¨ì¥i±µ¨üªºµ{«×¡C¤Ö¶q¯ä®ñ
¯à§¹¥þ±±¨î¯f¬r¡A¤w¸g¥R¤ÀÃÒ©ú¡C
²Ó¯ä®ñ¯à¨Ï¯fµßªº²ÓM¾À¯}µõ¦Ó¦º¤`¡A¥]
¬A¡G¤j¸z±ìµß¡BÃì²yµß¡Bµ²®Ö±ìµß¡B¥¨¤jªÞÌU
±ìµß¥H¤Îendamoeba histolytica¡C¡C¡C
¥Ø«e¥þ¥@¬É¦³¤G¤d¤¦Ê¦hÓ³£¥«¨Ï¥Î¯ä®ñ
²b¤Æ¤ô·½¡A¥]¬A¬¥§üÁF¡B¤Ú¾¤¡B²ö´µ¬ì¡B·s¥[
©Y¡B¡C¡C1950¦~°_¡A¯ä®ñ¤w³Q¥Î¨Ó²b¤Æ¤½¦@´å
ªa¦À¡C1984¦~®L©u¬¥§üÁF¥@¹B¡A¼Ú¬wªa¶¤°í«ù
¨Ï¥Î¯ä®ñ(¤Ï¹ï´â¾¯)³B²z´åªa¦À¡A§_«h©Úµ´°ÑÁÉ
¡C
¯ä®ñ»P¤u·~
¯ä®ñ³Q¥Î©ó¨T¤ô²~©M°à°s²~®ø¬r¡A°à°s·~
¥Î¯ä®ñ¨Ó®ø°£²§¨ý¡A»sÃļt¥Î¯ä®ñ®ø¬r¡A¹q¤l
¹s¥ó¼t¥Î¯ä®ñ¨Ó²M°£ªí±Âø½è¡C¦Ê¸U¤À¤§¤@¦Ü
¤Tªº¯ä®ñ·»²G³Q¥Î¨Ó³J¡B¦×¡B½µæµ¥¹ª«¨¾»G
¡C
¼o¤ô¦Ã¬V±±¨î
¯ä®ñ¯à¤À¸Ñ¤u·~¼o®Æ¦p¥ÛºÒ»Ä(×ô)©MÙæ¤Æ
ª«¡A¨Ï¦¨¬°¥Íª«¥ié»kª¬ºA¡C¯ä®ñ±`³Q¥Î¨Ó®ñ
¤ÆÄq·~¡B·Ó¹³¤u·~ªº¼oª«¡A¥H¤Î«ª÷ÄÝ¡B¤A¾J
¡BÆQ»Äµ¥¦³¬rª«½è¡C
¯ä®ñ¤]³Q¥Î¨Ó®ø¬r³£¥«¼o¤ô¡A²M¼ä³Q¤U¤ô
·¾©M¨ä¥¦¦Ã¬Vª«©Ò¦Ã¬Vªºªe¡B´ò¡C¯ä®ñ¨S¦³´â
®ðªº®`³B¡A¥¦¤£·|¶Ë®`ªe´ò¤¤ªº°Êª«¡A©Î³y¦¨
¦³®`¥ÍºA¨t²Îªº¤Æ¾Ç´Ý¯dª«¡C
°£¯ä
¬ü°ê¦³¦Ê¦hÓ¯ä®ñ²£¥Í¾¹³Q¥«Âí©M¨p¤H¤½
¥q¥Î¨Ó±Æ°£³B²z¹Lªº¼o¤ô¤§¦³®`®ð¨ý¡C¡C¡C
·Ò¯×¼t¡B¯È¼t¡BªÎ®Æ¼t¡B¦a¤UÅK¹D¡BÀG¹D
©MÄq³õ¡A¤]¥Î¯ä®ñ¨Ó´î¤Ö®ð¨ý¡C¹«~·~¦p¹T¼t
¡B³½¼t¡B±O®_³õ¡A¤]¥Î¯ä®ñ°£¯ä¡C
¯ä®ñ»PÂåÃÄ
¡C¡C¡C
®Ú¾Ú¼Ú¬w¯ä®ñÂåÀø¨ó·|(Medical Society
for Ozone)©M¥j¤Ú°ê®a¬ì¾Ç¬ã¨s¤ßªº³ø§i¡AÂå¥Í
¨Ï¥Î¦U¦¡¯ä®ñÀøªkªvÀø¤U¦C¯e¯f¡F
Áw½H(abscesses)
¯»¨ë(acne)
·R´þ¯f
¹L±Ó
µõ¨z
Ãö¸`ª¢
Ãö¸`°h¤Æ
®ð³Ý
´c©Ê¸~½F
¸£¦åºÞµw¤Æ
´`Àô²V¶Ã
¨xµw¤Æ
§ó¦~´Á»Ùê
«K¯µ
²´¨¤½¤¼ìºÅ
»H¯Öª¢
¿È½H
µg¯e
ºÞº|(fistulae)
Åðµß¯f(fungal disease)
ðK¯f(furunculosis)
Ãa¯j(gangrene)
G»P¤Q¤G«ü¸z¼ìºÅ
G¸z¯f
±ù§ÎÃ@¤ò¦ä
«C¥ú²´(glaucoma)
¨xª¢
ªw¯l(³æ¯Â»P±aª¬)
°ªÁx©T¾J
ÂH²G©Ê¤j¸zª¢
Åðµß¯f(mycosis)
¯«¸g¥¢½Õ°©Å誢
¤Úª÷¥Í¤ó¯f(Parkinsonism)
¦h¼ÆÃö¸`ª¢
¹p¿Õ¤ó¯f
¦â¯À©Êµøºô½¤ª¢(retinitis pigmentosa)
·Àã©ÊÃö¸`ª¢
¬Í(¿ç®gªvÀøµ²ªG)
¦Ñ¦~·ö§b
±Ñ¦å¯f(sepsis control)
»óÄuª¢
¯á´Õª¢(spondylitis)
¤fµÄª¢
Ĭ¡§J¤ó¯f(Sudeck's disease)
¦å®êÀR¯ßª¢(thrombophlebitis)
»L³¡µõ¤f½H(ulcus cruris)
¥~³±¹Dª¢
¶Ë¤f´_ì²V¶Ã
¯ä®ñ»P¤ú¬ì
¯ä®ñÀøªkªº¥ý¾W¤§¤@¬O¤@¦ì¤úÂå¡C¡C¡C®Ú
¾Ú¼w°ê¤úÂå§J©Ô°¨(Fritz Kramer)ªº»¡ªk¡A§t¯ä
®ñªº¤ô·»²G¦³¤U¦C®Ä¥Î¡G
l ±j¤O®ø¬r¾¯
l ±±¨î¬y¦å
l ²M¼ä°©Àf©M³n²Õ´ªº¶Ë¤f
l §ïµ½¶Ë¤f®ñ®ð¨ÑÀ³¡A¥[³t´_ì
l ´£°ª¶Ë¤f³¡¦ìªº·Å«×¥H§ïµ½§½³¡
·s³¯¥NÁ¡C
§J©Ô°¨Âå¥Í»¡¡A¯ä®ñµ}ÄÀ²G¦³´XºØ¥Î³~¡G
l §@º¤¤f¤ô(¯S§O¬O¾¦Åiª¢¡B
paradentosis¡BÅðµß¤fª¢¡B¤fµÄª¢
l §@¼QÃú¾¯¡A²M¼ä·P¬V°Ï¡AÂH²G½¤©M
³E¤ú¬}¡A¥H¤Î¤@¯Z¤ú¬ì¤â³N®ø¬r
¯ä®ñÀøªk¤§¹B¥Î
¹L¥h¤»¤Q¦~¨Ó¡A¤wµo®i¥X¤Q¦hºØ¯ä®ñÀøªk
¡C¤j³¡¤Àªº±¡ªp¤U¡A¤º¥Î¤§¯ä®ñ»P¯Â®ñ²V¦X¾¯
¤§¦¨¤À¤ñ¬°0.05 : 99.95¡A¥~¥Î¾¯¤§¤ñ¬°5 : 95
¡Cºë½Tªº¾¯¶q¨ÌÓ§O±¡ªp¦Ó©w¡CÂå¥Íµo²{¡A¾¯
¶q¤£°÷¥¼¥²¦³®Ä¡A¦ý¾¯¶q¹L¦h«h·|§í¨î§K¬Ì¨t
²Î¡C¥Ø«e¡A¦³¤KºØ²³æ¡B¤@ºØ½ÆÂøªº¤èªkÀ³¥Î
©óÁ{§ÉÂåÀø¡C
ª½±µ°Ê¯ßª`®g»PÀR¯ßª`®g
³o¤@¤èªk¥Dn¥Î©ó°Ê¯ß´`Àô¥¢½Õ¡C±N¯ä®ñ
»P®ñªº²V¦X¾¯¥Îª`®g¾¹½wºCª`¤J°Ê¯ß©Î¦åºÞ¡C
¾ÚĬ«nÂå¥Í(Gerard V. Sunnen, M.D.)»¡¡A"¥Ñ©ó
ª`¤J³t«×¤Ó§Ö·|¤Þ°_·N¥~¡A³o¤@¤èªk¤w«Ü¤Ö¨Ï
¥Î"¡C
ª½¸z¼Qª`
±N²V¦X¾¯¥Ñª½¸z¾É¤JÅ餺¡A³q±`100-800
ml ²V¦X¾¯¾É¤JÅ餺¡A¶O®É¤@¤À¥b¨ì¨â¤ÀÄÁ¡A²V
¦X¾¯°±¯d¦b¸z¤º¤Q¨ì¤G¤Q¤ÀÄÁ¡C³o¤@¤èªk³Q»{
¬°¬O³Ì¦w¥þªº¡C¼ìºÅ©Ê¤j¸zª¢¨å«¬ªº¦¨¤À¬°¨C1
ml ®ñ®ð©M¥H75 mcgªº¯ä®ñ¡A³Ì¥X¥Î¶q50 ml ®ñ
¡A¥iº¥¼W¨ì¨CÀø¦¸500 ml¡C³o¤@¤èªk¦b¼w°ê¡B
Ĭ«X¡B¥j¤Ú¥ÑÂå¥Í·þ¾É¬I¦æ¡A¦b¬ü°ê«h¶V¨Ó¶V
¦hªºÀù¯g¡BHIV©M¨ä¥L¯f±w¥Î¨Ó¦Û§ÚªvÀø¡C
¦Ù¤ºª`®g
¤Ö¶q²V¦X¾¯(10 ml¥H¤U)³q±`¥ÑÁv³¡ª`¤J
¡A¦p¤@¯ëª`®g¡A¥Î¨ÓªvÀø¹L±Ó©Mª¢¯g¡C³o¤@¤è
ªk¦b¼Ú¦{¦³®É°t¦XÀù¯gªvÀø¡C
¤j¡B¤p¦Û¦åÀøªk
¤p¦Û¦åÀøªk(minor autohemotherapy)¡A±q±w
ªÌ¦åºÞ©â¨ú¤Ö¶q¦å²G(³q±`10 ml)¡A¸g¯ä®ñ©M®ñ
®ð³B¸Ì«á¡A¦A¥Î¦Ù¤ºª`®g¾É¤J±wªÌÅ餺¡C³o¤@
§t¯ä®ñªº¦å²G´N¹³±wªÌªº²ÓM¾É¥Xªº¦ÛÅé¬Ì]
¡A¹ïªvÀø±wªÌªº¯e¯f«D±`¦³®Ä¡C
¤j¦Û¦åÀøªk(major autohemotherapy)¡A©â¨ú
±wªÌ¦å²G50-100 ml¡AÄéª`¯ä®ñ»P®ñªº®ðªw´X¤À
ÄÁ¡AµM«á±N¦¹§t¯ä®ñªº¦å²G¥Ñ¦åºÞ¾É¤J±wªÌÅé
¤º¡C
³o¨âºØÀøªkÀø®Ä½d³ò«Ü¼s¡A¥]¬Aªw¯l¡BÃö
¸`ª¢¡BÀù¯g¡B¤ßŦ¯e¯f¥H¤ÎHIV·P¬V¡A¥i¯à¬O
¥Ø«e³Ì³q¥Îªº¯ä®ñÀøªk¡C
¯ä®ñ¤ô
§t¯ä®ñªº¤ô¥Î¨Ó¬~º°¶Ë¤f¡B¿N¶Ë©MºC©Ê¥Ö
½§¶Ç¬V¯f¡A¤]¥Î©ó¤ú¬ì¤â³N®ø¬r¡CĬ«XÂå¥Í¥Î
¨Ó¨R¬~¤â³N¤¤ªº¶}¤M³B¡CĬ«X©M¥j¤ÚÂå¥Í¥Î¯ä
®ñ¤ôªvÀø¦UºØ¸z¯e©M°ü¬ì¯e¯f¡A¥]¬A¼ìºÅ©Ê¤j
¸zª¢¡B¤Q¤G«ü¸zª¢¡BGª¢¡Bµg¯e©M¥~³±¹Dª¢¡C
Ãö¸`¤ºª`®g
±N¯ä®ñ¤ôª½±µª`¤JÃö¸`±µÁ_¡AªvÀøÃö¸`ª¢
¡B·Àã¯g©M¨ä¥LÃö¸`¯e¯f¡C
¯ä®ñ³U
¥Î¶ì½¦³U¥]ºò±w³¡µM«áÄé¤J®ñ»P¯ä®ñ²V¦X
®ð¡A¥Ñ¥Ö½§§l¦¬¡A¥Dn¬°ªvÀø»L³¡¼ìºÅ¡BÃa¯j
¡BÅðµß¯f¡B¿N¶Ë¤ÎºC©Ê¶Ë¤f¡C¡C¡C
¯ä®ñªo
±N¯ä®ñ²V¤J¾ñÆVªo¡B¸ªªáªoµ¥¡A§@¦¨¥~¼Å
ªo¡C»I¡AªvÀø¡GÅðµß·P¬V(¥]¬A»´ä¸})¡B»L³¡¼ì
ºÅ¡B¿È½H¡B¾¦Åiª¢¡B³æ¯Âªw¯l¡B²©½H¡B¥~³±¹D
ª¢¡B¸ÁÁ±¡B¦ä«r¡B¯»¨ë¤Î¨ä¥L¥Ö½§°ÝÃD¡C
ªÍ§l¯ä®ñ
ªÍ³¡¬O¹ï¯ä®ñ³Ì±Ó·Pªº¾¹©x¡C¨Ï¥Î¯ä®ñÀø
ªkªºÂå¥Íĵ§i¡G§l¤J¯ä®ñ¥i¯à¤Þ°_ªÍ³¡²Õ´ªº
§ïÅÜ¡A·l®`²Ó½oªºªÍ½¤¡A¨ë¿E®ðºÞ©M¤ä®ðºÞªí
¼h¡A¦Ó¤Þ°_ªÍ®ð¸~¡C¥L̦P®É´£¿ô¨Ï¥ÎªÌ¤£n
Åý¯ä®ñ¶h¤J©Ð¶¡¡C¦C¤ZÂå¥Í(Dr. Stephen A.
Levine)¡AAntioxidant Adaption¤@®Ñªº¦XµÛªÌ¡A
¤Ï¹ï¨Ï¥Î§Q¥Î¯ä®ñ²M¼äªÅ®ðªºªÅ®ð²M¼ä¾¹¡A¦]
¬°¯ä®ñ¤£À³§l¤JÅ餺¡C
«nªº¤@ÂI¥²¶·«ü¥X¡GĬ«X¦³¤@¨Ç¯f¨Ò¡A
Âå¥Í±N·L¶q¯ä®ñ²V¥H®ñ®ðÅý¤@®ñ¤ÆºÒ¤¤¬rªº±w
ªÌ§l¤JªÍ³¡¡A®ÄªG¥OÂå¥Í²`¨ã¦L¶H¡AµL¤Ï§@¥Î
µo¥Í¡C
¦Û¦å§K¬ÌÀøªk(AHIT)
¦Û¦å§K¬ÌÀøªk(autohomologous
immunotherapy)¬°¼w°ê©_ºÖÂå¥Í©ó1980¦~¥Nªì
³Ðµo¤§±M§QÀøªk¡C¼Ú¬w¦³¤@¦Ê¤G¤Q¦h¦WÂå¥Í¨Ï
¥Î¦¹¤@Àøªk¡C¬ü°ê¥¼§å㦹¤@Àøªk¡C¡C¡C
¤G®ñ¤Æ²BH2O2
¤G®ñ¤Æ²B¬O¼ä²bµL¦â²GÅé¡A©M¯ä®ñ¥i»¡¬O
ªñ¿Ë¡A¦]¬°¯ä®ñ±µÄ²§N¤ô«á§YÅܦ¨¤G®ñ¤Æ²B¡C
¡C¡C¹³¯ä®ñ¤@¼Ë¡A¤G®ñ¤Æ²B«Ü®e©ö©M¨ä¥Lª«½è
°_§@¥Î¡A¥B¯à±þ·À²Óµß¡B±H¥Í¦ä¡B¯f¬r©M¬Y¨Ç
¸~½F²ÓM¡C
¤G®ñ¤Æ²B²£¥Í©ó¦ÛµM¥Íª«°é¤¤¡A¦s¦b©ó«B
¤ô©M³·¤¤¡A¥H¤Î¥@¬É¦U¦a¦³Àø®Äªº·Å¬u¡C¡C¡C
¤G®ñ¤Æ²B¤]¬O´Óª«ªº«n¦¨¥÷¡A³\¦h½ªG¥iµo
²{¤Ö¶qªº¤G®ñ¤Æ²B¡A¦p¥ÌÂŵæ¡B¿»X¡BĪµ«¡B
«C´Ô¡B¤ôªà¡B¾ï¤l¡BÄ«ªG©M¦è¥Ê¡C
¤G®ñ¤Æ²B¤]¦s¦b©ó°Êª«¦ÛµM¥Í²z¬yµ{¤¤¡C
§@¬°®ñ¹¡©M¾¯¡A¤G®ñ¤Æ²B¯à¿é°e¤Ö¶q®ñ®ð¨ì¦å
²G¤Î¨ä¥L¨Åé«n²Õ´¡C¤G®ñ¤Æ²B¨Ã¤£¬O²£¥Í
®ñ®ð¦Ó¼W¥[¨Å骺®ñ®ð¶q¡A¥¦¦³¤@ºØ¯S§Oªº¯à
¤O¡A¨ë¿E®ñ¤Æ»Ã¯À¡A³o¨Ç»Ã¯À¯à§ïÅܨä¥Lª«½è(
¦p¯f¬r©M²Óµß)ªº¦¨¥÷¦Ó¦Û¨¤£°_ÅܤơC¤G®ñ¤Æ
²B¤£´£¨Ñ®ñ®ðµ¹²ÓM¡A¦Ó¬O«P¶i¤ÑµMªº²ÓM®ñ
¤Æ§@¥Î¡A¼W¥[¨Åé§Q¥Î®ñ®ðªº¯à¤O¡C¦pªkº¸Âå
¥Í»¡¡G
¥¦À°§U²ÓM½¤¶Ç¿é¡A§@¶Pº¸»X¶Ç´C
¡A½Õ¸`Åé·Å¡A¿EÀy¤Î½Õ¨î§K¬Ì¥\¯à
¡A½Õ¨î¯à¶q»s³y(Ãþ¦ü¯Ø®q¯À)©M°_
¥L«n·s³¯¥NÁÂ¥\¯à¡C¥¦¦³·N¦a¬°
¨Åé©Ò¥Î¡A²£¥Í²B®ñ°ò´åÂ÷½è¥h±þ
·À²Óµß¡B¯f¬r¡B±H¥Í¦äµ¥¡C³o¤@¤Ñ
µMªº¨¾½Ã¨t²Î©M®ñ®ðªº¼W¥[µLÃö¡C
§K¬Ì¨t²Î»Ý¦³¤G®ñ¤Æ²B¤~¯àµo´§¾A·í¥\¯à
¡C§Ü·P¬Vªº²É©Ê¥Õ¦å²y²£¥Í¤G®ñ¤Æ²B§@¬°©è§Ü
¥~¼Äªº²Ä¤@¹D¨¾½u¡C¥¦¬O²ÓM·s³¯¥NÁªº°Æ²£
«~¡A¶Pº¸»X½Õ¨î¾¯¡A²£¥Í»Û¿E¯À¡B¶ÀÅé¯À©M¥Ò
ª¬¸¢¯Àªº¥²n¦¨¥÷¡C¥¦¤]©M¦å¿}½Õ¨î¡B²ÓM¯à
¶q»s³y¦³Ãö¡C
¡C¡C¡C
¤G®ñ¤Æ²Bµ¥¯Å
l ¥~¥Î¾¯ ¤@¯ëÃÄ©±¸g°â¡A§t¦³¦UºØéw
¾¯¡A¤£¥i¤ºªA¡C
l ¬ü®e¥Î ¥Î©ó¬ü®e°|¬V¾v¡A¤£¥i¤ºªA¡C
l ¸Õ¾¯ ¥Î©ó¬ì¾Ç¹êÅç¡A§t¦³Ã©w¾¯¡A¤£
¥i¤ºªA¡C
l ¹q¾¹²M¼ä¾¯ ¤£¥i¤ºªA¡C
l ¤u·~¥Î¾¯ ¤£¥i¤ºªA¡C
l ¹¥Î¾¯ ¥Î©ó¹«~¤u·~§@µL¬r®ø¬r¾¯¡A
¦p¨Å¹T,³J©M§t¨Å¼ß¹«~¡C¤]¥Î©ó¼QÅx
¸ËªG¥Ä©M¥¤»s«~ªº¨¾»G¥]¸Ëºä¯È¤º¼h
¡C
l ¤õ½b¿U®Æ
¤G®ñ¤Æ²B¥Dn¥Î³~
º}¥Õ
¦Ã¬V±±¨î
¹A·~
¤@«~²æ(¤K¤À¤§¤@¥[¨Ú)35%¹«~¯Å¤G®ñ¤Æ
²B²V¦X1000¥[¨Ú¹¥Î¤ô¡A¥Î¥H¹}Áý°Êª«¡A´£¤É
¦å²G®ñ¹¡©M§@¥Î¡A°£·À¯fµß©M¦³®`ªº¸zµß¡A¥i
¼W¥[¨Å¤û²£¶q©M¥¤¯×¥÷¶q¡C
¥i¥Î§@¨Å»s«~®ø¬r¾¯¡BÀxÜ®ø¬r¾¯¡C
¥H¤G®ñ¤Æ²Bµ}ÄÀ²G¼QÅx¹A§@ª«¡A¥i¼W¥[§@
ª«²£¶q¡C
¤G®ñ¤Æ²B»PÂåÀø
ªì¦¸¤G®ñ¤Æ²BÂåÀø³ø¾É¨£©ó1920¦~¶ø§Q
ºÖÂå¥Í(T.H.Oliver)¡A±N¤G®ñ¤Æ²Bµ}ÄÀ²Gª`¤J¦å
ºÞ¡AªvÀø25¦W«·P«_ªÍª¢¡A¦º¤`²v¬°48%¡A¤@
¯ëÀøªk¤§¦º¤`²v¬°80%¡CÁöµM¨Ï¥Î¤G®ñ¤Æ²B¥i
¯à³y¦¨¦åºÞ®ð®ê¦Ó¤¤·¡A¦ýµL¤@±wªÌ¦³¦¹²{¶H
¡C
1920¦~¥N¬ü°ê¥d§JÂå¥Í¥Î¥L»{¬°©M¤G®ñ
¤Æ²B§@¥Î¤@¼ËªºgloxylideªvÀøÀù¯g¡A¥L¨Ï¥Î¦Ù
¤ºª`®g¦Ó¤£¥Î¦åºÞª`®g¡CÁöµM¥LªºªvÀø¦¨¥\¡A
¦ý¨Æ«á³Q¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)±±§i¡CÁöµM
«Å§iµL¸o¡A¥L¨M©w²¾©~°ê¥~Ä~Äò¥LªºÂåÀø»P¬ã
¨s¡C¡C¡C
¼w¦{¨©°Ç¤j¾ÇÂå¾Ç¤¤¤ß¬ã¨sûµo²{¤G®ñ¤Æ
²B¥i±j¤Æ¤ß¦Ù¡A¸Ñ°£¤ß¦Ù¯Ê®ñ¯g(myocardial
ischemia)¡C¡C¡C¤G®ñ¤Æ²B¯àªø´Á©Ê®ø°£¦åºÞ¾À
´³¡A¥i¥H§K¥h©ù¶Q¦ÓµL®Äªº¤ßŦ¦åºÞ¶¹D¤â³N
¡C³o¤@µo²{¨Ã¨S¦³¨ü¨ì²{«eªºÂåÀøÅé¨î«µø¡C
¥Ø«e³Ì«nªº¤G®ñ¤Æ²BÀøªk¬ã¨sÀ³Äݶø§J
©Ô²ü°¨¦{ªºªkº¸Âå¥Í(Charles H. Farr)¡Cªkº¸Âå
¥Í¬O¤G®ñ¤Æ²BÀø®Äªºº¥ý«ØijªÌ¤§¤@¡C¹³¯ä®ñ
ªºÂåÀø¬ã¨sªÌ¤@¼Ë¡A¥Lªº¤G®ñ¤Æ²BÂåÀø¬ã¨s³Q
¬ü¡B¥[¶Ç²ÎÂåÀø¬É©Ò©¿µø¡A¦ý¬O¥~°êªºÂå¾Ç¬É
ªÖ©w¥Lªº¦¨´N¦Ó´£¦W¥L¬°1993¦~¿Õ¨©º¸¼úÔ¿ï
¤H¡C
¤G®ñ¤Æ²B¦³¦ó§@¥Î¡H
ªÍ
¤G®ñ¤Æ²B¥H¼W¥[¦å¬y¶q¨Ó¨ë¿EªÍ³¡ªº®ñ¹¡
©M§@¥Î¡A¼W¥[¦å²G»PªÅ®ðªº±µÄ²¡A¤]À°§U¬õ¦å
²y©M¦å¬õ¯À¹B°e®ñ®ð¨ìªÍ²ÓM¡C³o¦³§U©ó±N¥~
¨Óª«½è©M¦º¤`¤Î¨ü·l²Õ´±q®ðªw²¾¥X¡C
·s³¯¥NÁÂ
¤G®ñ¤Æ²B½Õ¸`¤@¨Ç¶Pº¸»X®ÄÀ³¡A¥]¬A¶ÀÅé
¯À¡B¥Òª¬¸¢¯Àªº²£¥Í¡A¥H¤Î§í¨î¥Íª«®ò
(bioamines)¡B¦h¤Ú®ò(dopamine)¡B¥¿µÇ¤W¸¢¯À
(noradrenalin)¡B¦å²M«P¶i¯À(serotonin)¡C¤G®ñ¤Æ
²Bª½±µ©Î¶¡±µ¨ë¿E¬Y¨Ç®ñ¤Æ»Ã¯À¨t²Î¡C»Ã¯À¬O
¤@ºØ½Æ¦X³J¥Õ¡A¯à¤Þ°_¨ä¥Lª«½èªº¤Æ¾ÇÅܤơA
¨Ò¦p®ø¤Æ»Ã¯À¡A¯à¤À¸Ñ¹ª«¥H«K¨Åé§l¦¬§Q¥Î
¡C
¤ßŦ»P´`Àô¨t²Î
¤G®ñ¤Æ²B¯àÂX±i¤ßŦ¡B¥|ªÏ¡B¸£¡BªÍªº¦å
ºÞ¡A°§C¤ß¸õ²v¡B¼W¥[¦å¬y¶q¡A´î¤Ö¦åºÞªý¤O
¡C
¦å¿}§Q¥Î
¤G®ñ¤Æ²B¦³Ãþ¦ü¯Ø®q¯À¡A¥B¦³®Ä¦aéw¿}
§¿¤A«¬±wªÌªº¦å¿}¡C
§K¬Ì¤ÏÀ³
²É©Ê¥Õ¦å²y§Ü¿m·P¬V¡A·í¤G®ñ¤Æ²B¤ô·»²G
ª`¤JÅ餺«á¡A²É©Ê¥Õ¦å²y¶q¥ý´î«á¼W¡C¤G®ñ¤Æ
²B¤]¨ë¿E³æ®Ö²ÓM§Î¦¨(³æ®Ö²ÓM¬O¤@ºØ²M°£¯f
µßªº¥Õ¦å²y)¡A¨ë¿ET-§U¤â²ÓM(t³d§K¬Ì¤ÏÀ³
ªº¥Õ¦å²y¡A¨Ã³qª¾§K¬Ì¨t²Î¤º¨ä¥L²ÓMµo´§§@
¥Î)¡A¼W¥[¥¨¾½³J¥Õ¡A«OÅ@°·±d²ÓM¡C
¤G®ñ¤Æ²B¯àªv¤°»ò¯f¡H
¯Â«×3%ªºÂù®ñ¤ô¬O¤@¯ë©Òª¾ªº¥~¶ËÀø¾¯
¡C¦ý«Ü¤Ö¤Hª¾¹D35%¹«~¯Å¤G®ñ¤Æ²Bµ}ÄÀ«á¤º
ªA¡A¥Î§@¥Íª«®ñ¤ÆÀøªk¡C
¤G®ñ¤Æ²B¹³¯ä®ñ¤@¼Ë¦³¼sªxªºÀø®Ä¡A®Ú¾Ú
ªkº¸Âå¥Í©Ò»¡¡AÀR¯ßª`®g¤G®ñ¤Æ²B¤ôÄÀ²G¡A¹ï
¤U¦C¯e¯f¦³¦UºØµ{«×ªºÁ{§É®ÄªG¡G
«æºC©Ê´±¶Ç¬V¯f
¹L±Ó(allegies)
è§b¯g(Alzheimer's disease)
¤ßµ±µh
®ð³Ý(asthma)
¤ß«ß¤£¾ã(cardiac arrhythmia)
¸£¦åºÞ¯f(¤¤·¡B°O¾Ð³à¥¢)
¤ßªý¶ë(cardioconversion)
ºC©ÊªÍªý¶ë
ºC©Ê¯kµh(¦UºØì¦])
ºC©Ê³æ®Ö¥Õ¦å²y¼W¦h¯g(Epstein-Barr
Infection)
ºC©ÊµLÃĮIJӵ߷P¬V
ÀYµh¸s(cluster headaches)
¿}§¿¯f¤A«¬(diabetes type II)
ªÍ®ð¸~(ephysema)
³æ¯Âªw¯l(herpes simplex)
±aª¬ªw¯l(herpes zoster)
§K¬Ì¥\¯à¥¢½Õ¯f¬r·P¬V(HIV realted
infection)
·P«_
Âಾ©ÊÀù¯g(metastatic carcinoma)
°¾ÀYµh(migraine headaches)
¦hµo©Ê¯«¸g¦åºÞµw¤Æ(multiple
sclerosis)
±H¥Í·P¬V(parasitic infections)
¤Úª÷¥Í¤ó¯f(Parkinson's disease)
¥|ªÏ¦åºÞ¯f(´`Àô¤£¨})
·Àã©ÊÃö¸`ª¢
ºC©Ê©À¯]µß¯f
ù®°Ê¯ßª¢(temporal arteritis)
¦åºÞ¯gÀYµh(vascular headaches)
¤G®ñ¤Æ²B¦p¦ó¨Ï¥Î¡H
ÀR¯ßª`®g
¤fªA
¤@ªM¤ô¤¤¥[¤J´Xºw35%¤G®ñ¤Æ²B¡A¤éªA¨â
¤TªM¡C¤@¦ìµÛ¦W¤ßŦ¤â³NÂå¥Í¦b¤@«Ê«H¤W»¡¡G"
§ÚªºÃö¸`ª¢¯g®ø¥¢¡AnÂk¥\©ó¨C¤éªA¥Î¤G®ñ¤Æ
²B¤ô·»²G´X¦¸¡C"
¤@¦ìª¾¦Wªº·~¾l¬ã¨sªÌ«Øij¡G¤@ªM8¯s¥q
ªº»]ÃH¤ô¥[¤J10ºw¹«~¯Å¤G®ñ¤Æ²B¡A¨C¤éªÅ¸¡
ªA(¶º«e¥b¤p®É©Î¶º«á¤T¤p®É)¥Î¨â¡B¤T¦¸¡Cı±o
¤G®ñ¤Æ²B¤f¨ý¤£¨Îªº¤H¥i¥[¤J´Xºw¾ñÆVªo¡C©Î
¥i²Ä¤@¤é¨Ï¥Î¤@ºw¤G®ñ¤Æ²B¡AµM«á¨C¤é²Ö¼W¦Ü
10ºw¡C
𨩧JÂå¥Í¤Ï¹ï¤G®ñ¤Æ²B»P¤û¥¤¡BªG¥Ä©Î
¨ä¥L¾A¤fª«¦PªA¡C¦]¬°¥¦·|"¤Þ°_®ñ¤Æ§@¥Î¡Aé
¹Ü¦å²G©Ò´Á«Ýªº®ñ¤À"¡Cªkº¸Âå¥Íĵ§i¡G"°£¤Fªo
»P¤ô¤§¥~¡A¥ô¦ó²K¥[ª«³£·|¯}Ãa¤G®ñ¤Æ²Bªº¥\
¯à¡C"¬Y¨ÇÂå¥Í¤]ĵ§i¡G¤£n¨Ï¥Î§tÅK½èªº¤ô¡A
¦]¬°¥¦·|¤Þ°_¤j¶q´åÂ÷½è¡A³y¦¨¤ÏG¡Aªø´Á¤U
¨Ó¡A¥i¯à·|¤Þ°_Àù¯g¡C©Ò¥H³Ì¦n¨Ï¥Î»]ÃH¤ô¡C
ªA¥Î¤G®ñ¤Æ²B¤ô·»²G«e«á¤@¤p®É¤º¤£nªA¥Î§t
¦³ÅK½èªº¸É¾¯¡C
¦³¨Ç±Ä¥Î¤G®ñ¤Æ²BÀøªkªºÂå¥Í¤£¦P¨Ï¥Î·N
¤fªAªk¡Cªkº¸Âå¥Í»{¬°¡A°£¤FG¤¤¦³ÅK½è¦s¦b
¤§¥~¡A¥L¬Û«H¯×ªÕ»Ä²V¦Xª«·|±N¤G®ñ¤Æ²B®ø´î
¦¨¤@¨Ç´åÂ÷½è¡A¹ïG¸zÂH½¤³y¦¨t®ÄªG¡A¡C¡C
¤fªA¦ÛÀø¤´¦³½Øij¡A¦]¬°³\¦hªø´Á¤fªA¨Ï
¥ÎªÌ¨Ã¨S¦³P¯f¡A¤]¨S¦³¯Ê¥FÁ{§É¬ã¨s¡C°£«D
¬ã¨sµ²ªGÃÒ¹ê¤fªA¦³®`¡A¸T¤î¤fªA¤~¦³»¡ªA¤O
¡C
®ûªw
¸û¦w¥þ¥B¤Ö½Øijªº¤èªk´N¬O¥Î¤@«~²æ35%
¹«~¯Å¤G®ñ¤Æ²B©ñ¤J·Å¤ô¯D¬û¤¤¡AµM«á®û¦b¤ô
¤¤¦Ü¤Ö20¤ÀÄÁ¡A¤G®ñ¤Æ²B¥Ñ¥Ö½§§l¤JÅ餺¡C¨Ï
¥ÎªÌ«ÅºÙ¨C¶gªw®û¤@¦Ü¤T¦¸¡A¥iªvÀøÃö¸`»øµw
¡BºÅ¸~¡B¤û¥ÖÅ~©MÅðµß·P¬V¡C¦ý¨S¦³Á{§É¸ê®Æ
µý¹ê¨ä®Ä¤O¡C
Ãö¸`Á_»P³n²Õ´¾÷¨îÂIª`®g
ªkº¸Âå¥Íº³Ð±N0.03%¤G®ñ¤Æ²Bª`¤JÃö¸`
Á_»P³n²Õ´¡C¥Lµo²{¦UÃþ«¬Ãö¸`ª¢¹ï³o¤@ª`®g
ªk¤ÏÀ³¨³³t¡A¹ï©ó«üÀY¡B½¥»\ªº°©Ãö¸`ª¢¯S§O
¦³®Ä¡C¹ï¦Ù¦×©Mµ¬Á䪺¾÷¨îÂIª`®g¤]¯à¨³³t¸Ñ
°£¯fµh¡C
´åÂ÷½è»P¤G®ñ¤Æ²B
¤G®ñ¤Æ²B¬O¬¡©Ê®ñ®ð±Ú¡A¥i¥H¤À¸Ñ¦ÓÄÀ¥X
´åÂ÷½è¡A§@¥Î¹³´åÂ÷½è¡A¦ý³q±`¬O§Î¦¨¨ä¥L´å
Â÷½èªº´C¤¶¡A¦p²B®ñ°ò¡A¥¦¬O§Ü¯fªºn¶µ¡A¦ý
¬O¹L¶q«h¹ï¨Å馳®`¡C³\¦hÂå¥Í¬Û«H¥Î²B®ñ°ò
ªv¯f¹ï¨Å馳®`¡A¦]¬°¥¦·|¨ÏÅ餺´åÂ÷½èªº²£
¥Í¥¢¥h±±¨î¡C¦ý¬O³Ìªñªºµo²{©M³o¤@±À½×¤£¦X
¡C
ªkº¸Âå¥Íªº¬ã¨s«ü¥X¡A¤G®ñ¤Æ²B¥u¦³¦b¯S
§O±¡ªp¤U¤~·|§Î¦¨²B®ñ°ò´åÂ÷½è¡A¥Dn¬°®ñ¤Æ
ÅK(ferrous oxide)¦s¦b¡A©Ò¥HÂå¥Í«Øij¡G¤fªA©Î
ª`®g¤G®ñ¤Æ²B®É¡A¤£¥iªA¥Î§tÅKª«½è¡C·í®ñ¤Æ
ÅK¤£¦s¦bªº®ÉÔ(¤j³¡¥÷ªº®É¶¡¦p¦¹)¡A¤G®ñ¤Æ²B
³q±`³Q»Ã¯ÀIJ´CÂà¤Æ¦¨¹ï¨Å馳¯qªº®ñ¡C
¡C¡C¡C
·í¤Ö¶q¤G®ñ¤Æ²B¶i¤JÅ餺¡A¤G®ñ¤Æ²B±N®z
¯f©M¦º¤`ªº²ÓM®ñ¤Æ¡A¦P®É¨Ï°·±dªº²ÓM§ó±j
§§¡A¨Ã²£¥Í¸û¯à§Ü¯fªº·s²ÓM¡C³o¬O¨Åé±d´_
ªº¥Dn¹Lµ{¡C
¤ß¦åºÞ¯e¯f
Âå¥Í¨Ï¥Î¥Íª«®ñ¤ÆÀøªkªvÀø¤ßŦ¯f©M¬ÛÃö
ªº´`Àô°ÝÃD¤w¦³¤T¤Q¦h¦~¾ú¥v¡C¯ä®ñÀøªk(¥Î©ó
¦Û¦åÀøªk¡B¦Ù¤ºª`®g¡BÀR¯ßª`®g¡B°Ê¯ßª`®g©Î
ª½¸z¼Qª`)¡B¤G®ñ¤Æ²BÀøªk(¥Dn¬°ÀR¯ßª`®g©Î°Ê
¯ßª`®g)³Q¥Î¨ÓªvÀø¤ßŦ¯f¬ðµo(heart attack)¡B¸£
¤¤·¡B°ª¦åÀ£¡B¤ß¾÷¯à¤£¥þ¡B°ªÁx©T¾J¡B¤ßµ±
µh¡B°Ê¯ßµw¤Æ¡A¥H¤Î¦UºØ´`Àô¤£¨}ªº°ÝÃD¡C
¦b¥j¤Ú¡A¯ä®ñÀøªk¤w¦¨¬°¤ßµ±µh©M¤ßŦ¯f
¬ðµoªººD¦æÀøªk¡C1994¦~¤¸¤ë³X°Ý¥j¤Ú´Á¶¡¡A
Manuel Gomez (¯ä®ñ³¡Department of Ozoneªº
³Ð¥ßªÌ¤§¤@)»¡¦oªº¥À¿Ë(¤K¤Q·³)¤T¦~«e±oÄY«
¤ßµ±µh¡A±q¤@©Ð¶¡¨«¨ì¥t¤@©Ð¶¡³£·P¨ì¤ßµh©M
©I§lµu«P¡C¸g¹L¤T¶g¦Û¦åÀøªk¡A¤ßµ±µh§¹¥þ®ø
¥¢¡A¤T¦~¨Ó¥¼´¿´_µo¡C
¥Íª«®ñ¤ÆÀøªk«P¶i¦å²G´`Àô¡A§ïµ½²Õ´ªº
®ñ®ð¨ÑÀ³¡A¼W±j²ÓMªº·s³¯¥NÁ®IJv¡C
¯ä®ñ©M¤G®ñ¤Æ²B§ïÅܦå²Gªºµ²ºc©M¬y³q°Ê
¡BÀR¯ßªº¤è¦¡¡C¬õ¦å²y°ï¿n(¨å«¬ªº°Ê¯ß³¬¶ë¯g)
¸g¥Ñ¬õ¦å²y²ÓM½¤¹q²üªº§ïÅܦӵθѡA¦P®É¡A
¼W¶i¬õ¦å²yªº¦ùÁY©Ê©M¼u©Ê¡A§ïµ½¦å²Gªº¬y³q
¯à¤O ¡A¼W¥[¤ßŦ©M²Õ´©Ò»Ýªº¥Í©R¤§®ñªº¨ÑÀ³
¶q¡C
¤@¨Ç³o¤è±ªì´Áªº«n¬ã¨s¨Ó¦Ûªi¤h¹y·s
^®æÄõÂå¾Ç¤¤¤ßÂå°|¡C¬ã¨sûµo²{¤Ö¶qªº¤G®ñ
¤Æ²B¥i¥H§ïÅܦå¤pªOªº¿n»E¡C¦å¤pªO¦b¦å²G¾®
©T©M¦å¾®¶ôªº²{¶H§êºt«n¨¤¦â¡C³ø§iµ²½×¡G"
¤G®ñ¤Æ²B¥i¨Ï¦å¤pªO¿n»E©Î¸Ñ´²¦Ó§ïÅܦ微¶ô
ªºµo®i¡C¡C¡C"
¥t¨â¶µ¬ã¨s½T©w¤G®ñ¤Æ²B¬°¦å¤pªO¬¡°Êªº
½Õ¨î¾¯¡C
¥t¦³ÃÒ¾Ú«ü¥X¤G®ñ¤Æ²B¯à®ñ¤Æ¦åºÞ¾À´³µ¥
ªo¯×¡C¤@½g³q°T¤å³¹¼g¹D¡G
®ñ¤Æªº¦n³B¥]¬A¦åºÞ¾Àªo¯×ªº®ñ¤Æ¡C
¤G®ñ¤Æ²B©Ò¤Þ°_ªº²Õ´²G®ñ¹¡©Mªº¦n
³B¥i¯à¬O¦¸nªº¡C¤G®ñ¤Æ²B°Ê¯ßª`®g
«á¡AÁx©T¾J©M¤T¥Ìªo¯×ªº«~½è´£°ª¡C
¦h¦¸°Ê¯ßª`®g¤G®ñ¤Æ²B¥i²¾°£¦åºÞªº
ªo¯×¾À´³¡A¼W¥[¦åºÞ¾Àªº¼u©Ê¡C
¥Íª«®ñ¤ÆÀøªk¤]¯à¬¡¤Æ«nªº»Ã¯À(¦p
glutathione peroxidase, catalase, superoxide
dismutase)¡A³o¨Ç»Ã¯À¨ã¦³²M°£´åÂ÷½èªº¥\¯à¡C
¹L¶qªº´åÂ÷½è·|¤Þ°_¤ßŦ¯e¯f©M´`Àô²V¶Ã¡C
¥Íª«®ñ¤ÆÀøªk¦³®ÄªvÀø¦UºØ¤ßŦ¯e¯fªºÃÒ
¾Ú¤Q¤À¥R¨¬¡C¤ß¦åºÞ¯f¬°¬ü°ê¦¨¤H¦º¤ý©Î´Ý»Ù
ªº¥D¦]¡AÀ³¸Ó¬O±´¨s¥Íª«®ñ¤ÆÀøªk¹ï¤ß¦åºÞ¯f
ªºªvÀø©M¹w¨¾®ÄªGªº®ÉÔ¡C
°Ê¯ßµw¤Æ
¤ß«a¦åºÞ»P¤j¸£¦åºÞªº°ÝÃD
Ĭ«XNzhny NovgorodªºÂå¾Ç°|ªvÀø39¦W
ÄY«ªº¦åºÞµw¤Æ¯f¤H¡A©Ò¦³¯f¤H³£¦³¤ßµ±µh¡A9
¦W¦³¹L¤ßŦ¯f¬ðµo¡A1¦W¨ü¹L¤ß¦åºÞ¶¹D¤â³N
¡A2¦W¸£¤¤·¡A´X¥G¤T¤À¤§¤G±wªÌ¸£¦å²G¨ÑÀ³
¤£¨¬¡C¥|¤À¤§¤@¦³¸£¦å´`Àô¤£¨}ªºª¬ªp¡C
±wªÌ¨C¤éªA¥Î¯ä®ñ³B²z¹Lªº´â¤Æ¶u¤¦¸¡C
¤G¤Q¤Ñ«á¡A¤ßµ±µh¨C¤éµo§@²v±q6.1°¨ì2.5¡A
ªv¤ßµ±µhªº¦åºÞÂX±i¾¯¡A¤Tµv»Ä¥Ìªo¯×
(nitroglycerine)ªA¥Î¶q´î§C¡C82.1%±wªÌªºÅé¯à
@¤O¼W¥[¡C51.1%¦A·¥¤Æ ¤£¨}ªº±wªÌ¥\¯à§¹¥þ
´_ì¡C¦¹¥~¡AÁx©T¾J¤ô¥°§C48%¡A¤T»Ä¥Ìªo
¯×(triglyceride)¤ô¥°§C53%¡C³o¨Ç¶¶§Qªºµ²ªG
¨Ï¬ã¨sû»{¬°¡G¶E©ÒÀ³±N¯ä®ñÀøªk¦C¬°ªvÀø°Ê
¯ßµw¤Æªº¦³®Ä¤èªk¡C
¥|ªÏ°ÝÃD
1980¦~¥Nªì¡A¬ã¨sû¶i¦æ¤@¶µ¥|ªÏ°Ê¯ßµw
¤ÆªºªvÀø¬ã¨s¡C³o¨Ç¯f¤H²Å¦Xªk°ê¤ßŦ±M®aG.
Fontaine©Ò¹º¤Àªº¥|¶¥¬q¤§«á¤T¶¥¬q¡G
I. ®e©ö¯h¡A§N·P
II. Áô¬ù¯kµh¡A¶¡·²©Ê¶_¦æ
III. ½öª×®É¯kµh
IV. ¥Í¯j
²Ä¤T¡B¥|¶¥¬q©¹©¹»Ýn¤â«ü¡B¸}«ü¡B¥|ªÏ
ªº¤Á°£¤â³N¡C
±wªÌ¨Ì¯gª¬¡B¦~¬öÃþ¦ü¤À¦¨¹êÅç²Õ»P±±¨î
²Õ¡C±N®ñ»P¯ä®ñ²V¦X¾¯¥Î°Ê¯ßª`®gªk¿é¤J232
¦W¹êÅç²Õ(¥Ò²Õ)±wªÌªº¦å²G¤¤¡A¦¹¥~¡A¥Î¶ì½¦³U
±N¤â¨¬±w³¡¥]¦í¨ÃÄé¤J¯ä®ñ¡C140¦W±±¨î²Õ(¤A
²Õ)±wªÌ«h¨Ì¶Ç²Îªº¦åºÞÂX±iÀøªk¬Iªv¡CªvÀøµ²
ªG¡A¹êÅç²Õ²Ä¤T¶¥ªº»LªÑ¤Á°£²v±q15%°¬°
10%¡A²Ä¥|¶¥±q50%°¬°27%¡A¨ä¾l¤ñ¸û¦p¤U
¡G
¶¥¬q
¤H¼Æ
©úÅã§ïµ½
²¤¦³§ïµ½
´c¤Æ©ÎµL§ïµ½
¥Ò²Õ
¤A²Õ
¥Ò²Õ
¤A²Õ
¥Ò²Õ
¤A²Õ
¥Ò²Õ
¤A²Õ
II
105
73
80.0%
43.8%
11.4%
19.2%
8.5%
37.0%
III
72
46
70.8%
39.1%
19.4%
17.4%
9.7%
43.5%
IV
55
21
50.9%
28.6%
21.8%
19.0%
27.3%
54.0%
1988¦~¥j¤Ú¶i¦æ¤@¶µ60¦W¦åºÞµw¤Æ¯f¤H
ªº¬ã¨s¡A¥Dn¬°¥|ªÏ¡A¤×¨ä¬O¸}³¡´`Àô¤£¨}¡C
¯f¤H¨Ì¯gª¬¡B¦~ÄÖÃþ¦üµ¥¤À¦¨¨â²Õ¡C¤@²Õ¨C¤é
±µ¨ü§t®ñ©M¯ä®ñªº¦Û¦åÀøªk©Î®ñ»P¯ä®ñ°Ê¯ßª`
®g¡C¥t¤@±±¨î²Õ«hµ¹¤©¶Ç²ÎÀøªk¡C
¤Q¤Ñ«á¡A¹êÅç²Õ15¦W¦åºÞµw¤Æ¸û»´ªº±wªÌ
¦³73.4%ªº¤HÅã¥Ü©úÅã§ïµ½¡A20%ªº±wªÌ´c¤Æ
¡F±±¨î²Õ15¦W¦åºÞµw¤Æ¸û»´ªº±wªÌ¦³40%±wªÌ
§ïµ½¡A53%¯f¤H´c¤Æ¡C¹êÅç²Õ15¦W¦åºÞµw¤ÆÄY
«ªº±wªÌ(¥]¬AÄY«¯kµh¡BÃa¯j¡A¯Ê¦å¼ìºÅ)60%
ªº¤HÅã¥ÜÁ{§É§ïµ½¡A6¤H(40%)´c¤Æ¡F±±¨î²Õ15
¦W¦åºÞµw¤ÆÄY«ªº±wªÌ¥u¦³26%ªº¤H§ïµ½¡A11
¤H(73%)´c¤Æ¡C
¤ßŦ¯Ê·l(¤ß¤º½¤ª¢·P¬V¤Þ°_)
·í¤ß¤º½¤ª¢(endocarditis)¥X²{¡A¥|¤À¤§¤@
ªº¤ßŦ¯f¤H¦º©ó¤â³N¤¤©Î¤â³N«á¡CĬ«X¬ã¨sû
¹ï±µ¨ü¤ßŦ¤â³Nªº¯f¤H¶i¦æ¤@¶µ¤£´M±`ªº¬ã¨s
¡C¦b¤â³N¤¤¡A¯f¤Hªº¤ßŦ³Q®û©ó§t¯ä®ñªº¤ßŦ
³Â¾K²G(¥Î¨Ó°±¤î¤ßŦ¸õ°Ê)¡A¥Î¤ßªÍ¾÷´`Àô¦å²G
¡A¦P®É±N®ñ»P¯ä®ñ²V¦X¾¯¥[¤J¦å¤¤¡Cµ²ªGÅã¥Ü
¡A¤ß¤º½¤ª¢¨Öµo¯gªº¦º¤`²v±q26.6%°¨ì4%¡C
¦åÁx©T¾J¹L¦h¯g
¤@¶µ¬ã¨s«ü¥X¡A¦åºÞ±µ¨ü¤G®ñ¤Æ²Bª`®gªº
³¡¦ì¡AÁ`ªo¯×´î¤Ö¬ù50% ¡C
¥j¤Ú¶i¦æ¤@¶µ¬ã¨s¡A22¦W46-72·³ªº¤ßŦ
¯f±wªÌ¡A±µ¨ü¤Q¤¦¸ªº§t¯ä®ñ¦Û¦åÀøªk¡C²Ä¤
¦¸ªvÀø«á¡AÁx©T¾J¥§¡¤U°5.5%¡C¤Q¤¦¸ªvÀø
«á¡A¦åÁx©T¾J¥§¡¤U°9.7%¡C´c©ÊÁx©T¾J¦b¤
¦¸¬Iªv¤§«á¡A¤U°15.4%¡F²Ä¤Q¤¦¸¬Iªv¤§«á¡A
¤U°19.8%¡C
¬ã¨sû§@¦p¬Oµ²½×¡G"ÀR¯ßª`¤J¯ä®ñÀøªk¹ï
¤ß¦Ù±ð¶ë±wªÌªº¦å¯×¦³¨}®Ä¡F¦P®É¯à¦³®Ä¦a¿E
Ày§Ü®ñ¤Æ×Q¨t²Î"¡C
¯Ê®ñ
¤@¶µ¬ã¨sµo²{¤G®ñ¤Æ²B¯à´£¨Ñ®ñ®ðµ¹¯Ê®ñ
©Î§½³¡³h¦åªº¤ßŦ¡AÀ°§U¤ß«ß¦^´_¥¿±`¡A®¾±Ï
¤ß¸õ°±¤î¡C¬ã¨s³ø§i¤¤¦³¦p¤U±Ôz¡G
¤G®ñ¤Æ²BÄÀ¥X·»¸Ñªº®ñ¡Aµ¥©ó3-8
®ðÀ£·»²G¤¤ªº§t¶q(§Y°ªÀ£®ñ)¡C¤G®ñ
¤Æ²Bªº¬I¥Î¤£»Ý¸gªÍ³¡Âà°e¡A¥¦¥i
ªø¨ä¨ÑÀ³¡A¥¦¥i¥ÑÂå®v¤@¤H³æ¿W¾Þ
§@¡A¤£»Ý©ù¶Q³]³Æ©M¤j¶q¤H¤O¡AÁ×
§KÀ£ÁY©M¸ÑÀ£ÁYªº¦MÀI¡A¥H¤Î¯«¸g
¤¤¼Ï©MªÍ³¡¤¤¬rªº¦MÀI¡C
¥t¤@¶µ¬ã¨s¥H°Êª«¬°¹êÅç¡A±´°Q¤ß¦Ù±ð¶ë
ªº¯Ê¦å¶¥¬q¡A¤G®ñ¤Æ²B«OÅ@¤ßŦªº¯à¤O¡C¬ã¨s
ûµo²{¦b¯Ê¦å¶¥¬q¡A¤G®ñ¤Æ²Bµ}ÄÀ²G¯à«OÅ@¤ß
Ŧ¥\¯à¡C¤G®ñ¤Æ²B©MDMSO(dimethyl sulfate)ªº
²V¦X²Gªº«OÅ@®ÄªG¤ñ¨âªÌ¦U§O³æ¿W¨Ï¥Î§ó¦n¡C
¯ä®ñ¤]¦³Ãþ¦üªº®ÄªG¡CĬ«X¤@¶µÁ{§É¬ã¨s
¡A±´°Q¯ä®ñ¦p¦ó¦b¦åºÞ¤¤¼W¶i®ñ®ð¬y¶q ¡C¯ä®ñ
¼W¥[¤j¸£©M¤ßŦªº®ñ®ð¿é°e¶q¡A³o¤@µ²½×¨Ï¯ä
®ñÀøªk¦b¥j¤Ú³\¦h¸û¤jÂå°|ªº¤ßŦ¯f©Î¤¤·«æ
¶E«Ç©M¥[Å@¯f©Ð¡A¦¨¬°ºD¥ÎªºÀøªk¡C
¤j¸£¦åºÞ³h¦å
¤j¸£¦å²G¨ÑÀ³¨üªý¡A±`¨Ï±wªÌ¨¤ß³à¥¢¥\
¯à¡C³o¤@¯e¯f¬°¤u·~¤Æ°ê®a¦Ñ¤H¦º¤`ªº¥D¦]¤§
¤@¡C¥j¤Ú¤@¶µ120¦W±wªÌªºÁ{§É¬ã¨s¡C¡C¡C¬ã
¨sû§@¦p¤Uµ²½×¡G
1. ¯ä®ñÀøªk§ïµ½¤j¸£¦åºÞ³h¦å±wªÌ¯gª¬
¡A¶V¦ªvÀø®ÄªG¶VÅãµÛ¡C
2. 88%ªº±wªÌª¬ªp§ïµ½¡A«æ©Ê±wªÌÀò±o¸û
¨Îµ²ªG¡C
3. ¸g¦h¼h¦¸µû¦ô¡A©Ò¦³°Ñ¼Æ§¡¦³§ïµ½¡A¤×
¨ä¬O¤é±`¬¡°Ê¡C
4. ªvÀø´Á¶¡¡A¨S¦³¤Ï§@¥Îªºª¬ªp¡C
³o¤@µ²ªG¨ÏÂĺ¸¥Ë¦hªüªL¹FÂå°|¹ï³o¤@Ãþ
¯f±w¤@·§¬I¥H¯ä®ñÀøªk¡C
¾¨ºÞ¥Íª«®ñ¤ÆÀøªkµ¹¤ß¦åºÞ¯f±w±a¨Ó·¥¤j
§Æ±æ¡A¬ü°ê¥»¤g«Ü¤Ö¶i¦æ¯ä®ñ©M¤G®ñ¤Æ²BªºÂå
Àø¬ã¨s¡C¬ü°ê¤ßŦ¨ó·|¨S¦³¤ä«ù¹L³o¤è±ªº¬ã
¨s¡A°ê®a½Ã¥Í¸p¡B¯e¯f¹w¨¾»P±±¨î¤¤¤ß¡A©Î¥ô
¦ó¨ä¥L¤j¾÷ºc¥¼´¿±q¨Æ¤j«¬ªºµû¦ô¡C¡C¡C
Àù ¯g
¥Î¤G®ñ¤Æ²B©M¯ä®ñªvÀøÀù¯g¤w¦³´X¤Q¦~¾ú
¥v¡C¤ä«ù³o¤@¥Íª«®ñ¤ÆÀøªkªvÀùªº²z½×°ò¦¬O
®Ú¾Ú¤T¶µ«nªºµo²{¡C
²Ä¤@¶µµo²{¬O¨Ó¦Û¿Õ¨©º¸¼ú±o¼ú¤H¥Ë§B®æ
Âå¥Í(Dr. Otto Warburg)¡A¼w°ê°¨§J´µªiÄõ§J²Ó
M¥Í²z¾Ç°|(Max Planck Institute for Cell
Physiology)°|ªø¡C¦b¤@¦¸¿Õ¨©º¸¼ú±o¼ú¤HÁp½Ë·|
¤W(1966¦~¼w°êConstance´ò¯`)ÃÒ¹êÀù¯g§Î¦¨ªº
¥ý¨MÃöÁä¬O²ÓM¼h¯Ê®ñ¡C
²Ä¤G¶µ¦]¯À¬O¥Ñ¥t¤@¿Õ¨©º¸¼ú±o¼ú¤H¥Ë´Ë
Âå¥Í(Dr. James D. Watson¡AÂùÁ³±ÛDNAµo²{ªÌ
)´£¥X¡A¥Lµo²{"¥Ø«e©Òª¾¡A³Ì¦³¥ÎªºPÀùª«¬O¤@
¨ÇÂo¹L©Ê¯f¬r(viruses)" ¡C¦¹«e¡A¤£ª¾Àù¯gªº§Î
¦¨¦³Âo¹L©Ê¯f¬rªº¦¨¥÷¡C
²Ä¤T¶µµo²{¥Ñ¼w°ê¥Ë¿cÂå¥Í(D. Joaquim
Varro)©ó1974¦~º¥ý´£¥X¡A¥L«ü¥X¡GÀù²ÓMµL
ªk§Ô¨üÂù®ñª«½è¡A´£¥Ü¯ä®ñ©Î¤G®ñ¤Æ²B¥i§í¨î
¬Y¨ÇÀù²ÓMªº¦¨ªø¡C ³o¤@³ø§iª½¨ì1980¦~¤~³Q
^¤å¥Zª«©ÒÃÒ¹ê¡A¦b¬ì¾Ç(Scienc)´Á¥Z¤W¡A¥vºû
¯SÂå¥Í(Dr. Frederick Sweet)©M¥Lªº¦P¹±´£¥X¹ê
ÅçÃÒ¾Ú¡AÃÒ¹ê¯ä®ñ¯à§í¨îÀù²ÓM¦¨ªø¡C
¡C¡C¡C
¥H¤U±NÀËÅç¤@¨Ç¹êÅç«Ç©MÁ{§ÉÃÒ¾Ú¡A³o¨Ç
ÃÒ¾Ú¤ä«ù¯ä®ñ©M¤G®ñ¤Æ²B¦³§U©óÀù¯gªvÀø¡A¤£
½×³æ¿W¨Ï¥Î©Î°t¦X¶Ç²Î»P«D¶Ç²ÎÀøªk¡C
¤G®ñ¤Æ²B¬ã¨s
¦´Á¹F©Ô´µ(Dallas)¨©°Ç¤j¾ÇÂåÀø¤¤¤ß
(Baylor University medical Center)ªºÀù¯g¬ã¨s©l
©ó1960¦~¥Nªì¡A¥ÑªâÀOÂå¥Í(Dr. J. W. Finney)
©M¥Lªº¦P¤¯¶i¦æ¡C¤@½g¦´Á³ø§iµn©ó1962¦~3
¤ë«n¤èÂåÀø¾Ç³ø(Southern Medical Journal)¡A´£
¨ì¤G®ñ¤Æ²B°t¦X´T®gÀøªkªvÀùªº»ùÈ¡G¦b¤G®ñ
¤Æ²B©Ò¼W¥Íªº®ñÀ£(oxygen tension)¤§¤U¡AÀù²ÓM
¹ï·Ó®g§ó¬°±Ó·P¡C²Ä¤@¡B¤G¶¥¬q¬ã¨s¬°°Êª«¹ê
Åç¡A²Ä¤T¶¥¬q±Nµ}ÄÀ¤G®ñ¤Æ²Bª`¤J¦UºØÀù¯g±w
ªÌªº°Ê¯ß¤º¡A¬ã¨sûª`·N¨ì§½³¡©Êªº®ñ¤À¡A³o
¨Ï¥L̬۫H¡G¤G®ñ¤Æ²B¨Ï±w³¡¼W¥[®ñ¤ô¥¡A¥i
¨Ï±µ¨ü¿ç®gªvÀøªº´c©Ê¸~½F"¼W¥[ªv¡²v" ¡C
¤@¶µ¨©°Ç¤j¾ÇÀù¯g¬ã¨s(µLªk¤â³Nªº¤j¸¡
½F)¨Ï¥Î°Ê¯ßª`®g¤G®ñ¤Æ²B©M·Ó®g¡A¬ã¨sûnÆ[
¹î¤G®ñ¤Æ²B¬O§_¥i¨Ï¸~½FÁY¤p¨ì¥i¤â³Nªºµ{«×
¡C¤T¦ì¯f¤H¤¤¦³¨â¦ìªº¸~½FÁY¤p¨Ã¥B¤Á°£¤â³N
¦¨¥\¡C²Ä¤T¦ì¥|¶g¤º¨S¦³ÅܤơA³Q°e¦^®aµ¥¦º
¡C¨Ï¤H·N¥~ªº¬O¡A±wªÌªºª¬ªp´XӤ뤤³vº¥§ï
µ½¡A¸~½F¤]©úÅãÁY¤p¡A²×©ó³Q¦w¥þ¤Á°£¡C¬ã¨s
³ø§i¤¤¦³¦p¤Uªºµ²½×¡G
¸~½F¤Á°£¦¨¥\ÅãµM±o§U©ó¤â³N«e¤¤¶q·Ó®g
©M¸¡³¡¤j°Ê¯ßª`®g¤G®ñ¤Æ²Bµ}ÄÀ²G¡A¼W¥[
§½³¡®ñ¤À¤ô¥¡C±q¥t¤G¦ì¸¡¤º¸~½Fªº±wªÌ
¸g¾ú¡Aµo²{°Ê¯ßª`®g¤G®ñ¤Æ²Bµ}ÄÀ²Gªº¯q
³B¡C³o¨Çµo²{½T©w¤F³o¤@¤è±¶i¤@¨Bªº¬ã
¨s¡C
¥t¤@¶µ¬ã¨s¤G®ñ¤Æ²B§@¬°ªvÀù»²§U¾¯ªº»ù
È1966¦~¦b¤é¥»Tottori¤j¾ÇÂå¾Ç°|¶i¦æ¡C¤Q¤
¦W¤WÀX(»óµÄ¤ÎÃE)°©Àù±wªÌ³Q¬I¥H¤G
®ñ¤Æ²B°Ê¯ßª`®g¡A³sÄò¤Q¤Ñ¡AÀH«á¨C¤éª`®g§Ü
Àù§Ü¥Í¯Àmitomycin C¡A¥t¤@29¤Hªº±±¨î²Õ¥u
±µ¨ü§ÜÀù¾¯¡C
±µµÛ¸~½F³Q¤Á°£¨Ã§@¤ÀªR¡C¤Q¤¦W¹êÅç²Õ
±wªÌ¡A¤K¦W¸~½F´X¥G§¹¥þ®ø¥¢¡A¤»¦W³¡¥÷ÁY¤p
¡A¥u¦³¤@¦WÅܤƬƷL¡C¦³Åܤƪº¡A¤£¬O«æÁØÁY
¤p´N¬Oµw½F³n¤Æ¦¨¨§»G¯ë¡C¥u±µ¨ü§ÜÀù¾¯ªº¤@
²Õ¡A¤»¦W¸~½F§¹¥þ®ø¥¢¡A¤G¤Q¤@¦W³¡¥÷ÁY¤p¡A
¤G¦WµL¤ÏÀ³¡C¬ã¨sûµ²½×¡G"¦¹ªk©úÅã¼W¶i§ÜÀù
¾¯ªº®ÄªG¡CÁ{§ÉÃҹꦹªk¹ï±wªÌµL®`¡C"
¯Ã¬ù¥«¬¥§J´´¬¥¤j¾Ç¯Ç©ZÂå¥Í(Dr. Carl F.
Nathan)»P¥i«íÂå¥Í(Dr. Zanvil A. Cohn)¤]¬ã¨s
¤G®ñ¤Æ²Bªº§Ü½F®ÄªG¡A¥L̪º³ø§i¥Z¸ü©ó1979
¦~¹êÅçÂåÃľdzø(Journal of Experimental
Medicine)¡A¨ä¤¤»¡¹D¡G"¤G®ñ¤Æ²BÀ°§U¥¨¾½²ÓM
©M²É©Ê¥Õ¦å²y¶Ê·´¸~½F²ÓM¡C"(¦b«á¨Óªº¤@¶µ¬¡
¼â¹êÅç¡A¥L̵o²{8 mgªº¤G®ñ¤Æ²B±þ¦º90%¥H
¤WªºP338²O¤Ú½F²ÓM) ¡C
¡C¡C¡C
º¸¤Z(Irvine)¥[¦{¤j¾Ç¬ã¨s¤G®ñ¤Æ²B±þ·À
»PÀNªNª÷¤ó¯f(Hodgkin's disease)¦³ÃöªºÀù²ÓM
ªº¯à¤O¡C¬ã¨sµ²ªGµoªí©ó1989¦~6¤ë¸~½F´Á¥Z
(Cancer)¡C¤s¼¯´µ§JÂå¥Í(Dr. Michael K.
Samoszuk)©M¥Lªº¯f²z¾Ç¨t¤u§@¦P¤¯±q23¦W±w
ªÌ©â¨ú²O¤Úµ²Äa¯Bª«(suspensions)¡A¸m©óµ}ÄÀªº
¤G®ñ¤Æ²B¤¤¡A¥L̵o²{¡A¤Q¤¤ÀÄÁ«á¦³¯f¬rªº
²ÓM³vº¥³Q®ø·À¡C¬ã¨sûÆ[¹î¨ì¡G"ÀNªNª÷¤ó¯f
¤¤ªº¤G®ñ¤Æ×Q(peroxidase)¨Ï¸~½F²ÓM©ö¬°µ}ÄÀ
ªº¤G®ñ¤Æ²B©Ò®ø·À"¡C¡C¡C
¯ä®ñ¬ã¨s
¦p¦P¤G®ñ¤Æ²B¬ã¨s¡A¬ü°êªº¯ä®ñÀø®Ä¬ã¨s
º¥ý¬I©ó°Êª«¹êÅç¡C¤@¶µ¬ü°ê¯ä®ñ¹ï¨Å©ÐÀùªº
¼vÅT¤§ªì¨B¬ã¨s³ø§i¡A©ó1980¦~¥Nªì¡A¥Ñ¯Ã¬ù
¦{·x¥_§J(Rhinebeck)¥_²üÄõÂå°|(Northern
Dutchess Hospital)¨È«nÂå¥Í(Dr. Migdalia Arnan)
»P¼wºÖ¨ÓÂå¥Í(Lee E. DeVries)´£¥X¡C±o¨ÅÀùªº¹ê
Å繫³Qª`¤J¯ä®ñ»P®ñªº²V¦X¾¯¡A¥O¥t¤@±±¨î²Õ
¯f¹««h¤£§@¥ô¦óªvÀø¡C±µ¨ü¯ä®ñª`®gªº¯f¹«¡A
¸~¦º©óÅ餺¡A¦ý¥¼¥[¥H³Î°£¡A¬ã¨sû¬Û«H¥¦¦¨
¬°²Õ´¥¨¾½²ÓMªºt¾á¡A§í¨î¤F§K¬Ì¨t²Î¡C¦ý
¤£½×¦p¦ó¡A±µ¨ü¯ä®ñªvÀøªº¦Ñ¹«¤ñ¥¼¨üªvÀøªº
¤@²Õ¦h¬¡¤F30¨ì48¤Ñ¡C
©M¤G®ñ¤Æ²B¤@¼Ë¡A¾ÇªÌ¬Û«H¡G¯ä®ñªºÂåÀø
¥\®Ä¡A¦b©ó¥¦«P¨Ï¨ÅéÄÀ©ñ¸~½FÀZÃa¦]¤l¡A±þ
¦ºÀù¯g¸~½F¡C1991¦~Lymhokine and Cytokine
Research¥Z¸ü¤@½g¤å³¹¡A°Q½×§t¯ä®ñªº¦å²G¤§
¸~½FÀZÃa¦]¤l¤§´ú¶q¡C¬ã¨sûµo²{¡G¤j³¡¥÷ªº
¸~½FÀZÃa¦]¤l¦b¯ä®ñ¤ÏÀ³µo¥Í¤§«á¡A¥ß§Y³QÄÀ
©ñ¥X¨Ó¡C¥LÌ»{¬°³o¤@µo²{¦³§U©ó»¡©ú¦Û¦åÀø
ªk(autohemotherapy, ¤w¬I¦æ©ó¼Ú¬w´X¤Q¦~)ªºÁ{
§É®Ä¯q¡C¬ã¨sûµ²½×¡G³o¤@µo²{ÅãµM¤£¥u¹ïÂo
¹L©Ê¯fªvÀø¦³«n·N¸q¡A¹ï§K¬Ì¥¢±`©M¸~½F¯f
±w¤]¦P¼Ë«n¡C"
¥vºû¯SÂå¥Í(Dr. Frederick Sweet)©Ò»â¾Éªº
¤@¶µ¬ã¨s¡Aµo²{¬I¥H0.8parts/million¯ä®ñ³sÄò
¤K¤Ñ¡A¥i¥H§í¨î90%¥H¤WªºªÍ½F¡B¨Å½F¡B¤l®c
½FÀù²ÓMªº¦¨ªø¨ì50%¥H¤U¡A¹ï©ó¥¿±`²ÓM«h
µL·l¡C¬ã¨sªÌ»{¬°³o¬O¥Ñ©óÀù²ÓM¯ä®ñ®ñ¤Æ®ø
¯Óªº¸É¥R¤O¤£¦p¤@¯ë¥¿±`²ÓM¡C
¦´Á¤@¶µ¨Ï¥Î¯ä®ñÀøªk¦¨¥\ªº°O¿ýµoªí©ó
1983²Ä¤»©¡¥@¬É¯ä®ñ¤j·|¡A¥Ñ¼w°ê¥Ë¿cÂå¥Í(D.
Joaquim Varro)´£¥X¡C¡C¡C¥Ë¿cÂå¥Í¬Û«HÀù¯g¤£
¬O¨Ó¦ÛÅé¥~·P¬V¡A¦Ó¬O¦Û¨Å餺¡C¡C¡C
±q¯f¤H¤§¤¤¡A¥Lµo²{¯ä®ñÀøªk¦³©úÅ㪺®Ä
ªG¡A¯f¤H¹±ý¼W¥[¡AÅé¤O¼W¥[¡AÅé¯à¬¡°Ê¸ûÀW
Ác¡AµhW´î»´¡C¥L¹ï±µ¨ü¯ä®ñÀøªkªº¯f¤H§@¤F
¥H¤Uªºµû¦ô¡G
1. ¤â³N©M·Ó®gªº°Æ§@¥Î©M«áÄò§@¥Î¨³³t
´î»´©Î®ø¥¢¡C¹ï¤Æ¾ÇÀøªk(¨¾¤î²ÓM¥Í
ªø¤Î¼W¥Í)¥çµM¡C
2. ¯f¤Hªø´Á§K©óÂಾ¯fÅÜ©M´_µo¡C
3. ¦s¬¡®É¶¡©µªø¡A»·¶W®³®º¤£©wªº¹wÂ_
¡A§Y¨ÏµLªk¤â³N¡B§Ü¿ç®g¡B¤£³ô¤ÆÀø
¡A¤]³£¯à§ïµ½¥Í©R«~½è¡C
4. ¤j³¡¥÷±µ¨ü²V¦XÀøªkªº¯f¤H¡A¦b¤â³N
©M·Ó®g¤§«á¡A¯à«Ü§Ö¦^¨ì¥L̪º¥þ®É
¤u§@±^¦ì¡C
¥Ø«eªºÀøªk
𨩧JÂå¥Í(Kurt W. Donsbach) ¦b¾¥¦èô
©Ò«Ø¥ßªºÂå°|(Hospital Santa Monica)¥i¯à¬O¥@
¬É¤WÀ³¥Î¾ãÅé«O°·ªk(holistic health care)³Ì¤jªº
Âå°|¡C¤G®ñ¤Æ²BÀR¯ßª`®gªk³Q¼sªx¦a¥Î¨ÓªvÀø
Àù¯g¡C¼Æ¤d¯f¤H¦b¶Ç²ÎÂåÀøµL®Ä¤§«á¡A¨Ó¨ì³o
¸Ì°l¨D¥L̳̫᪺¤@½u§Æ±æ¡A¨Ã¥B¦³³\¦h¤H§¹
¥þ±d´_¡C𨩧JÂå¥Í¦b¥Lªº®ÑWholistic Cancer
Therapy½Í¨ì¹«~¯Å¤G®ñ¤Æ²BªºÂåÀøÀ³¥Î¡G
1. ¦b°ª®ñÀô¹Ò¡AÀù²ÓM¬r©Ê´î¤p¬Æ¦Ü³Q
®ø·À¡C
2. ¤fªA©ÎÀR¯ßª`®g¤G®ñ¤Æ²B¯à¼W¥[¦å
²G¤¤ªº®ñ§t¶q¡A¶i¦Ó¼W¥[Àù²ÓM©P³ò
ªº®ñ¤À¡C
3. ¤j¶qªºÁ{§ÉÃҾڨϧڬ۫H¡A¤G®ñ¤Æ²B
¬OªvÀøÀù¯gªºÄ_¶Q§U¤â¡C
°£¤F¤G®ñ¤Æ²B¡A𨩧JÁÙÀ³¥Îºû¥L©R¡BÄq
ª«½è¡B°ª¼ö©M¨ä¥L¤ÑµMÀøªkªvÀøÀù¯g¡C¦b¨C¤é
¤G®ñ¤Æ²BÀR¯ßª`®gªº¦P®É¡AÁÙ¥]¬A¤G¥Ò¨È(¥Û+
·)(dimethyl sulfoxide/DMSO)¡A¤@ºØ¥Î¨Ó«P¶i¥Ö
½§§l¦¬Ãľ¯ªº·»²G¡A𨩧Jµo²{¥¦¯à½w©M¤@¨Ç
±wªÌ±µ¨ü¤G®ñ¤Æ²Bª`®g©Ò¤Þªº¹L±Ó(irritation)¡C
¥L»{¬°DMSO¥»¨´N¬OÀù¯gÀø¾¯¡A¯àªý¤î²Óµß
¡B¯f¬r¡B¿¸Ãþµ¥¥Íªø¡A¯à®øª¢®ø¸~¡C¥Lµ¹©Ò¦³
¯f¤H¨C¤Ñª`®g¤G®ñ¤Æ²B©MDMSO¡C𨩧JÂå¥Í
©M¥Lªº¦P¹±ÁöµM¤]¥Î¯ä®ñªv¯f¡A¦ý¨S¦³¹³¤G®ñ
¤Æ²B¨º»ò¼sªx¡C¥L¦bOxygen-Peroxide-Ozone¤@
®Ñ¤W¼g¹D¡G
³ÌÖGªñ¯ä®ñ»s³y§Þ³Nªº¶i¨B¤Þ°_§Ú¨Ï¥Î
Àã¼í¤Æ¯ä®ñÄé¸zªk¡C³o¤@¤èªk¥i¥H¨C¤é
¦h¦¸¨Ï¥Î¦Ó¤£»Ýn¹³ÀR¯ßª`®gªk¨º¼Ë«I
²¤©Êªºµ{§Ç¡C¡C¡CµLµh¥B¦å²GÀò±oªº®ñ
¤À±K«×¤ñ¯ä®ñª½±µª`¤J¦å²Gªº¤èªk°ª¡C
¯f¤H³ßÅw³oºØÄé¸zªk¡A¦]¬°°¨¤W¦³µÎªA
ªº·Pı¡C¹ï©ó¦M«æªº¯f±w¨C¨Ï¥Î¤T¦¸¡A
³o¥i¥HÁקK¹³ª`¤J°®¯ä®ñ©ó¤j¸z©Ò¤Þ°_
ªºµ±µh¡C
§Ú°Ý𨩧JÂå¥Í¦³ÃöÀù¯gªv¡ªº²Îp¼Æ¦r
¡A¥L»¡²Îp¼Æ¦r¬O°g´b¤HªºªF¦è¡A¦ý¬O¥L±µµÛ
»¡¡G
¤j¬ù70%ªì¶E«á¤T¦~¤´µM¬¡µÛ¡A¦³¨Ç²¬
¡¤F¡A¦³¨Ç½w¸Ñ¤F¡A¦³¨Ç¥¿ºCºC¦º¤`¡C
¦ý®Ú¾Ú¥L̨Ӱ|¤§«eªºÂå¥Í¹wÂ_¡A«Ü¤Ö
¯à¬¡¹L´XӤ몺¡A³o¼Ëªº²Îp¹³¤°»ò¡H
§Ú̬ݨ쥻°|¬Û·í¤ñ¨Òªº¯f¤H¡A®Ú¾ÚÂå
¾Ç¶EÂ_ªºÃÒ©ú¡A§¹¾ã¤S§¹¥þ¦a²¬Â¡¡C
©_ºÖÂå¥Í(Dr. Horst Kief)¼sªx¦a¨Ï¥Î¦ÛÅé
¦P½è§K¬ÌÀøªk(autohomologous immunotherapy,
AHIT)ªvÀø¦UºØÀù¯g¡C1993¦~12¤ë§Ú³X°Ý¥Lªº
¶E©Ò´Á¶¡¡A§ÚÆ[¹î¤F¤@¦ì¨ÅÀù°ü¤k¡A¦o¸g¶Ç²Î
Àøªk«á´_µo«e¨Ó¨Dªv¡A¥ÎAHIT¤fªA©M±w³¡©P³ò
ª`®g¡A±wªÌ·P¨ì¨³³t½w¸Ñ¡C©_ºÖÂå¥Í¥H«eªº¦P
¨Æ¡A®æ³®«OÂå®v(Jon Greenberg, M.D.)«ü¥X¡A¨Ó
©_ºÖÂå¥Í¶E©Ò±µ¨üAHITªvÀøªºÀù¯g±wªÌ¡Aªø´Á
½w¸Ñ²v¦³60%¡A¥t20%«h¦³©Ò§ïµ½¡C
1988¦~¡A©_ºÖÂå¥Í¬ã¨s31¦W¿©±w´c©Ê¸~
½Fªº¯f¤H¡A¥]¬A¥Ö½§½F(carcinomas)¡B²O¤Ú½F
(lymphomas)¡B¦×½F(sarcomas)¤ÎµÇŦ½F(kidney
tumor)¡C¤j³¡¥÷ªº±wªÌ±µ¨ü¹L¤Æ¾Ç©M¿ç®gÀøªk¡A
¨S¦³ªø´ÁÀø®Ä¡C±wªÌ¨C¤Ñ±µ¨üAHITªvÀø¡A¬°´Á
¥|Ó¤ë¡CÀøµ{²Ä¥|¶g¡A±wªÌªº¥[º¿¤zÂZ¯À(gamma
interferon)¤ô¥¼W¬°7-9¿¡C¤zÂZ¯À¬O¤@ºØ¨ü¯f
¬r«I¤J¤§²ÓM»s³yªº³J¥Õ½è¡A¥H«OÅ@¥¼¨ü«Iŧ
¤§²ÓM¡C¾ãÓ»¡¨Ó¡A±µ¨üAHITªº¯f¤H¦Ûı¤j´T
§ïµ½¡A¥]¬A¯kµh´î»´70%¡A¤¸®ð¼W¥[90%¡C
»P©_ºÖÂå®v·|½Í¤§¶¡¡A°Ñ»P¤WzÀøµ{ªº¤@
¦ì±wªÌ¡A62·³¨k©Ê¡Aè¦n¨Ó°|§@¨Ò¦æÀˬd¡C
1988¦~¥L³Q¶EÂ_¬°immunocytoma²ÄIVb¯Å¡A
¤@ºØ»P²O¤Úµ²¦³ÃöªºP©R¯e¯f¡A¸~½FÂå®vÂ_©w
¥L´_ìµL±æ¡C¸g¤Q¤@¤ëAHITªvÀø«á¡A±wªÌ·Pı
§¹¥þ½w¸Ñ¡Aµ§ªÌ¹J¨£¥L¬°¥|¦~«á¤§¨Æ¡C
¡C¡C¡C
¶V¨Ó¶V¦hªºÁ{§É©M¹êÅçÃÒ¾ÚÅã¥Ü³o¨Ç®ñ®ð
Àøªkªº»ùÈ¡C¼Æ¸U¼Ú¬wÀù¯g±wªÌ·PÁ¯ä®ñÀøªk
¨Ï¥L̲æÂ÷¯fW¡A¦Ó¼Æ¦Ê¤H¤~¶}©l»{ÃѤG®ñ¤Æ
²B©M¯ä®ñÀøªkªº»ùÈ¡C³\¦hª¾¦Wªº¼Ú¬w°·¨·Å
¬u§Q¥Î¯ä®ñ§@¬°¨Ò¦æªº·Å¬u³B²z¡A´N¹³¨T¨®n
©w®É½Õ¾ã¤@¼Ë¡C¤£¤Ö¼Ú¬wÂå¥Í¤£¦ý¥Î¯ä®ñªvÀø
¯f¤H¡A¤]¥Î¨Ó¦Û§Ú«O°·¡C³o¨Ç¨Ò¤l¥YÅã¤F¯ä®ñ
©M¤G®ñ¤Æ²B¨¾Àù©M¨ä¥L¯e¯fªº«O°·»ùÈ¡C¡C¡C
HIV»PAIDS
·R´þ¯f(AIDS)¢w¢w«á¤Ñ©Ê§K¬Ì¤£¥þ¼xÔ¸s
(acquired immunodeficiency syndrome)¡A¥i¯à¬O
¥@¬É¤W³Ì¥i©Èªº¯e¯f¡C¥¦ºCºC¦a¶Ê·´§K¬Ì¨t²Î
ª½¨ì±wªÌµLªk§Ü¿m¦UºØ±`¤H¤£©ö¿©±wªº¯e¯f¡C
³o¨Ç¯e¯f¥i¯à¼vÅT¸£¡BªÍ¡B²´¤Î¨ä¥L¾¹©x¡A¨Ò
¦pªÍÅn¸~©ÊªÍª¢(pneumocystis carinii
pneumonia)»P¥dªi¦è´c©Ê¸~½F(Karposi's
sarcoma)¡C¦³AIDSªº¤H·|³vº¥®ø½G¡AµL¤O¡A¤Þ
µoµg¯e¡Bªq³àµ¥¡C
¡C¡C¡C
¬ü°ê¬F©²1994¦~·R´þ¯f¬ã¨s¸g¶O¶W¹L15
»õ¬ü¤¸¡FBurroughs WellcomeÃļt1992-1993
·|p¦~«×¥X°â¤F3.79»õ¬ü¤¸ªºAZT(¥Î¨Ó§í¨î
HIVÁc´ÞªººZ¾PÃÄ)¡C¹ï©ó³\¦hÂå¥Í¡BÂå°|©M«O
ÀI¤½¥q¨Ó»¡¡A³o¤@¯e¯f¬O¤@¤j¦¬¯q¨Ó·½¡A¦]¦¹
¡A´M§ä·G»ù¦³®ÄªºÀøªk¨Ã¤£¬O¤@¶µ°ª«×Àu¥ýªº
¨Æ¡C
³\¦h¥Î¨Ó¹ï§Ü¯e¯fªºÀø¾¯¡A°ò¥»¤W¨Ì§í¨î
¯f¬rÁc´Þ¦Ó³]p¡A¦ý¤j³¡¥÷§å·Ç¤W¥«ªºÃľ¯¥u
¦³³¡¥÷®ÄªG¡A³\¦h±wªÌ¹ï¥¦µL¤ÏÀ³¡A¥t¤@¨Ç±w
ªÌ«h¤Þ¤Ï¦V°Æ§@¥Î¡A¨Ò¦p³h¦å¡B¯ØŦª¢¡B¯«¸g
©Ê¯fÅÜ(neuropathy)¡C¦Ó¥B³o¨ÇÃľ¯ªºªø´Á§@¥Î
¤£¸Ô¡C
³oºØ±¡§Î¾ÉP³\¦h±wªÌÂà¦Ó¨D§U©ó¨ä¥LÀø
ªk¡A³q±`¬O¶Ç²Î»P«D¶Ç²ÎÀøªk¦X¥Î¡A¥]¬A°wª¥
¡B¥Þ¹D«üÀ£¡A¤¤¦è¯óÃÄ¡B©]¬X§pªû(ayurveda¡A
µÛ«¶¼¹»P¯óÃĪº¥j¦L«×Àøªk)¡B¶¶¶ÕÀøªk
(homeopathy)¡B¯á´Õ«üÀ£(chiropractic)¤ÎÀç¾iÀø
ªk¡C
¥Íª«®ñ¤ÆÀøªk¤]¬O¨ä¤¤ªº¤@Ó±´¨sªù®|¡C
¯ä®ñ©M¤G®ñ¤Æ²B¹ïHIV©MAIDS±wªÌªºÀø®Ä¡A
¦³·¥¤jªº¼ç¤O¡A¦]¬°¹êÅç«ÇÃÒ¾ÚÅã¥Ü¡A¯ä®ñ©M
¤G®ñ¤Æ²B§Y¨Ï¤£±þ¦º¯f¬r¤]¯à§í¨î¥i¯à¤Þ°_·R
´þ¯fªº¯f¬rÁc´Þ¡C¥¦¬O¦p¦ó°_§@¥Îªº¡H
¯f¬r¦s¦bÃþ¯×ªÕªºÅnM¡AµßÁJ¤Wªº²yªw¥i
¥H³sµ²¦Ó·P¬V¨ä¥L²ÓM¡C¿é¤J¯ä®ñ©Î¤G®ñ¤Æ²B
¤§«á¡A«Ü§Ö¤Þ°_´X¶µÅܤơG¶i¤J¦å²Gªº¯ä®ñ§ï
ÅܤFµßÁJ¤W²yªwªºµ²ºc¦Ó¨ÏµßÁJ¥¢¥h§@¥Î¡AÁö
µM¯f¬r¥¼¦º¡A¥¦¤w¤£¯àµ²¦X¨ä¥L²ÓM¡C¦P®É¡A
¯ä®ñ¨Ï¯f¬r¥~³òªºÅnM®ñ¤Æ¡A¨S¦³¤FÅnM¡A¯f
¬r´NµLªk¥Í¦s¡C
°£¤FÅé¥~¿é¤Jªº¤G®ñ¤Æ²B²£¥Í§@¥Î¡AÅ餺
²ÓM¥»¨¤]²£¥Í¤G®ñ¤Æ²B§Ü©Ú¯f¬r«I¥Ç¡C¦b¬Y
¨Ç±¡ªp¤U¡A¤×¨ä·í²ÓM¤@¶}©l´N¤£°·±d¡A¥¦©Ò
²£¥Íªº¤G®ñ¤Æ²B¦b¯f¬rÁc´Þ¤§«e´N¨Ï²ÓM¯}µõ
¡C¦b¥t¤@¨Ç±¡ªp¡AÅé¥~¤Þ¶iªº¤G®ñ¤Æ²B¨ó¦P²Ó
M¤ºªº¤G®ñ¤Æ²B¶Ê·´¤J«Iªº¯f¬r ¡C²³æ¦a»¡¡A
¦pªG²ÓM°I®z¡A¥¦´N¬°¤G®ñ¤Æ²BªºÃz¬µ©Ò¶Ê·´
¡A¦pªG²ÓM±j§§¡A¥¦´N±þ·À¯f¬r¦ÓÅܱo§ó±j§§(
¥Ñ©ó®ñ¤À¼W¥[)¡C¡C¡C
´N¹³±j¤Oªº§K¬Ì½Õ¸`¦]¤l¡A¯ä®ñ©M¤G®ñ¤Æ
²B¯à¼W±j¨ü¶Ëªº§K¬Ì¨t²Î¡AÁקK·P¬V¯f¬r¡A¨Ã
¨Ï¨ü·P¬Vªº¤H¬¡±o¸û¤[¡A¸û¦³¤¸®ð¡A¦³·N¸q¡C
ÁöµM¤£À³±N¯ä®ñ©M¤G®ñ¤Æ²B¬Ý°µAIDSªºÀø¤è
¡A¥¦Ì¤]³\¶}±Ò¤F¤@¹Dªø´Á½w¸Ñªºªù®|¡A¤×¨ä
»P¨ä¥L§K¬Ì¨t²Î¼W±jÀøªk°t¦X¨Ï¥Î¡C¡C¡C
I´º
®Ú¾Ú¬ü°ê¯e¯f¹w¨¾»P±±¨î¤¤¤ß(Centers for
Disease Control and Prevention)¡AHIV¯e¯fªº¯S
¼x¬O§K¬Ì¥\¯à³vº¥°I°h¡C±w¯f´Á¶¡¡AÅ餺¤@ºØ
¯S§Oªº²ÓM(¥s°µCD4+T²ÓM¡A)¥¢¥h¥\¯à¥B³Q
±þ¦º¡C(³o¨Ç¥Õ¦å²y²ÓM¡A¤S¥s°µT-À°¤â²ÓM¡A
²Õ¦X§K¬Ì¤ÏÀ³¨Ã³qª¾§K¬Ì²Ó²Î¤ºªº¨ä¥L²ÓMµo
´§¥\¯à¡C)¨ä¥L§tCD4¤À¤lªº§K¬Ì²ÓM¤]¨ü¯f¬r
·P¬V¡C
°·±dªº¤H¨C¤d¤À¤§¤@¤É(ml)ªº¦å²G³q±`¦³
800-1200ÓCD4+T²ÓM(¤SºÙCD4²ÓM)¡C³oºØ
T-À°¤â²ÓM¦pªG°¨ì200/ml¥H¤U¡A¨Åé«Ü®e©ö
¾D¨ü¦UºØP©Rªº¯f¬r©MÀùµß·P¬V¡A¥]¬AªÍÅn¸~
©ÊªÍª¢(pneumocystis carinii pneumonia, PCP)¡B
¥dªi¦è´c©Ê¸~½F¡B¬r¼ßÅéì¦ä¯f(toxoplasmosis)
¡B¸£Å轤ª¢(meningitis)¡A¥H¤Î¤@ºØ¥H¤Wªº²O¤Ú
½F(lymphoma)¡CHIV©Ò·P¬Vªº±wªÌ¡A¦pªGT-À°
¤â²ÓM¦b400¥H¤U¨Ã·P¬V¦Ü¤Ö¤@ºØ¯f¬r(¯S§O¬O
PCP)¡A©ÎµL¼xª¬¦ýT-À°¤â²ÓM¦b200¥H¤U¡A³q
±`³QÂ_©w¬°·R´þ¯f±w¡C
¥@¬É«O°·²Õ´(World Health Organization)
¦ôp¡A1993¦~¤¤¡A¤@¤d¥|¦Ê¸UHIV·P¬VªÌ¦³¤T
¦Ê¸U¤H¥ª¥k±o¤F·R´þ¯f¡CWHO¦ôp¡A¨ì¦è¤¸¤G
¤d¦~¡A±N¦³¤T¤d¨ì¥|¤d¸U¤H·P¬VHIV¡C¤@¯ë¬Û
«H¡A¨ì1993¦~©³¡A¦Ü¤Ö¦³¤@¦Ê¸U¬ü°ê¤H·P¬V
HIV¡C¦P¦~¤E¤ë¡A¬ü°ê¯e¯f¹w¨¾»P±±¨î¤¤¤ß³ø
§i¡A¦³331845¦ì±wªÌ³Q¶EÂ_¬°·R´þ¯f¡C
1983¦~¹êÅç«Çº¦¸¹jÂ÷¤HÅé§K¬Ì¤£¥þ¯f
¬r(HIV)¡C¦¸¦~¡A½T©wHIV¬°·R´þ¯f¦]¡A¦]¬°·R
´þ¯f¤Hªº¦å²G¤¤µo²{¦³HIV¡C¥Ñ©óHIV¦s¦b©ó
¦å²G¡Bºë²G©M¨ä¥LÅé²G¤¤¡A¾ÇªÌ¬Û«H¯f¬r¶Ç¼½
ªº¥DnºÞ¹D¬°©Ê¥æ¡B¦@¥Îª`®g°w¡B¿é¦å¡C
¥Ñ©ó·R´þ¯fªº«Â¯Ù¡A³\¦h»sÃļt¬ã»s¤@¨Ç
©ù¶QªºÃľ¯¡A¥Î¨Ó±þ¦º©Î§í¨î¯f¬rÁc´Þ¡CµJÂI
¶°¤¤¦b°fÂà¿ýªº¹Lµ{¡A¯f¬r¶i¤J²ÓM«á¡A¯f¬r
¯S¦³ªº»Ã¯À(¥s°µ°fÂà¿ý×Q, reverse
transcriptase)§â³æ¦êRNAÂà¤Æ¦¨DNA¡A¨Ï¯f¬r
±o¥HÁc´Þ¡C©Ò¥H³o¤@¯f¬r³QÂkÃþ¬°°fÂà¿ý×Q¯f
¬r(retrovirus)¡C¼g§@¥»¤å¤§®É¡A¦³¤TºØªvÀø¦¹¯f
ªºÃľ¯¦b¬ü°ê§åãµo°â¡G
zidovudine/azidothymidine (AZT)¡Bdianosine
(ddl)¡Bzalcitabine (ddC)¡C³o¤TºØÃij£¤Þ°_¤£¤Ö
½Øij¡A¦³¤£¤ÖÁ{§É¬ã¨s»é¥¸¥¦ÌªºÃĮġC³o¨Ç
ÃÄ«D±`©ù¶Q¡A¥B³£¤Þ°_¤Ï¦V´_§@¥Î¡C
À³¸Ó°O¦íªº¤@ÂI¬O¡GHIV±wªÌ¨Ã¥²µM³£·|
±o¨ì·R´þ¯f¡C1980¦~¥Nªì¡A·R´þ¯f¦¨¬°¤½²³°·
±dªº°ÝÃD¡A¦³Ãö·í§½«Å¥¬¡AHIV±wªÌ¦b¤@¦~¥b
¨ì¤T¦~¤§¤º±N·P¬V·R´þ¯f¡C²{¦b¡A³o¤@®É¤w
©µªø¨ì¤Q¦~¥H¤W¡C¦¹¥~¡AÅç¦å¨Ã¨S¦³pºâ¦å²G
¤¤ªº¯f¬r¼Æ¶q¡A·í¤@Ó¤H´ú±o¶§©ÊHIV¡Aªí¥Ü
Å餺ªº§K¬Ì¨t²Î¶}©l²£¥Í§ÜÅé¹ï§Ü¯f¬r¡A¤@¤è
±·N¨ý¸Ó¤H©ö¾D¯f¬rÁc´Þ¡A¥t¤@¤è±¤]¥i»¡¸Ó
¤Hªº§K¬Ì¨t²Î¯à¹ï§Ü¯f¬r¡C
«Ü¤Ö¤H¤Ï¹ï·R´þ¯f¶Ê·´§K¬Ì¨t²Î¡A¶V¨Ó¶V
¦hªº¬ã¨sû¡BÂå¥Í©M¯f¤H¡A¤£¦P·N·R´þ¯f"³æ¦]
"½×©M²{¦³ªºÂåÀøªk¡C³o¤]¬O¥»¤åªº«ÂI¡A¦]¬°
¥Íª«®ñ¤ÆÀøªk¥H´XºØ¤£¦Pªº¤è¦¡¹ï§Ü¯e¯f¡C³Ì
ª¾¦Wªº§å§PªÌ¡A¥i¯à´N¬O¬f§J¨Ó¥[¦{¤j¾Ç¤À¤l
¥Íª«¾Ç±Ð±ÂDr. Peter Duisberg¡A°fÂà¿ý×Q¯f¬r
ªºÅv«Â¡A¥L¦b1989¦~ªºProceedings of thenew
York Academy of Sciences»é¥¸HIV/AIDSªºì©l
°²³]¡C
1992¦~²üÄõªü©i´µ¯S¤¦¤j·|¡ADuisberg©M
¼Æ¦Ê¦ì¾ÇªÌ¡BÂå¥Í¡B«D¶Ç²ÎÀøªkÂå®v¡B·R´þ¬¡
ÅD¤H¤h©M¯f¤H(¥]¬Aªø´Á¦s¬¡ªÌ)¡A°Q½×·R´þ¯fªº
©w¸q©M¬Fµ¦¡AHIV¦p¦ó·P¬V¡A¦p¦ó¥H«D¶Ç²ÎÀø
ªkÂåªv¡C¡C¡C
ª`·N¤O¶°¤¤¦b±wªÌ§K¬Ì¨t²Î¨ü·l¦b¥ý¡A
HIV¯f¬r¥u¬O¼µê¦Ó¤J¡C¨Ó¦Û¯Ã¬ùªºMichael
Ellner»{¬°"AIDS ¬O¤@ºØ¤¤¬rª¬ºA¡A¦Ó¤£¬O¯f
¬r¤Þ°_¡A¥¦¬O¤@ºØ¬r¯À©Ò¤Þ°_ªº§K¬Ì¨t²Î¥\¯à
²V¶Ã"¡C¼w°êªkÄõ§JºÖªºJuliane SacherÂå®v¡A¾Ö
¦³¥H¯ä®ñªvÀø·R´þ¯fªº¥@¬É¤jÂå°|¤§¤@¡A¦b»P
¦o¬ù½Í®É¡A¦o¤]¹ï§Ú´£¥X³o¤@¬Ýªk¡C¦o¯S§OµÛ
«©ó¦UºØ¼vÅT¦]¯À¡GªÅ®ð¦Ã¬V(¤×¨ä¬O¤j³£¥«)
¡B¹ª«¤¤ªº±þ¦ä¾¯¡BÀݥΧܥͯÀ©M§í¨î§K¬Ì¨t
²ÎªºÃľ¯¡B°g¤ÛÃÄ¡B¹¥Îºë¦ÓµLÀç¾iªº¹«~¡A
³y¦¨¦UºØºû¥L©R¡BÄqª«½èªº¯Ê¥F¡C¦o¬Û«H°£¤F
¾¨¶qÀ°§U¯f¤H±Æ¬r¡AÀ³¯S§OµÛ««Ø¥ß§K¬Ì¨t²Î
¡C
ÁöµM§Ún¤Þ¥Î¹êÅç«ÇÃÒ¾Ú¡AÃÒ©ú¯ä®ñ¯à¨Ï
HIV³à¥¢¬¡¤O(¥H¤Î¤@¨Ç¶§©ÊHIVÂàÅܬ°³±©Êªº
®×¨Ò)¡A§Ú¦A«×Án©ú¡G¯ä®ñ©M¤G®ñ¤Æ²B¨Ã¤£¬O·R
´þ¯fªºÀø¤è¡C¦ý¬O¡A¦pªG§´µ½¹B¥Î¡A¥¦Ì¥i¦b
¾ãÅéÀøªk(holistic treatment)¤¤§êºt¤@«n¨¤¦â
¡C³o¤@Æ[ÂI²©ú¦aªí¹F¦b¤ºµØ¹F¦{¨FªL«OÂå¥Í
(Frank Shallenberger)ªº½Í¸Ü¤¤¡A¥L¨Ï¥Î¯ä®ñ©M
¨ä¥L¤ÑµMÀøªkªvÀøHIV¯f±w¡G
1. ¯ä®ñÀøªk¥¼´¿¡A¤]¥Ã¤£¥i¯àªv¡·R
´þ¯f¡C
2. ·R´þ¯f¦³¦UºØ¼h±ªº¦¨¦]¡A¥B¤£¬O
¶Ç¬V©Êªº¯e¯f¡C¥u¥Î§Ü¶Ç¬VªºÀøªk
¹ïªv·R´þ¯f¨M¹ï¤£·|¦³®Ä¡C
3. ¯ä®ñ§@¬°§K¯q¨t²Î½Õ¸`¾¯¡A¹ï·R´þ
¯f¦³®Ä¡C¦b³o¤è±¡A¥¦«D±`¦³®Ä¡A
¦w¥þ¡A«K©y¡A¦Ó¥B¨ÑÀ³¤£¥F¡C
4. ¾A·íªº·R´þ¯fªvÀøÀ³°w¹ï
l ªì´Á¤z¹w(§YCD4¼Æ¤j©ó300)
l ¯ä®ñ°t¦X¨ä¥L§K¬Ì¨t²Î¼W±jªk
l ±q±H¥Íª«§í¨î§K¬Ì¥\¯àªº¨¤«×
¡A²M¸z¬°³Ì°ªºõ»â¡C
¥H¤U±N±´°Q¦³ÃöHIVªº¹êÅç«Ç©MÁ{§Éµo²{
¡A¥H¤Î¯f¤H¦p¦ó¨Ï¥Î¯ä®ñ©M¤G®ñ¤Æ²B¡C
¸ÕºÞ¬ã¨s
¬ü°ê¡BĬ«X©M¥[®³¤jµ¥¦³¦Wªº¬ì¾Ç®a§@¤F
¸ÕºÞ¬ã¨s¡Aµû¦ô¯ä®ñ±þ·ÀHIVªº¯à¤O¡C1988¦~
²Ä¥|©¡°ê»Ú·R´þ¯f¤j·|¡Aª÷¤s¥[¦{¤j¾ÇÂå¾Ç
°|±Ð±Â¥d¥»¼wÂå¥Í(Michael T. F. Carpendale,
M.D).©M¥Lªº¦P¹±º¥ý´£¥X¸ÕºÞ¬ã¨s³ø§i¡AÀH«á
µoªí©óAntiviral Research¡C³ø§i«ü¥X¡A¨C²@¤É
(ml)¤HÃþ¦å²M(serum)§t0.5²@§J(mg)¯ä®ñ¡A¥i±þ
¦º99%ªºHIV¡C4 mg/mlªº¯ä®ñ¥i§¹¥þ®ø·ÀHIV
¡C¹ï°·±d²ÓMµL®`¡C
¥t¤@¾÷ºcªº¸ÕºÞ¬ã¨s³ø§i¥Zµn©ó1991¦~
10¤ë¥÷Âå¾Ç´Á¥ZBlood¡C±NÃĥίŤG®ñ¤Æ²B©Ò
²£¥Íªº¯ä®ñ¾É¤JHIV-1°ö¾iµßÅé¡A¬ã¨sûµo²{
¡G¯ä®ñ±N¯f¬r§¹¥þ®ø·À¦Ó¤£¶Ë¤Î¥¼¨ü·P¬Vªº²Ó
M¡C¡C¡C
Ĭ«X¬ã¨sû±N¿@«×4 mg/mlªº¯ä®ñ¾É¤J§t
¦³HIVªº°ö®ñµß¡A¯f¬r²ÓM¦b´X¤ÀÁ餺¸ÑÅ馺
¤`¡C¬ã¨sû«ü¥X¡A"¥Î®ðÅé¯ä®ñ¥i¨Ï§tµß²G¤¤ªº
³Ñ¾l¯f¬r§¹¥þ®ø·À"¡C
¥[®³¤jªº¸ÕºÞ¬ã¨s¡A´ú¸Õ¯ä®ñ±þ·ÀHIV¡B
¨xª¢©Mªw¯l(herpes)¯f¬rªº¯à¤O¡A³ø§i«ü¥X¡A§t
1,000,000/ml HIV-1 ªº¿é¦å¥Î¦å²M¡A¦b¾É¤J¯ä®ñ
¤T¤ÀÄÁ«á¡A¯f¬r§¹¥þ³Q®ø·À ¡C¡C¡C"¹L¥h¤T¤Q¦~
¡A¼w°êÂå°|¤w¥Î¯ä®ñªvÀø¼Æ¤d¯f±w¡A¦Ó¨S¦³¤£
¨}·l®`¡C¾¨ºÞ¹êÅçµ²ªG¦³«¤j·N¸q(¿é¦å¥Î¦å²G
¸g¹L¯ä®ñ³B²z¡A¥i¥H²M°£HIV¡Bªw¯l¡B¨xª¢©M
¨ä¥L¯f¬r)¡A¥[®³¤jªº¬ã¨sµo²{¨Ã¨S¦³¨ü¨ì¥_¬ü
¶Ç¼½´CÅ骺ª`·N¡C
Á{§É¸gÅç
¼w°ê
©_ºÖÂå¥Í(Dr. Horst Kief)¥i¯à¬OªvÀøÀù¯g
©M¯«¸g©Ê¥Öª¢(neurodermatitis)ªº¥@¬Éª¾¦WÂå®v
¡A¥L¤]µo®iAHITÀøªk¡A¥i¯à¤]¬O1980¦~¥Nªì
¥@¬É²Ä¤@¦ì¥H°ªÀ£¯ä®ñ¬°AIDS¯f±w"²M¬~¦å²G"
ªºÂå¥Í¡C¥Lªº¼Ð·ÇÀøµ{¥]¬A¨C©P¤@¦¸¦Û¦åÀøªk
(autohemotherapy)¡A«ùÄò¤TÓ¤ë¡C¥²n®É¥i«´_
¡C
1998¦~7¤ë¡A©_ºÖÂå¥Í¦b¥Lªº¤@½g±MÃD½×
¤å«ü¥X¡Aªì´Áªº¯f±w¸gªvÀø«á´X¥G§¹¥þ½w¸Ñ¤F
AIDS¦³Ãöªº¼xª¬¡A¥]¬AÃZ¤f½H(thrush)¡B¤fµÄÖß
½¤¥Õ´³¯g(leukoplakia)¡C¦¹¥~¡A65¤Ñ´Á¶¡¡AT4
²ÓM©MT4:T8¤ñȤj´T´£¤É ¡C¥L¦b¤@¶µ¹ï½Í¤¤
«ü¥X¡A¥Lªº³Ì¦¥ýªvÀøªº¤@¨Ç¯f¤H¸g¤C¦~°lÂÜ
¡A¤´µM¬¡µÛ¡A¤u§@¡A¦Ó¥Bª¬ªp¤Q¤À¨}¦n ¡C
1986¦~¡A¼w°ê´¶¾|¤hÂå¥Í(Dr. Alexander
Pruess)µoªí¤F²Ä¤@¥÷¯ä®ñÂåÀø·R´þ¯fªº°O¿ý¡C
¥L¥Î¯ä®ñªvÀø¥|¦ì¯f±w¡A°t¦XSuramin(¤@ºØ°f
Âà¿ý×Q§í¨î¾¯)¡B§K¬Ì¨t²Î½Õ¸`ªk¡Bºû¥L©RÄqª«
½è¸É¥R¡B¥H¤Îª½¸z²M¼ä(¯fµß¦s¦bª½¸z)¡C¥Lz»¡
¨Ï¥Î¯ä®ñªºì¦]¡G
·R´þ¯f¤Þµoªº¯e¯f¥]¬A¯f¬r¡BÅðµß¡B
²Óµß·P¬V¡A§Ú´M§ä¹ï³o¨ÇµßÃþ¦P®É¦³
®Äªº®ø¬r¾¯¡A¯ä®ñ¬O©úÅ㪺¿ï¾Ü¡C¡C
¡C
´¶¾|¤hÂå¥Í«Ü§Öµo²{¥|¦ì¯f¤H§ïµ½¡A¥]¬A
®ø°£HIV¦³Ãöªº°ÝÃD¦p¥Ö½§¯f¡BÅðµß·P¬V¡B¸z
G¯f©MµL¤O¡CªvÀø¤@¦~«á¡A¥|¦ì¯f¤H³£³Q¶EÂ_
¬°°·±d(clinically healthy) ¡C
1993¦~©_ºÖÂå¥Í¦b¤@½g±M½×¤W½Í¨ì¤@¶µ
¬ã¨s¡A¤ñ¸û©_ºÖ¶E©Ò¥HAHITÀøªk¬I¥Î¯ä®ñªº
30¦ì¯f¤H©MªkÄõ§JºÖ¤j¾ÇÂå¾Ç°|20¦ì¨Ï¥Î¶Ç²Î
Àøªk(¥]¬AAZT)ªº¯f¤H¡C©_ºÖÂå¥Íªº¯f¤H±µ¨üÆ[
¹î251¤Ñ¡AÂå¾Ç°|ªº¯f¤H±µ¨üÆ[¹î363¤Ñ¡C«e
ªÌT4:T8¤ñȱq0.324´£¤É¨ì0.352¡A«áªÌ«h±q
0.293´î¨ì0.223¡C
¦b¤@¶µ¬ÛÃö¬ã¨s¤¤¡A27¦WAIDS±wªÌ±µ¨ü
AHITªvÀø¡A18¤ë«á¤§¦s¬¡²v¬°80%¡A45¤ë«á
¤§¦s¬¡²v¬°70%¡C³o¤@¤ñ²v»·°ª©ó¥ô¦ó¶Ç²ÎÀø
ªk¡C
1992¦~¼w°ê½Ã¥Í·í§½¤U¥t©_ºÖÂå¥Í«Ø¥ß
¤@¹jÂ÷¦Ó°ª«×¦w¥þªºAHIT¹êÅç«Ç¡A¥Ñ©ó¦¨¥»¤Ó
°ª¡A©_ºÖÂå¥Í¤w¤£¦A¨Ï¥Î¦¹¤@Àøªk¡C
¬ü°ê
¬ü°êªº«e¾É¬ã¨sµo®i©ó1980¦~¥N¥½¡Aª÷
¤s¥[¦{¤j¾ÇÂå¾Ç°|¡A¸Õ¹Ïµo²{¯ä®ñ¬O§_¦bHIV
¦³ÃöªºªvÀø¦û¦³¤@®u¤§¦a¡C¦³¨â¦ìµL¼xª¬Åã²{
ªºHIV±wªÌ°Ñ»P¤@¶µ¬ã¨s¡A¤@±wªÌ(G)T-²ÓM¼Æ
309¡A¥t¤@±wªÌ(I)T-²ÓM¼Æ907¡CÀøµ{¥]¬A¨C¤é
¥Ñª½¸z¼Qª`¯ä®ñ»P®ñ®ð¡A³sÄò21¤Ñ¡AµM«á¨C¤T
¤Ñ¤@¦¸¡A³sÄò16¶g¡C³Ì«á¨C¶g¤@¦¸¡A³sÄò15
¶g¡AÁ`¦@34¶g¡A73Àø¦¸¡C¡C¡C
¬ã¨sû³ø§i¡AÀH«á¤»¦~¡A¨â¤HT-²ÓM¼Æ§¡
«O«ù¦bº¡·N½d³ò(430¥H¤W)¡A"ºû«ù°·±d³Ì¨Îª¬ºA
¡A³Ìªì¤¦~·Pıºë¯«Åé¤O³vº¥¼W¥[¡A¨S¦³·P¬V
¡A¨S¦³¤£¾A"¡CT-²ÓM°_©lȸû°ªªº±wªÌI¡A¤£
¦ýT-²ÓM¼Æ¹F¨ì1185¡A¥B´úªºHIV³±©Ê¤ÏÀ³¡C
¤¦~¤TÓ¤ë®É¡A±wªÌG¦b¬y¦æ·P«_±d´_´Á¤S¦b
¤@³õ¼É·«B¤¤²O¥¢¥þ¨¡A·P¬V¤j¸ªÍª¢(»PPCP
ªÍª¢µLÃö)¦Ó¬ðµM¦º¤`¡AÁöµM¤´µM¨ã¶§©ÊHIV¡A
¦ýT-²ÓM¼Æ«O«ù¦b500-700¡C¬ã¨sû§@¦p¤Uµ²
½×¡G
³o¨Ç¾ÉP¥¿±`¤Æªºµ²ªG¡A¤ä«ù¯ä®ñ¥i
§í¨î¬Æ¦Ü®ø·ÀHIVªº°²³]¡A¯S§O¬O¼x
ª¬ÁÙ¨S¦³¥X²{¥BCD4²ÓM¼Æ¦b¥¿±`½d
³òªº¶¥¬q¡C¦P®É¤]Åã¥Ü¥¦¦³ªø´Á¦ÛÀø
«O°·ªº®Ä¯à¡C
¥t¤@¶µ¬ã¨s¡A¤¦W±w¦³¹x©Tµg¯eªº·R´þ±w
ªÌ¡A±µ¨ü¨C¤éª½¸z¼Qª`¯ä®ñ(¾¯¶q2.7-30mg)«ùÄò
21-28¤Ñ¡Aµ²ªG¥|¦W¤¤ªº¤T¦Wªº¼xª¬§¹¥þ®ø¥¢¡A
¥t¤@¦W¥ÑÁôÃ@M¤lÂÎ(cryptosporidium)±H¥Í¤Þ°_
ªºµg¯e¡A¨S¦³ÅܤơC¯ä®ñ¤]¸Ñ°£¦¸¯Å·P¬V¡A¥]
¬A³æ©Êªw¯l(herpes simplex)¡B¤òÅnª¢(folliculitis)
¡BŽ½H(sycosis barbae)¡C±wªÌ·P¨ü¬r©Ê´î¤Ö¡A¤£
¾A´î»´¡A¸û«e¦³¤¸®ð¡C¨S¦³¤Ï§@¥Î¡C ¡C¡C
¡C¡C¡C¡C
¥j¤Ú
MenendezÂå®v»¡¡G¦bHIV¥¼Â«¤J²O¤Ú¨t
²Î©M¯áÅ褧«e¡A¨Ï¥Î¯ä®ñ³Ì¦³®Ä¡C¡C¡C
ÂåÀø¶h»D
¦h¦~¨Ó¥X²{³\¦h¥Íª«®ñ¤ÆÀøªkªvHIV©M
AIDS¦³®Äªº³ø¾É¡C³\¦h³ø¾É¨Ó¦Û¯f¤H©M¥L̪º
Âå¥Í¡C¦b¬ü°ê¤j³¡¥÷ªº¦{©M¥[®³¤j¦U¬Ù¨Ï¥Î¯ä
®ñ²£¥Í¾¹¬O«Dªkªº¡A¨Ï¥Î¸Ó¾¹§÷ªºÂå¥Í¦pªG³Q
µo²{¡A¥i¯à³Q¦Q¾P°õ·Ó©Î§¤¨c¡C
J.P.©ó1988¦~³QÂ_©w¦³HIV¡A1992¦~6
¤ë¡AT-²ÓM¼Æ237¡A¥L¨M©w¸ÕViroterm(¤@ºØ
alpha-¤zÂZ¯À)©M¯ä®ñ(¥ÎÁY¯Ç³Uªksauna-bag
method)¡C¨C¤é¨Ï¥Î¯ä®ñ¤T¶g«á¡A¸~¤F¤T¦~ªº²O
¤Úµ²®ø°h¨ì¥¿±`ª¬ºA¡C¦¹¥~¡AT-²ÓM±q(¤»¤ë
)237¼W¥[¨ì(¤Q¤ë)292¡C¤»¤ë¤¤´ú±o¶§©Ê
P24(HIV®Ö¤ß³J¥Õ)¡A¤Q¤ë®ÉÂå¥Í§i¶D¥LP24¤w
Âà³±©Ê ¡CÁY¯Ç³Uªº¨Ï¥Îªk°Ñ¨£²Ä¤»ª©AIDS
Control Diet¤ÎHIV Tratment News¡C
²¦º¸©ó1982¦~ªì´ú±o¶§©ÊHIV¡A1993¦~
T-²ÓM¼Æ36¡A¤K¤ë¶}©l¨Ï¥ÎÁY¯Ç³Uªk¡C¥L»¡¡A
¤T¦¸«á¡A©I§l§xÃø¼xª¬®ø¥¢¡CºC©Êªw¯l¤]±o¨ì
½w¸Ñ¡C¤Q¤@¤ë¥L¶}©l¨Ï¥ÎÀã®ð¤Æ¯ä®ñ¼Q¸z¨C¤é
¨â¦¸¡A¸¡µh©MºÎ¯vÀò±o§ïµ½¡C
¼Q¸z¥Îªº¯ä®ñ¾¯¶qÀ³¦U¤Hª¬ªp¥ÑÂå¥Í¨M©w
¡AMichael CarpendaleÂå¥Í¦b1993¦~²Ä¤Q¤@©¡
¥@¬É¯ä®ñ¤j·|µoªí¥Lªº¶E©Ò©Ò¥Îªºµoªk©M¾¯¶q
¡C¡C¡C¸Ô²Ó¥Îªk¤]¥i±qKeep Hope Aliveªº¥Xª©
ª«Àò±o¡C
¬ù¿«ªºT-²ÓM¦b200¥ª¥k¡A¥L¶}©l¨C¤é¤T
¦¸¡A¶º«á¤T¤p®ÉªA¥Î¤ºw35%¹«~¯Å¤G®ñ¤Æ²B
©M¤ô¡C¥L³vº¥¼W¥[¥÷¶q¨ì20ºw¡A«ùÄò¨âÓ¤ë¡A
µM«á´î¦^¤ºw¡A¦A«×ÀËÅ窺µ²ªG¡AT-²ÓM¼W¥[
¨ì800¡C·R´þ¶¼¹ºÞ²z(AIDS Control Diet)ªº§@
ªÌ¤£«Øij¤fªA¤G®ñ¤Æ²B¡A¥L»¡¡A¦P¼Ëªº®ÄªG¤]
¥i±q¤U¦C¤èªkÀò±o¡G¨C¤Ñ±N¤@«~²æªº¹«~¯Å¤G
®ñ¤Æ²B¥[¤J·Å¾þ¤ô¤¤¡A®ûªw20¤ÀÄÁ¡C
·R´þ¯f©M¥Íª«®ñ¤ÆÀøªkªº¬Fªv°Ý
ÃD
¥Íª«®ñ¤ÆÀøªk¥Rº¡½Øij¡C»sÃļt¡A¾aµÛ§Ü
·R´þ¯fÃľ¯Àò§Q¼Æ¤Q»õ¡A§¹¥þ¤Ï¹ï¨Ï¥Î¤G®ñ¤Æ
²B¡B¯ä®ñµ¥·G»ù¡B¦w¥þ¡B¦³®Äªºª«½èªvÀø³o¤@
¯e¯f¡C¦¹¥~¡A³\¦hÂå¥Í¤£¬OµLª¾´N¬O¼Äµø³o¨Ç
¥i¥H¦Û¤v¾Þ§@ªºÀøªk¡A¦p¤WzªºÁY¯Ç³Uªk©M¼Q
¸zªk¡C
³\¦hµÛ¦W¦Ó¦³¦P±¡¤ßªºÂå¥Í¡A¨Ï¥Î¤G®ñ¤Æ
²B©M¯ä®ñªvÀø·R´þ¯f¤H¡A¨ü¨ì¦Q¾P°õ·Ó©MÃö³¬
¶E©Òªº«Â¯Ù¡C¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)©M½Ã¥Í
¸p©Ú¨M¤ä«ù¤G®ñ¤Æ²B©M¯ä®ñªº¤HÅé¹êÅç¡A¨Ã¥B
¨Ï¤pªº¿W¥ß¤½¥q«ÜÃø±q¨Æ¬ã¨s¡C¶ÈºÞ¼Ú¬w¤w¦³
¤W¤d¸U¤H(¥]¬A¤@¤d¦h¦W·R´þ¯fªÌ)±µ¨ü¯ä®ñÀø
ªk¡A©M¼Æ¦Ê¬ì¾Ç¤åÄm©MÁ{§É¬ã¨s©Ò¤ä«ùªºÃÒ¾Ú
¡AFDAÁÙ¬O»{¬°¯ä®ñµ¥¥Íª«®ñ¤ÆÀøªk©|¥¼ÃÒ©ú
¦³®Ä©Î¦w¥þ¡C¡C¡C
¥Íª«®ñ¤ÆÀøªkªº¨ä¥L¥Î³~
°£¤F¤ßŦ¯f¡BÀù¯g©MHIV¡A¥Íª«®ñ¤ÆÀøªk
ªºÀø®Ä½d³ò·¥¼s¡C¥H¤U±N²¤¶¦U¦aªºÁ{§É©M¹ê
Åç°O¿ý¡C
¹L±Ó
¨C¦~¦³¤W¦Ê¦W¹L±Ó±wªÌ¨ì¼w°ê©_ºÖÂå°|±µ
¨ü¯ä®ñ©MAHITÀøªk¡C³\¦h¤H¸g¹L¦UºØ¶Ç²ÎÀøªk
¦ÓµL®Ä¡A¥]¬A§Ü¥Í¯À¡BÃþ©T¾J¡A©êµÛ³Ì«áªº§Æ
±æ¨Ó¨ì©_ºÖ¶E©Ò¡C39¦W¸gAHITÀøªkªº¹L±Ó±w
ªÌ¡A¤T¤À¤§¤@±wªÌªº¯gª¬§¹¥þ®ø¥¢¡A22%±wªÌ
¦³ÅãµÛ§ïµ½¡A¤T¤À¤§¤@²¤¦³§ïµ½¡A¤T¤À¤§¤@±w
ªÌ¹ïAHITÀøªkµL¤ÏÀ³¡C
¤îµh
1990¦~¥[®³¤j°ê¨¾³¡¶i¦æ·R´þ¯f¬ã¨s¡A·N
¥~µo²{¯ä®ñ¦³¤îµh¥\¯à¡C¬ã¨sû«ü¥X¡G"§Ṳ́£
¸g·N¦aµo²{³o¤@¯S®íÀøªk¹ï¯kµh¦³Ãø¥H¬Û«Hªº
©úÅã®Ä¥Î¡A¥¦¹ï¤îµh«D±`¦³¥Î¡C"
§ÚÓ¤HÆ[¹î¨ì¤G®ñ¤Æ²BÀR¯ßª`®g¹ï¤@Ó·R
´þ¯f±w¦UºØ¯gª¬¤îµh®ÄªG¡C±wªÌ¥u¦³´X¶gªº¹Ø
©R¡A¦ý¬OÀR¯ßª`®g´î»´¤F¥L³\¦hªºµhW¡A´£¤É
¤¸®ð¡AÀ°§UºÎ¯v¡CÁöµM¯f¤H²×©ó³u¥@¡A¦ý¬O¥L
ªºÁ{²×¥Í¬¡«~½èÀò±o¤j´T§ïµ½¡C
Ãö¸`°h¤Æ
Ãö¸`°h¤Æ(arthrosis)¬O¯á´Õ¡B½¥»\©M¨ä¥LÃö
¸`ªº°h¤Æ¡A¹³Ãö¸`ª¢¡AÃö¸`°h¤Æ¤Þ°_·¥«×ªº¯k
µh©M¦æ°Ê¤£«K¡C1990¦~¡A¥j¤Ú¶i¦æ¤@¶µ¬ã¨s¡A
230¦W¸y¯á¡B½¥»\©M¨ä¥LÃö¸`¯kµhªº±wªÌ¡A±µ¨ü
®ñ®ð©M¯ä®ñ¦Ù¦×ª`®g¡A¨C¤Ñ¤@¦¸¡C¤Q¤é«á¨C¨â
¤Ñª`®g¤@¦¸¡CÁ`¦@20¦¸ª`®g¡C
µ²ªG¡A208¦W(89%)¯kµh§¹¥þ®ø¥¢¡A24¦W
(10%)¦³¬YºØµ{«×ªº´î»´¡A¥u¦³¨â¦W±wªÌ(1%)¦Û
ıµLÅܤơC°lÂÜ°O¿ýÅã¥Ü¡A¤j³¡¥÷±wªÌ¤T¨ì¤»
Ӥ뤺¨S¦³¼xª¬µo§@¡A¥t¤@¨Ç¤H«h«O«ùµLµh¹F
¤Q¤@Ó¤ë¡C¯ä®ñ¹ï¯á´ÕªO¬ð¥Xªº±wªÌ¤]¦³¤îµh
ªº®ÄªG¡C
¤ä®ðºÞ©Ê®ð³Ý
¹ï©ó¤ä®ðºÞ©Ê®ð³Ý(bronchial asthma)ªº¬ã
¨s¤£¦h¡A¦ý¦b¥j¤Ú§@¬ã¨s³X°Ý´Á¶¡¡A§Ú·|¨£¤F
¤@¦ì¤Q¤@·³ªº¤ä®ðºÞ©Ê®ð³Ý¨àµ£¡C¥Lªº®ð³Ý¯f
¬°¯ä®ñ©Òªv¡¡C¯ä®ñì¨Ó¥Î¬°ªvÀø¥Lªº¦Õ¯e
(hypocusia)¡AťıÀò±o¾A«×ªº§ïµ½¡A«Ä¤lªº¦Ñ®v
©M¤÷¥À³£µoı¨ì¥Lªº®ð³Ýµo§@¦¸¼Æ³vº¥´î¤Ö¡A
³Ì«á´X¥G§¹¥þ®ø¥¢¡C
ªk°êÂå¥Í¦b1993¦~²Ä¤Q¤@©¡¥@¬É¯ä®ñ¤j
·|³ø§iªvÀø®ð³Ýªº¸gÅç¡G
B¤Ó¤Ó1947¦~¥X¥Í¡A81¦~¤ä®ðºÞ©Ê
®ð³Ýµo§@¡C¹L¥h¨C¦³¦Õ»ó³ï·P¬V«K
³Q¬I¥HLomudal¡BAminophylline¥H
¤Î§Ü¥Í¯À¡C´úÅçµ²ªG¡A±wªÌ¹ï¦í¦v
¤º¦Ç¹Ð¹L±Ó¡C²Ä¤@¦¸±¶E¬°1987¦~
12¤ë¡A·í®É®ð³Ý¨C¤Ñµo§@¡C¡C¡C¸g
¤Q¦¸¯ä®ñ¦Û¦åÀøªk«á¡Aµo§@¦¸¼ÆÅã
µÛ´î¤Ö¡A¡C¡C1988¦~11¤ë¡A®ð³Ý
®ø¥¢¡ALomudal ªvÀø°±¤î¡A«e«áÀø
´Á¬°¤EÓ¤ë¡C¦¹«á¥¼¦Aµo§@¡C
¼w°ê©ó1987¦~¶}©l¥Î¦Û¦å§K¬ÌÀøªk
(AHIT)ªvÀø¤ä®ðºÞ©Ê®ð³Ý¡C1990¦~¦¹¤@Àøªkªº
³ÐµoªÌ©_ºÖÂå¥Í(Dr. Horst Kief)³ø§i35¦W®ð³Ý
¯f¤HªºªvÀø¬ã¨s¡A¸g¤CÓ¤ëªvÀø¡A³\¦h±wªÌ©ú
Åã§ïµ½¡A®ð³Ý±±¨îÃĤj´T´î¤Ö©Î§¹¥þ°±¤î¡C©_
ºÖÂå¥Í»¡¡G"Ãþ©T¾Jªº¨Ï¥Î´î¤Ö90%(¤ñ¹ï©ó¶Ç²Î
Àøªkªº¤@²Õ)¡AÃþ©T¾Jl¥Íª«§l¤J¾¯ªº¨Ï¥Î´î¤Ö
85%¥H¤W¡A¹ê¦b¥O¤HªY¼¢"¡C
¿N¶Ë
¤@¶µ¥j¤Ú¬ã¨s¡A¯ä®ñ¥H¦Û¦åÀøªk¬I©ó25
¦WÄY«¿N¶Ë±wªÌ¡A¬°´Á¤Q¤Ñ¡A§K¬Ì²y³J¥ÕG«¬
¡BM«¬¡A¸ÉÅéC4¡A§Ü¾®¦å×QIII¡A¦^´_¥¿±`¤ô
¥¡C¬ã¨sûÂk¥\©ó¨ã¦³§Üª¢¡B§K¬Ì½Õ¨î¡B±þµß
¥\¯àªº¯ä®ñ¡C
©À¯]µß
¤Q¦h¦~¨Ó¡Aªk¦ÕÂå¥Í(Charles H. Farr)¤w¦¨
¥\¦a¥Î¤G®ñ¤Æ²BÀR¯ßª`®gªv¡¼Æ¦Ê¦W©À¯]µß¯f
±w¡C¥L¦b¤@½g±M½×´£¨Ñ¤@±wªÌªºªvÀø°O¿ý¡C
M¤p©j¡A34·³¡A¤Ï´_ªvÀøºC©Ê©À¯]
µß¯f¤w¦³¤¦~¡C¦oªº°ÝÃD»F©l©ó¤
¦~«e¡A´X¦¸¤W©I§l¹D·P¬V¡A³Q¬I¥H
¤j¾¯¶q¦UºØ§Ü¥Í¯À¡A¤§«á¤Ï´_¤Þ°_
»Ã¥Àµß³±¹Dª¢¡AÁÙ¦³Â_Â_ÄòÄòªºµg
¯e¡A¦¹«á§Î¦¨ªø´Á«å¡Bªø¯»¨ë¡B
©üºÎ¡B´å¨«Ãö¸`µh¡B¸g±`ÀYµh¡B¤ë
¸g¥¢±`¡B¤ß¯«§x´b¡BÃø¥H±Mª`¡A¥H
¤Î¤£@Àô¹Ò©M¹B°ÊÀ£¤O¡C
¦o³Q¬I¥H¦UºØ±Æ°£©M´`Àô¶¼¹ªk¡B
nystatin(¤@ºØªvÀø©À¯]µß¯fªº§Ü¥Í
¯À)¡Bnizoral¡Bmonostat¡B°£¹L±Ó¾¯
¡B¤Î¦UºØ¤ÑµM§Ü»Ã¥À°t¤è¡C¨C´«¤@
¦¸Àø¤è¡A´N¦Ûı§ïµ½¡A¹L¤F´X¤Ñ©Î
´X¶g¤S¦^¨ì쪬¡C¤w¨â¦~µLªk¤u§@
¡A§¹¥þ¨Ì¿à¥À¿Ëªº¸gÀÙ©M³Ò¤O¤ä«ù
¡B±`·P¨ìµLªk¬ïµÛ©M¶i¹¡C
¦o¶}©l±µ¨üªvÀø¡A¨C¶gª`®g250 ml
0.15%ªº¤G®ñ¤Æ²B¡A¨â¦¸ªvÀø«á¡A¦Û
zĵı¡Bª`·N¤O¦³©úÅã¶i¨B¡AµÎ¾A
·P¼W¥[¡A²Ä¤T¦¸ªvÀø«á¡A¦Ûı©Ê±¡
§ïµ½¯»¨ë¦n¤F³\¦h¡A¸g´Á¥¿±`¡A³±
¹Dª¢¼xª¬®ø¥¢¡C¤j«K¸û¦³³W«ß©M¥¿
±`¡C¨Ã½Í¤În¦^¥h¤u§@¡C
²Ä¥|¡B¤¡B¤»¦¸ªvÀø¡AÄ~Äòı±o§ï
µ½¡C²Ä¤K¦¸ªvÀø«á¡A¤¦~¨Ó²Ä¤@¦¸
¯gª¬§¹«e®ø¥¢¡C«ÈÆ[¦a»¡¡A¦oÅã±o
¤ñªì¦¸±¶E¸û°·±d¡B¬¡¼â¡B¦³¯º®e
¡B§Ö¼Ö¡C¡C¡C
¿}§¿¯f
¥j¤Ú¬ã¨s47¦W¨¬³¡¯«¸g©Ê·P¬Vªº¿}§¿¯f
±w¡A¦pªGª¬ªpµL§ïµ½¡A¦³®É»ÝnºIªÏ¡C³o¨Ç±w
ªÌ¤w¦³¤E¨ì¤Q¤E¦~¯f¾ú¡A³Q¤À¦¨¤T²Õ¡AÀø´Á¤Q
¤Ñ¡C²Ä¤@²Õ13¦W¡A±µ¨ü¯ä®ñÀøªk¡A¥]¬A¥H¯ä®ñ
¤ô²M¼ä¶Ë¤f¡AµM«á¥H¯ä®ñ³U©M¦Û¦åÀøªkªvÀø¡C
²Ä¤G²Õ(16¦W)¥Î¥Á¶¡Àø¤è¡A¥H½©¿}¼ß¥~¼Å¶Ë¤f
¡A¨Ã¥HÁ^±a¨Ï¿}¼ßÂл\¶Ë¤f24¤p®É¡C²Ä¤T²Õ(15
¦W)±µ¨ü¤fªA¡B¸z¥~¡BÀR¯ßª`®g§Ü¥Í¯À¥H¤Î¶Ç²Î
ªº¶Ë¤f¥~¼ÅÃÄ¡C
µ²ªG²¤À¬°¦n»PÃa¡A"¦n"«ü§K©ó¤â³N¡A"Ãa
"«ü»Ý¤â³N¡A¹ï¤ñ¦p¤U¡G
¦n
Ãa
²Ä¤@²Õ(¯ä®ñ)
15 (93.8%)
1 (6.2%)
²Ä¤G²Õ(½©¿}¼ß)
13 (81.3%)
3 (18.7%)
²Ä¤T²Õ(§Ü¥Í¯À)
10 (66.7%)
5 (33.3%)
¤Q¤G«ü¸z¼ìºÅ
¥j¤Ú¤@Âå°|¥H¯ä®ñ¤ôªvÀø20¦W¤Q¤G«ü¸z
¼ìºÅ±wªÌ¡A¤@Ó¤ë«á¡A40%±wªÌ§¹¥þ²¬Â¡¡A10%
³B©óµ²¬Í³Ì«á¶¥¬q¡A25%³B©óµ²¬Í¤G¤À¤§¤@¶¥
¬q¡A5%±wªÌµ²¬Í¤T¤À¤§¤@¡A20%±wªÌ¦]¹L«×
¯kµh¦Ó¤¤Â_ªvÀø¡C
²´¯e
¹L¥h´X¦~¡A¥j¤Ú¬ì¾Ç®a¬ã¨s¥H¯ä®ñªvÀø²´
¯eªº®ÄªG¡A¥]¬A¡G«C¥ú²´¡B²´¨¤½¤¼ìºÅ¡B¦â¯À
©Êµøºô½¤ª¢¡Bµø¯«¸gµäÁY¡B¿}§¿¯gµøºô½¤ª¢¡C
µø¯«¸gµäÁY
µø¯«¸gµäÁY¬O¥j¤Ú¤H³y¦¨²´ª¼ªººnì¦]
¡C40¦W±wªÌ(67°¦²´·ú)°Ñ»P1992¦~¤@¶µªì¨B
¬ã¨s¡A´X¶µ¼Ð·Ç´ú¸Õ¦bªvÀø«e«á³Q°O¿ý¤U¨Ó¡A
¥]¬A¡Gµø±Ó«×(VA)¡B°ª°Òµø³¥´ú©w(VF)¡Bµøı
»¤µo¹q¦ì(VEP)¡Bù»«´ËIJ±Ó«×´ú¸Õ(PRCST)¡A
µ²ªG¡G
VA¡G54.5%±wªÌ§ïµ½
VF¡G82.7%±wªÌ§ïµ½
VEP¡G37%±wªÌ§ïµ½
PRCST¡G85.7%±wªÌ§ïµ½
ÁöµM¯ä®ñ¨S¦³ªv¦n©Ò¦³ªº¯f±w¡A¦ý¬O¥¦ªº
ÅãµÛ®ÄªG¨Ï¬ã¨s²Õªø¨M©w¨Ï¥Î¯ä®ñªvÀøµø©Ò¦³
¯«¸gµäÁYªº±wªÌ¡C
¦â¯À©Êµøºô½¤ª¢
ªvÀø¦â¯À©Êµøºô½¤ª¢¬O¥j¤ÚÂåÀøªº«¤j¦¨
´N¤§¤@¡C³o¤@ºC©Ê¯f©¹©¹¾ÉP²´ª¼¡C1988¦~
200¦W±wªÌ(ºÞª¬µø¤O5«×¥H¤U)°Ñ»P¤@¶µªvÀø¬ã
¨s¡C¨ÌÓ¤H©M¯gª¬ÄY««×¡A±wªÌ¨C¤Ñ±µ¨ü¯ä®ñ
©M®ñ®ð¦Û¦åÀøªk©Î¦Ù¦×ª`®g¡A«ùÄò15-20¤Ñ¡C
¹êÅçµ²ªG¡A175¦W±µ¨ü¦Û¦åÀøªk¡A112¦W
¦³ÅãµÛ§ïµ½¡A45¦Wµy¦³§ïµ½¡A18¦W¨S¦³¶i¨B
¦ý¤]¨S¦³´c¤Æ¡C25¦W±µ¨ü¦Ù¦×ª`®g¡A12¦W¦³
ÅãµÛ§ïµ½¡A9¦Wµy¦³§ïµ½¡A4¦W¨S¦³¶i¨B¦ý¤]
¨S¦³´c¤Æ¡CÁöµM¨S¦³¹F¨ì²¬Â¡¡A¦ý89%±wªÌ©ú
Åã§ïµ½¡A¦Ü¤Ö«O«ù¨â¦~¡C
¨ì1994¦~ªì¡A¦ôp¤w¦³¤G¤d¦W¦UºØ²´¯e±w
ªÌ±µ¨ü¯ä®ñÀøªk¡C
G¸zª¢
¦ò¦{ÁÚªü±K¤p¨à¬ìÂå¥Í¥H¯ä®ñªvÀø¨à¦P¸z
Gª¢¡C2757¦W±wªÌ¡A¦~¬ö¦b¤@Ó¤ë¤j¨ì¤Q¤K·³
¤§¶¡¡A³Q¤À¬°¤G²Õ¡A²Ä¤@²Õ¦³1932¤H¡A¥Ñª½¸z
¼Q®g®ñ®ð©M¯ä®ñ©óÅ餺¡A¨ä¤¤1265¦W¤@Àø¦¸¡A
583¦W¤GÀø¦¸¡A84¦W¤TÀø¦¸¡C²Ä¤G²Õ825¦W¤À
¬°¤T¤p²Õ¡A¥Ò²Õ¥u±±¨î¶¼¹¡A¤A²Õ¥Ñª½¸z¼Qª`
ªÅ®ð¡A
²Ä¤@²Õ¤@Àø¦¸ªÌ95%±wªÌ¦b¤@¤Ñ¤º²¬Â¡¡A
¤GÀø¦¸ªÌ95%¦b¨â¤Ñ¤º²¬Â¡¡A¤TÀø¦¸ªÌ¤T¤Ñ¤º
¥þ³¡²¬Â¡¡C²Ä¤G²Õ´_ì¸ûºC¡A¦³ªø¹F¤»¤ÑªÌ¡C
±ù§ÎÃ@¤ò¦ä¯f
±ù§ÎÃ@¤òÂÎ(Giardia Lamblia)¬O¤@ºØ±H¥Í
¦ä¡A·|ª¦º¡¤p¸z¡A©Ò¤Þ°_ªº¯gª¬¥]¬A¡Gµg¯e¡B
®ø½G¡B¤ÏG¡BµjÅË©M¹Ã¦R¡C³o¤@±H¥Í¦ä§ÜÃĤO
·¥±j¡A¨S¦³ªÖ©wªºÀø¤è¡C
General Calixto Garcia Hospitalµ¹¤©50¦W
¦¨¤H±wªÌ¤GÓÀøµ{ªº¯ä®ñ¤ôªvÀø¡A¶Ç²ÎªºÂåÀø
¹ï³o¨Ç±wªÌµL®Ä¡A¨C¤@±wªÌ¨C¤Ñ¶¼¥Î¥|ªM§t¯ä
®ñªº¤ô¡A¤Q¤Ñ«á¡A°±ªA¤C¤Ñ¡AµM«á¦AªA¥Î¤Q¤Ñ
¡C¬ã¨sû«ü¥X¡A23¦W±wªÌ(46%)¦b²Ä¤@Àøµ{¶¡
¡A¯gª¬§¹¥þ®ø¥¢¡A24¦W±wªÌ¦b²Ä¤GÀøµ{«á¡A¯g
ª¬®ø¥¢¡C±wªÌ«ü¥X¡A¯ä®ñ¨S¦³¤Ï§@¥Î¡A¤£¹³ÃÄ
¾¯¨º¼Ë¡C¬ã¨sû«ü¥X¡A"¯ä®ñ®e©ö¨ú±o¡A»ù®æ§C
·G¡A®ÄªG§»¤j¡Aȱo¥Î¨Ó¨ú¥N¶Ç²Î¤èªkªvÀø¦¹
¤@±H¥ÍÂίf¡C"
°ü¤k¶Ç¬V¯f
¨ì1990¦~¬°¤î¡A¥j¤Ú¤w¦³¤@¥´¥H¤Wªº¬ã¨s
¡A¦³Ãö§t¯ä®ñªººÌ¸ªªáªo¹ï¦UºØ°ü¤k¶Ç¬V¯fªº
Àø®Ä¡A¥]¬A¥Õ±a¡Bªw¯l¡B¥~³±¹Dª¢¡C60¦W¥~³±
¹Dª¢±wªÌ°Ñ»P¤@¶µÂåÀø¬ã¨s¡A¨ä¤¤97%ªº±wªÌ
ÁÙ¦³¥Õ©À¯]µß(candida albicans)¡B¤òºwÂίf¥H¤Î
cardenela vaginalis¡C30¦W±wªÌ³Q¬I¥H§t¯ä®ñªº
¸ªªáªo¡A20¦W±µ¨ü¤@¯ëªvÀø¡A¨ä¾l10¦W«hµ¹
¤©¦w¼¢¾¯(¤£§t¯ä®ñªºªo)¡C
©Ò¦³¨Ï¥Î§t¯ä®ñ¸ªªáªoªº±wªÌ¡A¦b5-7¤Ñ
¤º²¬Â¡¡FÀ³¥Î¤@¯ëÀøªk20¦W±wªÌ¡A¦b10-15¤Ñ
²¬Â¡¡F¨Ï¥Î¦w¼¢¾¯ªÌªº¯gª¬ÂàÃa¡C
Ĭ«X¬ã¨sû¤]°µ¤F¤@¨Ç°ü¤k¶Ç¬V¯fªº¬ã¨s
¡C112¦W±wªÌ¥]¬A¿é§ZºÞµoª¢¡B©Ê¾¹ªw¯l¡BÀã
¬Ð¡B°©¬ÖµÄ¸¡½¤ª¢µ¥¡A°Ñ»P¤@¶µªvÀø¬ã¨s¡C®Ú
¾Ú¤£¦Pª¬ªp¡A±wªÌ±µ¨ü2-5 mg ¯ä®ñª`®g¾¯¡A§t
¯ä®ñ¥~¼Åªo¡BÄé¬~©Î¸¡¤ºª`®g4 - 6 mg/ml¯ä®ñ
·»²G¡Cµ²ªG±a¨ÓÅãµÛ§ïµ½¡A¨Ï±oÂå¥ÍÌ«Å¥¬¯ä
®ñ¨ã¦³±j¤Oªº§K¬Ì½Õ¨î¡B§Ü¯f¬r©M¤îµh¥\¯à¡C
¡C¡C¡C
¨xª¢
1970¦~¥N¤Ú¦è¤Õ©Ô¼wÂå¥Í(Dr. Heinz
Konrad)¶}©l¥Î¯ä®ñ¦Û¦åÀøªkªvÀø15¦W¦¨¤HA
«¬«æ©Ê¨xª¢±wªÌ©M7¦WB«¬ºC©Ê¨xª¢±wªÌ¡C¨C
¶gªvÀø¨â¦¸¡CA«¬«æ©Ê±wªÌÀò±o¸û¨Îµ²ªG¡G
80%(12¦W)±wªÌ¥§¡¤Àø¦¸«á±d´_¡A¾l3¦W«h»Ý
¤Q¤@Àø¦¸¡A¨Ãµ¹¤©Ãþ©T¾J¡CB«¬ºC©Ê±wªÌ¥|¦W
(57.1%)²¬Â¡¡A¤T¦W(42.9%)µL®Ä¡C¤Õ©Ô¼wÂå¥Í¤´
µM»{¬°¡AÃĥίä®ñ"¤ñ¨ä¥L¤wª¾ªºÀøªk¸û¦³®Ä¥B
¸û¤Ö°Æ§@¥Î"¡C
¬y¦æ·P«_
1920¦~´£¥X¤G®ñ¤Æ²BÀR¯ßª`®gªvÀø¬y¦æ
·P«_ªº³ø§i¤§«á¡A«K¤Ö¬°¤Hª¾¤G®ñ¤Æ²Bªv·P«_
ªº»ùÈ¡C1989¦~¤¸¤ë¡Aªkº¸Âå¥Í¬ã¨s¤G®ñ¤Æ²B
ÀR¯ßª`®g¹ï¤W®üA«¬·P«_ªºÀø®Ä¡C¦¹¤@¯gª¬«ù
Äò48-72¤p®É¡A¥§¡±d´_´Á»Ý12-15¤Ñ¡C
40¦W·P«_±wªÌ¨Ì¦~Ä֩ʧOÃþ¦ü¡Aµ¥¤À¬°¤G
²Õ¡C±±¨î²Õ±µ¨ü¶Ç²ÎÀøªk¡A¥]¬A§Ü¥Í¯À¡B¸Ñ°£
¥R¦å¾¯¥H¤Î¤îµh¾¯¡C¦³¨Ç±wªÌ¥tªA§K³B¤è·P«_
¡B«y¹ÂÃÄ¡C¹êÅç²Õ«hµ¹¤©ÀR¯ßª`®g250 ml¤G®ñ
¤Æ²Bµ}ÄÀ²G(¦¨¤À0.0375%)¡A1-3¤Ñ¡C¤îµh¾¯¤]
«ö»Ýn¨ÑÀ³¡C35%ªº±wªÌ»Ýn²Ä¤G¦¸ª`®g¡A2
¦W(10%)±wªÌ»Ý²Ä¤T¦¸ª`®g¡C
µ²ªG¡G±±¨î²Õ¦b4.1¤Ñ«á¦³¤@¥b¤H¼Æ§ïµ½
¡A7.8¤Ñ«á¦³75%±wªÌ§ïµ½¡A11¤Ñ«á¦³90%±w
ªÌ§ïµ½¡C¹êÅç²Õ¦b1.9¤Ñ«á¦³¤@¥b±wªÌ§ïµ½¡A
3.2¤Ñ«á¦³75%§ïµ½¡A5.5¤Ñ«á90%±wªÌ§¹¥þ±d
´_¡C¡C¡C
¤fµÄ¯e¯f
3%ªºÂù®ñ¤ô¤w¦¨´¶¹M¦Ó·G»ùªº®a±`¤fµÄ
¯e¯fÀø¤è¡C²{¦b¤w¦³¤@¨Ç§t¤G®ñ¤Æ²Bªº¤ú»I©M
º¤¤f¤ô¦b¥«±¤W¥X°â¡C
ª½¨ì1979¦~¤~¦³¤@¶µ¥Ñ·ç¨å°ª´Ë³ù¤j¾Ç
¤ä«ùªº¬ã¨s³ø§i¡AÃÒ¹ê¤G®ñ¤Æ²B¨ã¦³ªý¤î¾¦´³
¶ô©M¾¦Åiª¢¢w¢w¨âºØ³Ì±`¨£ªº¤ú¯f¢w¢wªº³Ç¥X
¥\¯à¡C³ø§i«ü¥X¡A¥¦¯à¨¾¤î¤@¨Ç²ÓµßÁc´Þ¦Ó§Î
¦¨¤ú´³¡A¦P®É¨Ï¤ú´³©M¾¦Åiª¢®ø°h¡C ¡C¡C¡C
¯«¸g©Ê¥Öª¢
¯«¸g©Ê¥Öª¢¬°¤@ºC©Ê¦ÛÅé§K¬Ì(¯}Ãa¦Û¨
²Õ´)¯e¯f¡A¯S¼x¬°§½³¡¡A¨Ã±`¬°¹ïºÙ©Êªº·kÄo
©Ê¥Öª¢´³¡C®Ú¾Ú¼w°ê©_ºÖ¶E©ÒªºªvÀø²Îp¡A115
¦W±wªÌ±µ¨ü¤TÓ¤ëAHITªvÀø¡A¦¨¤H¥]¬Aª`®g©M
¤fªAÃÄ¡C¯gª¬§¹¥þ®ø°£ªÌ¦³43¦W(37%)¡AÅãµÛ
§ïµ½ªÌ¦³50¦W(44%)¡A²¤¦³§ïµ½ªÌ13¦W(11%)
¡AµL¤ÏÀ³ªÌ7¦W(6%)¡A´c¤ÆªÌ2¦W(2%)¡C¦¹¬°
1989¦~¡AªvÀø«á¨â¦~¥b¤§°lÂܳø§i¡C¡C¡C¸ûªñ
ªº333¦W±wªÌªvÀø³ø§i(1993¦~3¤ë)¡A¥Ø«e¯g
ª¬§¹¥þ®ø°£ªÌ¦³65-67%¡C
¼W¥Í©ÊÃö¸`ª¢(¦ñ¦³°©¨ë)
¥j¤Ú¡A60¦W±wªÌ(¤j³¡¥÷¬°½¥»\°ÝÃD)¡A¨C
¶g±µ¨ü¤@¦¸Ãö¸`¶¡»Ø¯ä®ñª`®g¡A¦@¤Q¶g¡C93.3%
ªº±wªÌ¯gª¬§¹¥þ®ø°£¡A¨ä¾l4¦W©ó¨âÓ¤ë«á¯k
µh´_µo¡C¡C¡C
°©½è²¨ÃP¯g
ÃP°©¯g¥Ñ©ó¯Ê¶t³y¦¨¡A¥Dn¯f±w¬°¦~ªø°ü
¤k¡C
®Ú¾Ú1988¦~¤@¶µ¬ã¨s³ø§i¡A¶Ç²ÎÀøªk»²¥H
¯ä®ñ¦Û¦åÀøªk¤ñ³æ¯Âªº¶Ç²ÎÀøªk®ÄªG¸û¦n¡AY
¥[¤W¾A·íªº¦³³W«ß¹B°Ê¡A®ÄªG§óµÛ¡C
Ãþ·Àã©ÊÃö¸`ª¢
Ãþ·Àã©ÊÃö¸`ª¢¬O¤@ºØºC©Ê²Õ´¯e¯f¡A¤Þ
°_Ãö¸`¸~µh¡C¤@¯ë¦h¥Î§Üª¢¾¯ªvÀø¡C
1988¦~¥j¤Ú¤@¶µ¬ã¨s¡A¤ñ¸û¯ä®ñ©M§Üª¢¾¯
ªº®ÄªG¡C¯ä®ñÀø®Ä¸û§Üª¢¾¯°ª25%¡A¦P®É¨S¦³
´_§@¥Î¡A¨Ï¥Î§Üª¢¾¯ªÌ¤£¬O¥tªAÃþ©T¾J´N¬O¤Þ
°_Gª¢¡C¡C¡C
¦Ñ¦~è§b
1990¦~¥Nªì¡A¥j¤Ú¶i¦æ¤@¶µÂùª¼¬ã¨s¡C60
¦W±wªÌµ¥¤À¬°¤G²Õ¡A²Ä¤@²Õ±µ¨üª½¸z¼Qª`®ñ»P
¯ä®ñ²V¦X¾¯¡C²Ä¤G²Õ¥u±µ¨üª½¸z®ñ®ð¼Qª`¡CÀø
µ{21¤Ñ¡Cµû¦ôµ²ªG¡G²Ä¤@²Õ85%±wªÌÅã¥Ü¥þ±
§ïµ½¡A73%¯fªp©úÅã§ïµ½¡A83%ºë¯«ª¬ªp§ïµ½
¡A83%¥ÎÃĦ۲z¯à¤O§ïµ½¡A80%ªÀ¥æ©M¤é«ù±`
¬¡°Ê¯à¤O§ïµ½¡C²Ä¤G²Õ«hµL©úÅã§ïµ½¡CµL°Æ§@
¥Îµo¥Í¡C
1994¦~500¦W¦Ñ¤H±µ¨ü¯ä®ñÀøªk¡C¾¨ºÞ¥j
¤ÚÂå¥Í¤£¬Û«H¯ä®ñ¹ïè§b¯g¦³¥Î¡A±wªÌ(©M®a¤H)
¥Í¬¡«~½èªº¥þ±ÅãµÛ§ïµ½¡A¨Ï±o¦Ñ¤HÂåÀø³¡±N
¯ä®ñÀøªk¦C¬°¦Ñ¤HÂåÀø¼Ð·ÇÀøµ{ªº¤@³¡¥÷¡CÂå
¥Íµo²{±wªÌÅé¯à©M³B²z¤é±`¥Í¬¡ªº¯à¤O§ïµ½¡A
¯gª¬¤Þ°_ªº§íÆ{¤]©úÅã´î»´¡C
²Ä¤@¦¸¤G¶gªºÀøµ{¤§«á¡A±wªÌ±`¨C¦~¦^Âå
°|§@¤@¶gªº¯ä®ñªvÀø¡A¨S¦³¨Ï¥Î¨ä¥LÃľ¯¡C
±Ñ¦å¯f
±Ñ¦å¯f(sepsis)¬O¦MÀIªº¦å²G¤¤¬r¯g¡A¥i¯à
¥Ñ·N¥~©Î¤â³N«áµo¥Í¡C
¥j¤Ú¥H¯ä®ñªvÀø±Ñ¦å¯g¥[Å@¯f©Ð±wªÌ¡Aµo
²{¯ä®ñ¤£¦ý¥[³t®ñ¤À¶Ç°e¨ì²Õ´¡B´`Àô¨t²Î¡B
©I§l¨t²Î¡A¦P®É¤]¦¨¬°¦³®Äªº®ø¬r¾¯¡C³o¤@¹ê
Åçµ²ªG¡A¨ÏÂåÀø¥DºÞ«ü©w¯ä®ñÀøªk¥Î©ó©Ò¦³¥[
Å@¯f©Ð¦³Ãa¦å¯f«Â¯Ù¤§±wªÌ¡C
ÅIª¬¦å²y³h¦å
¸gÁ{§É¹êÅçµ²ªG¡A¥j¤Ú½Ã¥Í¸p( MINSAP)
§åã¯ä®ñÀøªk¬°ÅIª¬¦å²y³h¦å(sickle cell
anemia) ¯g¼Ð·ÇÀø¤è¡C
ª¿¤Æª«¤Þ°_§K¬Ì¥\¯à¥¢½Õ¯gª¬
1962¦~¥H¨Ó¡Aª¿¤Æª«¤Þ°_§K¬Ì¥\¯à¥¢½Õ¯g
ª¬¼vÅT¬ù¨â¦Ê¸U¨ü¹Lª¿¤Æª«¶©¨Å¤â³Nªº°ü¤k¡C
¬ÛÃö¯gª¬¥]¬A¡G¹ï¹ª«¡B¤Æ¾Çª«¡B¾`¡B¦Ç¹Ð±Ó
·P¡A«å¡AªÍ°ÝÃD¡AµJ¼{©M§íÆ{¡AÁx©T¾J¤É°ª
¡A¥Ö¯l¡A°O¾Ð³à¥¢¡AG¸z¯f¡CÁöµMª¿¤Æª«¤£¬O
°ÝÃDªº°ß¤@ì¦]¡A¦³¤@¨ÇÂå¥Í»{¬°¥¦¦û«Ü¤jªº
¤ñ«¡C
1994¦~¡A·R±o´ËÂå¥Í¦b¤@°ê»Ú¤j·|¤W³ø§i
¥L¥Î¤G®ñ¤Æ²BÀR¯ßª`®g°t¦X¾ãÅéÀøªk(holistic
therapy)ªvÀø¦¹¤@¯gª¬"¤j¬°¦¨¥\"¡A¥L±j½Õ¤G®ñ
¤Æ²B"«D±`«D±`¦³®Ä"¡A¤×¨ä¬O¹ïªv¯kµh©M«å¡C
¡C¡C¾¨ºÞ¦³«Ý§ó¦hªº¬ã¨s¡A¥Lªº³ø§i¹ï¾ãÅéÀø
ªk¤£µL°Ñ¦Ò»ùÈ¡C
¥Ö½§¯f
1993¦~Ĭ«X´£¥X¤@¶µªvÀø26¦W¥Ö½§¯f±w
ªºªì¨B¬ã¨s³ø§i¡C±wªÌ¦³¤@ºØ©Î¦hºØ¥Ö½§¯f¡A
¥]¬A±aª¬ªw¯l(herpes zoster)¡B³æ¯Âªw¯l(herpes
simplex)¡BÀã¯l¡B¥Í´Þ¾¹ªw¯l¡BÁw¥Ö¯f(pyoderma)
µ¥¡A¦@13ºØ¡C®Ú¾Ú¯gª¬µ¹¤©¤£¦P¾¯¶qªº¯ä®ñ¦Û
¦åÀøªk¡C¶Ç²ÎÃľ¯¤]¬I¥Î©ó19¦W±wªÌ¡C±aª¬ªw
¯lÀø®Ä³Ì¦n¡A80%ªº±wªÌ¯gª¬®ø¥¢¹F¤»Ó¤ë¡A
20%±wªÌ¹F¤TÓ¤ë¡C26¦W³£¦³Áw¥Ö¯f¡A25¦W¤£
¬O¯gª¬®ø¥¢(19¦W¤w¹F¤»Ó¤ë)´N¬OÅãµÛ§ïµ½¡C
16¦WÀã¯l±wªÌ¤£¬O²¬Â¡´N¬O©úÅã§ïµ½¡A¦³50%
²¬Â¡¹F¤»Ó¤ë¡C¬ã¨sûµ²½×»¡¹D¡G"ªì¨B¬ã¨sÃÒ
¹ê¯ä®ñÀøªkªºÀø®Ä©M¦w¥þ¹ïªvÀø©Ê¯f¡E¥Ö½§¯f
(dermatovenereology)¦³¥¿±®ÄªG¡C"
»´ä¸}
¥j¤Ú¶i¦æ¤@¶µ»´ä¸}ªvÀø¹êÅç¡C50¦W±w
ªÌ©ó±w³¡¨C¤Ñ¶î©Ù¤T¦¸§t¯ä®ñ¤§¸ªªáªo¡A¥t50
¦W«h¨Ï¥Î¶Ç²Î§ÜÅ𾯡C¨Ï¥Î¯ä®ñªº¤@²Õ¡A96%
ªº±wªÌ¦b10-15¤Ñ¤º±w³¡§¹¥þ²M°£¡A¨Ï¥Î¶Ç²ÎÃÄ
¾¯ªº¤@²Õ¥u¦³20%±wªÌ¦b15¤Ñ«á²¬Â¡¡C
³æ¯Âªw¯l
¤Ú¦è¤Õ©Ô¼wÂå¥Í(Dr. Heinz Konrad)¥H¯ä®ñ
ªvÀø28¦W¦UºØ³æ¯Âªw¯l±wªÌ¡A20¦W¥Í´Þ¾¹ªw
¯l¡A4¦W¥Ö½§ªw¯l¡A2¦W®B³¡ªw¯l¡A2¦W²´³¡
ªw¯l¡C±wªÌ¨C¶g¨â¦¸ªº9 mg¯ä®ñ¦Û¦åÀøªk¡C¤j
³¡¤À±µ¨ü6Àø¦¸¡A¦³¤@¨Ç±µ¨ü8-9Àø¦¸¡AªvÀø«á
°lÂÜÆ[¹î¨â¦~¥b¡C85%ªº¥Í´Þ¾¹ªw¯l±wªÌ"µ´¹ï
²¬Â¡"¡A15%±wªÌ³¡¥÷§ïµ½¡C©Ò¦³¥Ö½§ªw¯l±wªÌ
¥þ³¡±d´_¡A®B³¡¤Î²´³¡±wªÌ¦U¦³¤@¥b²¬Â¡¡C
¸q¤j§Q°¨¹F¦è(Dr. R. mattassi)Âå¥Í¥ÎÀR¯ß
ª`®g®ñ»P¯ä®ñ²V¦X¾¯ªvÀø27¦Wªw¯l±wªÌ¡A©Ò¦³
±wªÌ¦bª`®g1-5¦¸«á§¹¥þ´_ì¡A¥u¦³¤T¦W¦b¤¦~
¤º´_µo¡CµL°Æ§@¥Îµo¥Í¡C
±aª¬ªw¯l
°¨¹F¦è©M¥Lªº¦P¹±ªvÀø30¦W±aª¬ªw¯l±w
ªÌ(herpes zoster/shingles)¡C¡C¡C±wªÌ¨C¤ÑÀR¯ßª`
®g®ñ©M¯ä®ñ²V¦X¾¯¡A©Ò¦³±wªÌ¦b5-12Àø¦¸«á¡A
¥Ö½§¯gª¬§¹¥þ®ø¥¢¡C¡C¡C
¥j¤Ú¤@¶µÁ{§É¬ã¨s¡A¨C¤é¥Î§t¯ä®ñ¸ªªáªo
©MÀR¯ßª`®gªvÀø15¦W¦¨¤Hªw¯l±wªÌ¡A©Ò¦³±wªÌ
¦b¤TÀø¦¸«á«K¦³©úÅã§ïµ½¡A¤Q¤¤ÑÀøµ{µ²§ô«á
¡A©Ò¦³ªº±wªÌ¯gª¬§¹¥þ®ø¥¢¡A°lÂÜÆ[¹î¤@¦~¡A
¨S¦³´_µoªÌ¡C¬ã¨sûµ²½×¹D¡G"¥Î¯ä®ñªvÀøªw¯l
»·³Ó©ó¶Ç²ÎÀøªk¡A¶O¥Î§C·G¡A¾Þ§@®e©ö¡C¡C¡C
¬Ð
¬Ð¬O±`¨£ªº¯f¬r¤Þ°_ªº¥Ö½§¯f¡AÂå¥Í¹ïªv
ªº¤èªk¤£¥~¤Á°£¡A¿Nª¥©ÎÃĪ«ªvÀø¡C¤G®ñ¤Æ²B
¬O¤Ö¬°¤Hª¾ªºÀø¤è¡A¥¦¯àµLµh¦a®Úªv¸~¬Ð¡C¼w
°êÂå¥Í¼¯¨º§J(Dr. M. Manok)»¡©ú30%¯Â«×¤G
®ñ¤Æ²Bªv¬Ðªº¤èªk¡G
ªvÀøªÌ»Ýn¤@§â¾U§Q¤p¤M±N¬Ðªí±
¹º¶}¡A¤£n¹º¨ì¸~¬Ð®Ú³¡(·|¤Þ°_¥X
¦å)¡A¦b¶}¤f³BÂI¤@ºw30%Âù®ñ¤ô¡A
¥ô¨ä¦Û°®¡C¨â¡B¤T¤Ñ«á¡A¨í¥h°®¼h
¡A¦AÂI¤J¤G®ñ¤Æ²B¡C®É¶¡ªøµu¨Ì¸~
¬Ð¤j¤p¦Ó©w¡A¤@¯ën4-5Àø¦¸¡C¤p«ó
¥¬Ð¤j¦h¸g¨âÀø¦¸«K¥i®ø¥¢µL²ª¡C
ȱo¤@´£ªº¬O¤@¯ëÀøªkÃøªvªº¸}´x
¬Ð(plantar wart)¡A¥i¥Î¤G®ñ¤Æ²B¦¨¥\
ªv²z¡A³q±`¦b¬Iªv¤@¡B¨â¦¸«á«K¥i
¤îµh¡A¥i¥H¦æ¨«¡C
³D«r
¤@²Õ¹êÅ繫³Qª`¥H²´Ãè³D¬r²G¡A¥t¤@²Õ¨¬
ª`¤J§t¯ä®ñ¬r³D²G¡A²Ä¤@²Õ§Y®É¦º¤`¡A²Ä¤G²Õ
«hµL¤¤¬r¸ñ¶H¡C
¤@°¦ª¯¨¬³¡³QÅT§À³D«r¶Ë¡A°£¤FÀR¯ßª`®g
¨â¦¸¯ä®ñ©M®ñ®ð¤§¥~¡A¶Ë¤f¶g³ò¤]ª`®g¦P¼Ëªº
²V¦X¾¯¡C¤T¤Q¤»¤p®É¤º¡A§¹¥þ´_ì¡AÆ[¹î¥b¦~
¡A»L³¡¤Î²O¤Úµ²µL·P¬V¸ñ¶H¡C
ÀR¯ß¦±±i¼ìºÅ
¥Dn¬°¿}§¿¯f±wªÌ¥|ªÏ©Òªøªº½HºÅ¡AÃø¥H
ªv¡¡C¥j¤Ú¬ã¨sûÃhºÃ¨ã¦³®ø¬r¥\¯àªº¯ä®ñ¬O
§_¯à½HºÅ±wªÌªº²Õ´¦A¥Í¡C120¦W±wªÌ°Ñ»P¤@
¶µªvÀø¹êÅç¡A60¦W¨Ï¥Î§t¯ä®ñ¸ªªáªo¡A¥t60
¦W¨Ï¥Î¶Ç²Î¥~¼ÅÃÄ¡A²Ä¤@²Õ¦b15-30¤Ñ¤º²¬Â¡¡A
¨Ï¥Î¶Ç²ÎÂåÀøªÌ¥§¡53¤Ñ¤~²¬Â¡¡A¬Æ¦Ü¦³¤@¨Ç
¦b¬ã¨sµ²§ô(155¤Ñ)®É©|¥¼²¬Â¡¡C°£¤F¯ä®ñªºÀø
®Ä¡A¨Ï¥ÎªÌ¤£»Ý¦í°|¡C
Àø¶Ë
¬ã¨sûµo²{¤G®ñ¤Æ²B°Ê¯ßª`®g¤£¶È¥[³t¶Ë
¤f´_ì¡A¥B¹ï¿ç®g³¡¦ìªº¤ÏÀ³§ó§Ö¡A¡C¡C
Otto Warburg, The Prime Cause and
Prevention of Cancer (Wurzburg: K. Triltsch,
1966).
Natalie Angier, "The Price We Pay for
Breathing," The New York Times Magazine,
April 25, 1993, p. 64.
Marie Theres jacobs, ¡BAdverse Effects and
typical Complications in Ozone-Oxygen
Therpy," Ozonachrichten 1 (1982): pp. 193-
201.
Frank Shalenberger, "Intravenous Ozone
Therapy in HIV Realted Disease," Proceedings:
Fourth International Bio-Oxidative Medical
Conference, April 1993.
Sara Shannon, Good Health in a Toxic World:
The Complete Guide to Fighting Free Radicals
(New York: Waener Books, 1994).
¥Ö½§¥X²{¸`¦h¶qðK¡A©Îªv¡«á¤S¥X²{¡C
«¶Ë¤Þ°_°©°h¤Æ
Siegfried riling and Renate Viebahn, The Use
of Ozone in Medicine (Heidelberg: Haug
Publishers, 1987), p. 48.
R. T. Canoso et al., "Hydrogen Peroxide and
Platelet Function," Blood 43, no. 5 (May 1974).
C. H. Farr, "The Therapeutic use of Hydrogen
Peroxide," Townsend Letter for Doctors, July
1987, p. 185.
¦p¯«¸g¶Ç¾É©Î¦Ù¦×¿³¾Ä«á¤§«ì´_¡C
N. I. Zhulina et al., "Ozonotherapy Efficiency
in the Treatment of Patients with
Atherosclerosis of Coronary and Cerebral
Vessels," Ozone in Medicine: Proceedings of
the Eleventh Ozone World Congress (Stamford,
Conn.: International Ozone Association, Pan
American Committee, 1993): M-2: 9-11.
A. Romero et al., "La ozonoterapia en la
aterosclerosis obliterante," Revista CENIC
Ciencias Biologicas 20, no. 1-2-3: 70-76.
B. A. Korolyov et al., "Ozone Application by
Cardiosurgical Patients in Correction of Heart
Defects, Complicated by Infectious
Endocarditis," Ozone in Biology and Medicine
(Nizhny Novgorod: Ministry of Public Health of
Russia Federation, 1992), p. 88.
J. W. Finney et al., "Removal of Cholesterol
and Other Lipids from Experimental Animal
and Human Atheromatous Arteries by Dilute
Hydrogen Peroxide," Proceedings: Third
International Symposium on Hyperbaric
Medicine (1965).
F. Hernqndez et al., "Effect of Endovenous
Ozone Therapy on Lipid Pattern and
Antioxidative Response of Ischemia
Cardiopathy Patients," Ozone in Medicine:
Proceedings of He Eleventh Ozone World
Congress (1993): M-2-12-19.
H. C. Urschel, Jr., "Cardiovascular Effects of
Hydrogen Peroxide," Diseases of the Chest 51
(February 1967): 187-88.
J. W. Finney et al., "Protection of the Ischemic
Myocardium with DMSO Alone or in
Combination with Hydrogen Peroxide," Annals
New York Academy of Sciences (1967).
S. P. Peretyagin, "Mechanisms of Ozone
Medicinal Effect in Case of Hypoxy," Ozone in
Biology and Medicine (Nizhny Novgorod:
Ministry of Public health of Russia Federation,
1992), 76.
E. Devesa et al., "Ozone Therapy in Ischemic
Cerebro-Vascular Disease," Ozone in Medicine:
Proceedings of the Eleventh Ozone World
Congress (1993): M-4-10-18.
Otto Warburg, The Prime Cause and
Prevention of Cancer (Wurzburg: K Tritsch,
1966).
James D. Watson, Molecular Biology of the
Gene (New York: W. A. Benjamin, 1965), p.
469.
J. Varro, "Die krebsbehandlung mit ozon,"
Erfahrungsheikunde 23 1974): 178-81.
F. Sweet et al., "Ozone Selectively Inhibits
Growth of Cancer Cells," Science 209 (August
22, 1980): 931-32.
J. T. Mallams et al., "The Use of Hydrogen
Peroxide as a Source of Oxygen in a Regional
Intra-Arterial Infusion System," Southern
Medical Journal (march 1962).
B. L. Aronoff et al., "Regional Oxygenation in
Neoplasms," Cancer, 18 (October 1965): 1250.
H. Sasaki et al., "Application of Hydrogen
peroxide to Maxillary Cancer," Yonago Acta
Medica 11, no. 3 (1967): 149.
C. F. Nathan, and Z. A. Cohn, "Antitumor
Effects of Hydrogen Peroxide in Vivo," Journal
of Experimental Medicine 149 (January 1979):
109.
M. Arnan and L. E. DeVries, "Effect of
Ozone/Oxygen Gas Mixture Directly Injected
into the Mammary Carcinoma of the Female
C3H/HEJ Mice," in Medical Applications of
Ozone, edited by Julius laRaus (Norwalk,
Conn.: International Ozone Association Pan
American Committee, 1983): 101-7.
L. Paulesu et al., "Studies on the Biological
Effects of Ozone: 2. Induction of Tumor
Necrosis Factor on Human Leucocytes,"
Lymphokine and Cytokine Research 10 no. 5
(1991): 409-12.
F. Sweet et al., "Ozone Selectively Inhibits
Growth of Cancer Cells," Science 209 (August
22, 1980): 931-32.
Kurt W. Donsbach, and H. . Alsleben,
Wholistic Cancer Therapy (Tulsa: Rockland
Corporation, 1992), p. 49.
Kurt W. Donsbach, Oxygen-Peroxide-Ozone,
p. 66.
Letter from Dr. Kurt W. Donsbach, December
30, 1993.
Siegfried Rilling and Renate Viebahn, The Use
of Ozone in Medicine (Heidelberg: Haug
Publishers, 1987), pp. 41-44.
ĶªÌ«ö¡G³o¥i¯à¬O¬°¤F´î¤Ö³Â·Ð¦Ó»¡µ¹¬ü°ê
ÃĪ«ºÞ²z§½©M¤Ï¹ï¦¹ºØÀøªkªº¤HÅ¥ªº¡C
M. T. Carpendale and J. K. Freeberg, "Ozone
inactivates HIV at Non-Cytotoxic
Concentrations," Antiviral Research 16 (1991):
281-92.
K. H. Wells et al., "Inactivation of Human
Immunodeficiency Virus Type I by Ozone In
Vitro," Blood 78 no. 7 (October 1, 1991): 1882.
G. V. Kornilaeva et al., "Ozone Influence of
HIV Infection in Vitro," Ozone in Biology and
Medicine (Nizhny Novgorod: Ministry of
Public Health of Russia Federation, 1992): 86.
A. C. Baggs, "Are Worry-Free Transfusions
Just a a Whiff of Ozone Away?" Canadian
Medical Association Journal (April 1, 1993):
1159.
Horst Kief, "Die Biologischen Grundlagen der
Autohomologen Immunotherapie,"
Erfahrungsheilkunde 37, no. 7 (July 1988):
175-80.
Horst Kief, interview in Ozone and the Politics
of Medicine (Vancouver: Threshold Film,
1993).
Alexander Pruess, "Positive Treatment Results
in AIDS Therapy," OzoNachrichten 5 (1986):
3-5.
Horst Kief, Ozone and the Auto-homologous
Immune Therapy in AIDS Patients, monograph
(Ludwigshafen: Kief Clinic, 1993).
M. T. Carpendale and J. Griffins, "Is there a
Role for Medical Ozone in the Treatment of
HIV and Associated Infections?" in Ozone in
Medicine: Proceedings of the Eleventh Ozone
World Congress (Stamford, Conn.:
International Ozone Association, Pan American
Committee, 1993): M-1-38-43.
M. T. Carpendale et al., "Does Ozone Alleviate
AIDS Diarrhea?" Journal of Clinical
Gastroenterology 17 (1993): 142-45.
"A Special Report from Keep Hope Alive, no.
4, December 13, 1993, p. 2.
¥Xª©ªÌ¡GKeep Hope Alive, P.O.Box 27041,
West Allis, WI 53227.
R. A. mayer, "Experimences of a Pediatrician
Using Ozone as a Chemotherapeutic Agent fro
the Treatment of Diseases of Children,"in
Medical Applications of Ozone, edited by Julius
LaRaus (Norwalk, Conn.: International Ozone
Association, Pan American Committee, 1983):
210.
J. O. Sardina et al., "ratamiento de la giardiasis
recidivante con ozono," Revista CENIC
Ciencias Biologicas 20, no. 1-2-3; 61-64.
T. S. Kachalina et al., "Some Aspects of Ozone
therapy Application in Gynecological Practice,"
in Ozone in Biology and Medicine (Nizhny
Novgorod: Ministry of Public Health of Russia
Federation, 1992): 90.
H. Konrad, "Ozone vs. Hepatitis and Herpes,"
in Medical Applicatioins of Ozone, edited by
Julius LaRaus (Norwalk, Conn., International
Ozone Association, Pan American Committee,
1983): 140-41.
J. Wennstrom, and J. Lindhe, "Effect of
Hydrogen Peroxide on Developing Plaque and
Gingivitis in Man," Journal of Clinical
Periodontology 6 (1979): 456-59.
M. Rodriguez et al., "Ozone Therapy for Senile
Dementia," in Ozone in Medicine: Proceedings
of the Eleventh Ozone World Congress
(Stamford, Conn.: International Ozoine
Association, Pan American Committee, 1993):
M-4-19-25.
H. Calvo et al., "Experiencias preliminares en
la utilizacion del ozono en pacientes de terapia
intensiva del hospital 'Carlos J. Finlay'," Revista
CENIC Ciencias Biologicas 20, no. 1-2-3: 128-
35.
¤@ºØºC©Ê¿ò¶Ç©Ê·»¦å©Ê¯e¯f¡A¥Ñ©ó¯Ê®ñ¡A¬õ
¦å²y§eÅI¤Mª¬¡A¨ä¯S¼x¬°Ãö¸`µh¡B«æ©Ê¸¡µh
¡B¤UªÏ¼ìºÅ¤ÎÅI¤Mª¬¦å²y¡C
S. L. Krivatkin, "The Experience of Ozone
Therapy in Dermato-venereological
Dispensary," Ozone in Medicine: Proceedings
of the Eleventh Ozone World Congress
(1993):M-3-5-11.
M. Manok, "On a Simple and Painless
Treatment of Warts," Hautarzt 12 (September
1961): 425.
1
|